Quarterlytics / Basic Materials / Chemicals - Specialty / Kronos Worldwide, Inc. / FY2024 Annual Report

Kronos Worldwide, Inc.
Annual Report 2024

KRO · NYSE Basic Materials
Claim this profile
Ticker KRO
Exchange NYSE
Sector Basic Materials
Industry Chemicals - Specialty
Employees 2524
← All annual reports
FY2024 Annual Report · Kronos Worldwide, Inc.
Loading PDF…
Kronos Worldwide, Inc. 
2024
ANNUAL REPORT 

KRONOS WORLDWIDE, INC. CORPORATE AND OTHER INFORMATION 
Board of Directors 
Loretta J. Feehan  
Chair of the Board (non-executive) 
Financial Consultant 
Michael S. Simmons 
Vice Chairman of the Board
James M. Buch 
President and Chief Executive Officer 
Corporate and 
Operating Management 
Michael S. Simmons 
Vice Chairman of the Board
James M. Buch  
President and Chief Executive Officer 
Rainer M. Gruber 
Executive Vice President, 
Chief Manufacturing and Technology Officer
Tim C. Hafer  
Executive Vice President and  
Chief Financial Officer 
Kristin B. McCoy  
Executive Vice President, Global Tax 
Andrew B. Nace 
Executive Vice President 
Courtney J. Riley  
Executive Vice President,
Chief Transformation Officer 
Amy A. Samford 
Executive Vice President 
John A. Sunny  
Executive Vice President and 
Chief Information Officer 
William E. Miller
Vice President, 
Global Human Resources 
Bart W. Reichert 
Vice President, Internal Audit 
Alexis A. Thomason 
Vice President, General Counsel 
and Assistant Secretary
Product Information 
Information about our products and services is 
available online or by contacting:  
Kronos Worldwide, Inc.  
Three Lincoln Centre  
5430 LBJ Freeway, Suite 1700  
Dallas, Texas 75240-2620  
Phone: (972) 233-1700  
Customer Service: 1-800-866-5600.  
Email: kronos.marketing@kronosww.com 
Transfer Agent 
Computershare acts as transfer agent, 
registrar and dividend paying agent for the 
Company’s common stock.  
Communications regarding stockholder 
accounts, dividends and change of address 
should be directed to:  
Computershare Trust Company, N.A.  
P.O. Box 43006  
Providence, Rhode Island 02940-3006  
Telephone: (877) 373-6374  
http://www.computershare.com/investor  
Visit us on the Web 
http://www.kronosww.com 
Form 10-K Report 
The Company’s Annual Report on Form 10-K 
for the year ended December 31, 2024, as 
filed with the Securities and Exchange 
Commission is printed as part of this Annual 
Report. Additional copies are available without 
charge upon written request to:  
Bryan A. Hanley 
Investor Relations  
Kronos Worldwide, Inc.  
Three Lincoln Centre  
5430 LBJ Freeway, Suite 1700 
Dallas, Texas 75240-2620  
Brian W. Christian 
Executive Vice President and 
Chief Operating Officer
Benjamin R. Corona  
President, Americas
Dennis Werner
President, EMEAA
John E. Harper (a)(b) 
Private Investor 
Kevin B. Kramer (a) 
Senior Advisor
ATI Inc.
Meredith W. Mendes (a)  
Chief Financial Officer
Pierson Ferdinand LLP
Cecil H. Moore, Jr. (a)(b)  
Retired Partner 
KPMG LLP 
Dr. R. Gerald Turner (a)(b) 
President 
Southern Methodist University 
Board Committees 
(a)
Audit Committee
(b)
Management Development and
Compensation Committee
Annual Meeting 
The 2025 Annual Meeting of Stockholders will 
be held at the Conference Center at Three 
Lincoln Centre, 5430 LBJ Freeway, Suite 350, 
Dallas, Texas 75240-2620, on the date and 
time as set forth in the notice of the meeting, 
proxy statement and form of proxy that will be 
furnished to stockholders in advance of the 
meeting.  
Stock Exchange 
Kronos’ common shares are listed on the New 
York Stock Exchange under the symbol 
“KRO.”  
Ulrich F. Kabelac
Vice President and Controller, 
Global Operations 
Bryan A. Hanley  
Senior Vice President and Treasurer 
Bryan S. Bell
Vice President and Controller, 
Global Finance

 
 
UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION 
Washington, D.C. 20549 
 
FORM 10-K 
 
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF 
THE SECURITIES EXCHANGE ACT OF 1934 
For the fiscal year ended December 31, 2024 
OR 
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) 
OF THE SECURITIES EXCHANGE ACT OF 1934 
For the transition period from          to 
Commission file number 1-31763 
KRONOS WORLDWIDE, INC. 
(Exact name of Registrant as specified in its charter) 
 
 
 
 
 
DELAWARE 
    
76-0294959 
(State or other jurisdiction 
of incorporation or organization) 
  
(IRS Employer 
Identification No.) 
 
5430 LBJ Freeway, Suite 1700 
Dallas, Texas 75240-2620 
(Address of principal executive offices) 
Registrant’s telephone number, including area code: (972) 233-1700 
Securities registered pursuant to Section 12(b) of the Act: 
 
 
 
 
 
 
Title of each class 
     
Trading Symbol(s) 
     
Name of each exchange on which registered 
Common stock 
 
KRO 
 
NYSE 
 
No securities are registered pursuant to Section 12(g) of the Act. 
Indicate by check mark: 
If the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.   Yes  ☐    No  ☒ 
If the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.   Yes  ☐    No  ☒ 
Whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months 
and (2) has been subject to such filing requirements for the past 90 days.   Yes  ☒     No  ☐ 
Whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the 
preceding 12 months (or for such shorter period that the Registrant was required to submit such files).   Yes  ☒    No  ☐ 
Whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the 
definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. 
 
 
 
 
 
Large accelerated filer           
☐ 
Accelerated filer 
☒
Non-accelerated filer  
☐ 
Smaller reporting company 
☐
Emerging growth company   
☐ 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised 
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ 
Whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under 
Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.☒ 
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing 
reflect the correction of an error to previously issued financial statements.  ☐ 
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any 
of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐ 
Whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).   Yes  ☐    No  ☒ 
The aggregate market value of the 21.7 million shares of voting stock held by nonaffiliates of Kronos Worldwide, Inc. as of June 30, 2024 (the last business day of 
the Registrant’s most recently-completed second fiscal quarter) approximated $272.2 million. 
Number of shares of the registrant’s common stock, $.01 par value per share, outstanding on February 28, 2025:   115,036,016. 
Documents incorporated by reference 
The information required by Part III is incorporated by reference from the Registrant’s definitive proxy statement to be filed with the Commission 
pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this report. 
 

 
2 
Forward-Looking Information 
This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private 
Securities Litigation Reform Act of 1995, as amended. Statements in this Annual Report that are not historical facts are 
forward-looking in nature and represent management’s beliefs and assumptions based on currently available information. 
In some cases, you can identify forward-looking statements by the use of words such as “believes,” “intends,” “may,” 
“should,” “could,” “anticipates,” “expects” or comparable terminology, or by discussions of strategies or trends. Although 
we believe the expectations reflected in such forward-looking statements are reasonable, we do not know if these 
expectations will be correct. Such statements by their nature involve substantial risks and uncertainties that could 
significantly impact expected results. Actual future results could differ materially from those predicted. The factors that 
could cause our actual future results to differ materially from those described herein are the risks and uncertainties 
discussed in this Annual Report and those described from time to time in our other filings with the SEC and include, but 
are not limited to, the following: 
• 
Future supply and demand for our products 
• 
Our ability to realize expected cost savings from strategic and operational initiatives 
• 
Our ability to integrate acquisitions, including Louisiana Pigment Company, L.P., into our operations and 
realize expected synergies and innovations 
• 
The extent of the dependence of certain of our businesses on certain market sectors 
• 
The cyclicality of our business 
• 
Customer and producer inventory levels 
• 
Unexpected or earlier-than-expected industry capacity expansion 
• 
Changes in raw material and other operating costs (such as energy and ore costs) 
• 
Changes in the availability of raw materials (such as ore) 
• 
General global economic and political conditions that harm the worldwide economy, disrupt our supply 
chain, increase material and energy costs or reduce demand or perceived demand for our titanium dioxide 
pigments (“TiO2”) products or impair our ability to operate our facilities (including changes in the level of 
gross domestic product in various regions of the world, tariffs, natural disasters, terrorist acts, global conflicts 
and public health crises) 
• 
Operating interruptions (including, but not limited to, labor disputes, leaks, natural disasters, fires, 
explosions, unscheduled or unplanned downtime, transportation interruptions, certain regional and world 
events or economic conditions and public health crises) 
• 
Technology related disruptions (including, but not limited to, cyber-attacks; software implementation, 
upgrades or improvements; technology processing failures; or other events) related to our technology 
infrastructure that could impact our ability to continue operations, or at key vendors which could impact our 
supply chain, or at key customers which could impact their operations and cause them to curtail or pause 
orders 
• 
Competitive products and substitute products 
• 
Competition from Chinese suppliers with less stringent regulatory and environmental compliance 
requirements 
• 
Customer and competitor strategies 
• 
Potential consolidation of our competitors 
• 
Potential consolidation of our customers 
• 
The impact of pricing and production decisions 

 
3 
• 
Competitive technology positions 
• 
Potential difficulties in upgrading or implementing accounting and manufacturing software systems 
• 
The introduction of new, or changes in existing, tariffs, trade barriers or trade disputes (including tariffs 
imposed by the U.S. federal government on imports from Canada, where we have a manufacturing facility) 
• 
Fluctuations in currency exchange rates (such as changes in the exchange rate between the U.S. dollar and 
each of the euro, the Norwegian krone and the Canadian dollar and between the euro and the Norwegian 
krone), or possible disruptions to our business resulting from uncertainties associated with the euro or other 
currencies 
• 
Our ability to renew or refinance credit facilities or other debt instruments in the future 
• 
Changes in interest rates 
• 
Our ability to comply with covenants contained in our revolving bank credit facility 
• 
Our ability to maintain sufficient liquidity 
• 
The ultimate outcome of income tax audits, tax settlement initiatives or other tax matters, including future 
tax reform 
• 
Our ability to utilize income tax attributes, the benefits of which may or may not have been recognized under 
the more-likely-than-not recognition criteria 
• 
Environmental matters (such as those requiring compliance with emission and discharge standards for 
existing and new facilities) 
• 
Government laws and regulations and possible changes therein including new environmental, sustainability, 
health and safety, or other regulations (such as those seeking to limit or classify TiO2 or its use), and  
• 
Pending or possible future litigation or other actions. 
Should one or more of these risks materialize (or the consequences of such a development worsen), or should the 
underlying assumptions prove incorrect, actual results could differ materially from those forecasted or expected. We 
disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of changes in 
information, future events or otherwise. 
 
 

 
4 
PART I 
ITEM 1. 
BUSINESS 
General 
Kronos Worldwide, Inc. (NYSE: KRO) (“Kronos”), incorporated in Delaware in 1989, is a leading global 
producer and marketer of value-added titanium dioxide pigments, or TiO2, a base industrial product used in a wide range 
of applications. We, along with our distributors and agents, sell and provide technical services for our products to 
approximately 3,000 customers in 100 countries with the majority of our sales in Europe, North America and the Asia 
Pacific region. We believe we have developed considerable expertise and efficiency in the manufacture, sale, shipment 
and service of our products in domestic and international markets. Effective July 16, 2024 (“Acquisition Date”), we 
acquired the 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”) held by Venator Investments, Ltd. 
(“Venator”) for consideration of $185 million less a working capital adjustment. Prior to the acquisition, we held a 50% 
joint venture interest in LPC through a wholly-owned subsidiary. LPC was operated as a manufacturing joint venture 
between us and Venator. Following the acquisition, LPC became a wholly-owned subsidiary of ours. See Note 5 to our 
Consolidated Financial Statements. 
TiO2 is a white inorganic pigment used in a wide range of products for its exceptional durability and its ability to 
impart whiteness, brightness and opacity. TiO2 is a critical component of everyday applications, such as coatings, plastics 
and paper, as well as many specialty products such as inks, cosmetics and pharmaceuticals. TiO2 is widely considered to 
be superior to alternative white pigments in large part due to its hiding power (or opacity), which is the ability to cover or 
mask other materials effectively and efficiently. TiO2 is designed, marketed and sold based on specific end-use 
applications. 
TiO2 is the largest commercially used whitening pigment because it has a high refractive rating, giving it more 
hiding power than any other commercially produced white pigment. In addition, TiO2 has excellent resistance to interaction 
with other chemicals, good thermal stability and resistance to ultraviolet degradation. Although there are other white 
pigments on the market, we believe there are no effective substitutes for TiO2 because no other white pigment has the 
physical properties for achieving comparable opacity and brightness or can be incorporated in as cost-effective a manner. 
Pigment extenders such as kaolin clays, calcium carbonate and polymeric opacifiers are used together with TiO2 in a 
number of end-use markets. However, these products are not able to duplicate the opacity performance characteristics of 
TiO2 and we believe these products are unlikely to have a significant impact on the use of TiO2. 
TiO2 is considered a “quality-of-life” product. Demand for TiO2 has generally been driven by worldwide gross 
domestic product and has generally increased with rising standards of living in various regions of the world. According to 
industry estimates, TiO2 consumption has grown at a compound annual growth rate of approximately 3% since 2000. Per 
capita consumption of TiO2 in Western Europe and North America far exceeds that in other areas of the world, and these 
regions are expected to continue to be the largest consumers of TiO2 on a per capita basis for the foreseeable future. We 
believe Western Europe and North America each account for approximately 15% of global TiO2 consumption, 
respectively. Markets for TiO2 are generally increasing in China, the Asia Pacific region, South America and Eastern 
Europe and we believe these are significant markets which will continue to grow as economies in these regions develop 
and quality-of-life products, including TiO2, experience greater demand. 
At December 31, 2024, approximately 50% of our common stock was owned by Valhi, Inc. (NYSE: VHI) and 
approximately 31% was owned by a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL). Valhi also owns 
approximately 83% of NL Industries’ outstanding common stock. A wholly-owned subsidiary of Contran Corporation 
held approximately 91% of Valhi’s outstanding common stock. As discussed in Note 1 to our Consolidated Financial 
Statements, Lisa K. Simmons and a trust established for the benefit of Ms. Simmons and her late sister and their children 
(the “Family Trust”) may be deemed to control Contran, and therefore may be deemed to indirectly control the 
wholly-owned subsidiary of Contran, Valhi, NL and us. 

 
5 
Products and end-use markets 
Including our predecessors, we have produced and marketed TiO2 in North America and Europe, our primary 
markets, for over 100 years. We believe we are the largest chloride process TiO2 producer in Europe with 44% of our 2024 
sales volumes attributable to markets in Europe. The table below shows our estimated market share for our significant 
markets, Europe and North America, for the last three years. 
 
 
 
 
 
 
 
 
     
2022 
 
2023 
 
2024 
Europe 
 
14%  
12%  
14% 
North America 
 
17%  
16%  
17% 
We believe we are the leading seller of TiO2 in several countries, including Germany. Overall, we are one of the 
top five producers of TiO2 in the world. 
We offer our customers a broad portfolio of products that include over 50 different TiO2 pigment grades under 
the KRONOS® trademark, which provide a variety of performance properties to meet customers’ specific requirements. 
Our major customers include domestic and international paint, plastics, decorative laminate and paper manufacturers. We 
ship TiO2 to our customers in either a dry or slurry form via rail, truck and/or ocean carrier. Sales of our core TiO2 pigments 
represented approximately 90% of our net sales in 2024. We and our agents and distributors primarily sell our products in 
three major end-use markets: coatings, plastics and paper. 
The following tables show our approximate TiO2 sales volume by geographic region and end-use for the year 
ended December 31, 2024: 
 
 
 
 
 
 
 
Sales volume percentages  
 
Sales volume percentages  
by geographic region 
     
by end-use 
Europe 
     
44% 
 
Coatings 
 
60% 
North America 
 
40% 
 
Plastics 
 
27% 
Asia Pacific 
  
9%  
Paper 
  
9% 
Rest of World 
  
7%  
Other 
  
4% 
 
Some of the principal applications for our products include the following: 
TiO2 for coatings – Our TiO2 is used to provide opacity, durability, tinting strength and brightness in industrial 
coatings, as well as coatings for commercial and residential interiors and exteriors, automobiles, aircraft, machines, 
appliances, traffic paint and other special purpose coatings. The amount of TiO2 used in coatings varies widely depending 
on the opacity, color and quality desired. In general, the higher the opacity requirement of the coating, the greater the TiO2 
content. 
TiO2 for plastics – We produce TiO2 pigments that improve the optical and physical properties of plastics, 
including whiteness and opacity. TiO2 is used to provide opacity to items such as containers and packaging materials, and 
vinyl products such as windows, door profiles and siding. TiO2 also generally provides hiding power, neutral undertone, 
brightness and surface durability for housewares, appliances, toys, computer cases and food packages. TiO2’s high 
brightness along with its opacity, is used in some engineering plastics to help mask their undesirable natural color. TiO2 is 
also used in masterbatch, which is a concentrate of TiO2 and other additives and is one of the largest uses for TiO2 in the 
plastics end-use market. In masterbatch, the TiO2 is dispersed at high concentrations into a plastic resin and is then used 
by manufacturers of plastic containers, bottles, packaging and agricultural films. 
TiO2 for paper – Our TiO2 is used in the production of several types of paper, including laminate (decorative) 
paper, filled paper and coated paper to provide whiteness, brightness, opacity and color stability. Although we sell our 
TiO2 to all segments of the paper end-use market, our primary focus is on the TiO2 grades used in coated board and paper 
laminates, where several layers of paper are laminated together using melamine resin under high temperature and pressure. 
The top layer of paper contains TiO2 and plastic resin and is the layer that is printed with decorative patterns. Paper 
laminates are used to replace materials such as wood and tile for such applications as counter tops, furniture and wallboard. 

 
6 
TiO2 is beneficial in these applications because it assists in preventing the material from fading or changing color after 
prolonged exposure to sunlight and other weathering agents. 
TiO2 for other applications – We produce TiO2 to improve the opacity and hiding power of printing inks. TiO2 
allows inks to achieve very high print quality while not interfering with the technical requirements of printing machinery, 
including low abrasion, high printing speed and high temperatures. Our TiO2 is also used in textile applications where 
TiO2 functions as an opacifying and delustering agent. In man-made fibers such as rayon and polyester, TiO2 corrects an 
otherwise undesirable glossy and translucent appearance. Without the presence of TiO2, these materials would be 
unsuitable for use in many textile applications. 
We produce high-purity sulfate process anatase TiO2 used to provide opacity, whiteness and brightness in a 
variety of cosmetic and personal care products, such as skin cream, lipstick, eye shadow and toothpaste. In 
pharmaceuticals, our TiO2 is used commonly as a colorant in tablet and capsule coatings as well as in liquid medicines to 
provide uniformity of color and appearance. KRONOS® purified anatase grades meet the applicable requirements of the 
CTFA (Cosmetics, Toiletries and Fragrances Association), USP (United States Pharmacopoeia), BP (British 
Pharmacopoeia) and the FDA (United States Food and Drug Administration).  
Our TiO2 business is enhanced by the following three complementary businesses, which comprised 
approximately 10% of our net sales in 2024: 
• 
We own and operate an ilmenite mine in Norway pursuant to a governmental concession with an unlimited 
term. Ilmenite is a raw material used directly as a feedstock by some sulfate-process TiO2 plants. Along with 
supplying ilmenite ore to our sulfate plants in Europe, we also sell ilmenite ore to third parties, some of whom 
are our competitors. The mine has estimated ilmenite reserves that we expect, based on internal estimates, to 
last approximately 50 years. 
• 
We manufacture and sell iron-based chemicals, which are co-products and processed co-products of the 
sulfate and chloride process TiO2 pigment production. These co-product chemicals are marketed through our 
Ecochem division and are primarily used as treatment and conditioning agents for industrial effluents and 
municipal wastewater as well as in the manufacture of iron pigments, cement and agricultural products. 
• 
We manufacture and sell other specialty chemicals, which are side-stream products from the production of 
TiO2. These specialty chemicals are used in applications in the formulation of pearlescent pigments, 
production of electroceramic capacitors for cell phones and other electronic devices and natural gas pipe and 
other specialty applications. 
Manufacturing, operations and properties 
Manufacturing – We produce TiO2 in two crystalline forms: rutile and anatase. Rutile TiO2 is manufactured using 
both a chloride production process and a sulfate production process, whereas anatase TiO2 is only produced using a sulfate 
production process. Manufacturers of many end-use applications can use either form, especially during periods of tight 
supply for TiO2. The chloride process is the preferred form for use in coatings and plastics, the two largest end-use markets. 
Due to environmental factors and customer considerations, the proportion of TiO2 industry sales represented by chloride 
process pigments has remained stable relative to sulfate process pigments, and in 2024, chloride process production 
facilities represented approximately 41% of industry capacity. The sulfate process is preferred for use in selected paper 
products, ceramics, rubber tires, man-made fibers, pharmaceuticals and cosmetics. Once an intermediate TiO2 pigment has 
been produced by either the chloride or sulfate process, it is “finished” into products with specific performance 
characteristics for particular end-use applications through proprietary processes involving various chemical surface 
treatments and intensive micronizing (milling). 
• 
Chloride process – The chloride process is a continuous process in which chlorine is used to extract rutile 
TiO2. The chloride process produces less waste than the sulfate process because much of the chlorine is 
recycled and feedstock bearing higher titanium content is used. The chloride process also has lower energy 
requirements and is less labor-intensive than the sulfate process, although the chloride process requires a 
higher-skilled labor force. The chloride process produces an intermediate base pigment with a wide range of 

 
7 
properties. The chloride process produces a product with a blueish undertone and is the preferred form to 
produce TiO2 pigments for use in coatings and plastics, the two largest end-use markets. 
• 
Sulfate process – The sulfate process is a batch process in which sulfuric acid is used to extract the TiO2 from 
ilmenite or titanium slag. After separation from the impurities in the ore (mainly iron), the TiO2 is precipitated 
and calcined to form an intermediate base pigment ready for sale or can be upgraded through finishing 
treatments. The sulfate process produces a warmer undertone and is preferred for use in selected paper 
products, ceramics, rubber tires, man-made fibers, food products, pharmaceuticals and cosmetics, some of 
which generate higher profit margins. 
LPC – Prior to July 16, 2024, Kronos Louisiana, Inc., one of our subsidiaries, and Venator each owned a 50% 
interest in LPC, which was operated as a manufacturing joint venture. LPC owns and operates a chloride-process TiO2 
plant located near Lake Charles, Louisiana. On July 16, 2024, we acquired the 50% interest in LPC held by Venator for 
consideration of $185 million less a working capital adjustment. 
Prior to the acquisition, we accounted for our interest in the joint venture by the equity method. The joint venture 
operated on a break-even basis, and therefore we did not have any equity in earnings of the joint venture. We were required 
to purchase one-half of the TiO2 produced by the joint venture. All costs and capital expenditures were shared equally with 
Venator, with the exception of feedstock (purchased natural rutile ore or chlorine slag) and packaging costs for the pigment 
grades produced. Our share of net costs was reported as cost of sales as the TiO2 was sold. See Notes 5 and 14 to our 
Consolidated Financial Statements. 
As a result of the acquisition, for financial reporting purposes the assets acquired and liabilities assumed of LPC 
are included in our Consolidated Balance Sheet as of December 31, 2024, and the results of operations and cash flows of 
LPC are included in our Consolidated Statement of Operations and Cash Flows beginning as of the Acquisition Date. See 
Note 5 to our Consolidated Financial Statements. 
Operations – We produced 492,000, 401,000 and 535,000 metric tons of TiO2 in 2022, 2023 and 2024, 
respectively. Our production volumes for 2022, 2023 and 2024 through the Acquisition Date include our share of the 
output produced by our TiO2 manufacturing joint venture. Subsequent to the Acquisition Date, our 2024 production 
volumes include 100% of the production volumes from the LPC facility.  
Our average production capacity utilization rates were approximately 89% in 2022, 72% in 2023 and 96% in 
2024. Beginning in the fourth quarter of 2022 and continuing throughout the first quarter of 2024, we adjusted production 
levels to correspond with reduced customer demand resulting from challenging economic conditions and geopolitical 
uncertainties. We increased production levels to align with higher overall customer demand in 2024.  
Properties – We operate facilities throughout North America and Europe. We have four TiO2 plants in Europe 
(one in each of Leverkusen, Germany; Nordenham, Germany; Langerbrugge, Belgium; and Fredrikstad, Norway). In North 
America, we have a TiO2 plant in Varennes, Quebec, Canada and a TiO2 plant near Lake Charles, Louisiana.  
Our chloride process production and remaining sulfate production capacity has increased by approximately 5% 
over the past ten years due to debottlenecking programs with only moderate capital expenditures.  

 
8 
The following table presents the division of our expected 2025 manufacturing capacity by plant location and type 
of manufacturing process: 
 
 
 
 
 
 
 
 
 
     
    % of capacity by TiO2   
 
  
 manufacturing process  
Facility 
    
Description 
    Chloride  
Sulfate 
  
Leverkusen, Germany (1) 
 TiO2 production, chloride process, co-products 
 
 29 % 
 - %
Nordenham, Germany 
 TiO2 production, sulfate process, co-products 
 
 -  
 10   
Langerbrugge, Belgium 
  
TiO2 production, chloride process, co-products,  
   titanium chemicals products 
  
 15   
 -  
Fredrikstad, Norway (2) 
  TiO2 production, sulfate process, co-products 
  
 -   
 5  
Varennes, Canada (3) 
  
TiO2 production, chloride process, slurry facility,  
    titanium chemicals products 
  
 15   
 -  
Lake Charles, LA, US (4) 
  TiO2 production, chloride process 
  
 26   
 -  
Total 
   
 
 85 % 
 15 %
 
(1) 
The Leverkusen facility is located within a more extensive manufacturing complex. We own our Leverkusen 
facility, which represents approximately 29% of our current TiO2 production capacity, but we lease the land under 
the facility under a long-term agreement which expires in 2050. Lease payments are periodically negotiated for 
periods of at least two years at a time. A third-party operator of the manufacturing complex provides some raw 
materials including chlorine, auxiliary and operating materials, utilities and services necessary to operate the 
Leverkusen facility under separate supplies and services agreements.  
(2) 
The Fredrikstad facility is located on public land and is leased until 2063. 
(3) 
In the third quarter of 2024, we closed our sulfate process line at our plant in Varennes, Canada. See Note 18 to 
our Consolidated Financial Statements. 
(4) 
Effective July 16, 2024, we acquired the 50% interest in LPC we did not already own. See Note 5 to our 
Consolidated Financial Statements.  
We own the land underlying all of our principal production facilities unless otherwise indicated in the table above. 
We also operate an ilmenite mine in Norway pursuant to a governmental concession with an unlimited term. In 
addition, we operate a rutile slurry manufacturing plant near our Lake Charles, Louisiana facility, which converts dry 
pigment primarily manufactured for us at our Lake Charles TiO2 facility into a slurry form that is then shipped to 
customers. 
We have corporate and administrative offices located in the U.S., Germany, Norway, Canada, Belgium and 
France. 
Raw materials 
The primary raw materials used in chloride process TiO2 are titanium-containing feedstock (purchased natural 
rutile ore or chlorine slag), chlorine and petroleum coke. Chlorine is available from a number of suppliers, while petroleum 
coke is available from a limited number of suppliers. Titanium-containing feedstock suitable for use in the chloride process 
is available from a limited but increasing number of suppliers principally in Australia, South Africa, Sierra Leone, Canada 
and India. We purchase feedstock for our chloride process TiO2 from the following primary suppliers for certain 
contractually specified volumes for delivery extending, in some cases, through 2026: 
 
 
 
 
 
Supplier 
    
Product 
    
Renewal Terms  
Rio Tinto Iron and Titanium Ltd. 
 Chloride process grade slag 
 Auto-renews bi-annually 
Rio Tinto Iron and Titanium Ltd. 
 Upgraded slag 
 Auto-renews annually 
Sierra Rutile Limited 
 Rutile ore 
 Renewal terms upon negotiation 
Iluka Resources Limited 
 Rutile ore 
 Renewal terms upon negotiation 

 
9 
In the past we have been, and we expect that we will continue to be, successful in obtaining short-term and 
long-term extensions to these and other existing supply contracts. We expect the raw materials purchased under these 
contracts, and contracts we may enter into, will meet our chloride process feedstock requirements over the next 
several years. Multi-year contracts generally may be terminated with a 12-month written notice or based on certain defaults 
by either party or failure to agree on pricing as noted in the agreements. 
The primary raw materials used in sulfate process TiO2 are titanium-containing feedstock, primarily ilmenite or 
purchased sulfate grade slag and sulfuric acid. Sulfuric acid is available from a number of suppliers. Titanium-containing 
feedstock suitable for use in the sulfate process is available from a limited number of suppliers principally in Norway, 
Canada, Australia, India and South Africa. As one of the few vertically integrated producers of sulfate process TiO2, we 
operate a rock ilmenite mine in Norway, which provided all of the feedstock for our European sulfate process TiO2 plants 
in 2024. We expect ilmenite production from our mine to meet our sulfate process feedstock requirements for the 
foreseeable future. We expect the raw materials purchased under this contract, and contracts that we may enter into, to 
meet our sulfate process feedstock requirements over the next several years. 
Many of our raw material contracts contain fixed quantities we are required to purchase or specify a range of 
quantities within which we are required to purchase. The pricing under these agreements is generally negotiated quarterly 
or semi-annually. 
The following table summarizes our raw materials purchased or mined in 2024. 
 
 
 
 
     
Raw materials  
Production process/raw material 
     
procured or mined 
 
 
(In thousands  
 
 
of metric tons) 
Chloride process plants - 
 
   
Purchased slag or rutile ore 
  
 464 
Sulfate process plants: 
  
Ilmenite ore mined and used internally 
  
 233 
Purchased ilmenite ore (1) 
 
 11 
 
(1) Relates to our Canadian sulfate production line, which was closed in the third quarter of 2024. 
Sales and marketing 
Our marketing strategy is aimed at developing and maintaining strong relationships with new and existing 
customers. Because TiO2 represents a significant input cost for our customers, the purchasing decisions are often made by 
our customers’ senior management. We work to maintain close relationships with the key decision makers through 
in-depth and frequent contact. We endeavor to extend these commercial and technical relationships to multiple levels 
within our customers’ organizations using our direct sales force and technical service group to accomplish this objective. 
We believe this helps build customer loyalty and strengthens our competitive position. Close cooperation and strong 
customer relationships enable us to stay closely attuned to trends in our customers’ businesses. Where appropriate, we 
work in conjunction with our customers to solve formulation or application problems by modifying specific product 
properties or developing new pigment grades. We also focus our sales and marketing efforts on those geographic and 
end-use market segments where we believe we can realize higher selling prices. This focus includes continuously 
reviewing and optimizing our customer and product portfolios. 
We also work directly with our customers to monitor the success of our products in their end-use applications, 
evaluate the need for improvements in our product and process technology and identify opportunities to develop new 
product solutions for our customers. Our marketing staff closely coordinates with our sales force and technical specialists 
to ensure the needs of our customers are met, and to help develop and commercialize new grades where appropriate. 
We sell a majority of our products through our direct sales force operating in Europe and North America. We 
also utilize sales agents and distributors who are authorized to sell our products in specific geographic areas. In Europe, 
our sales efforts are conducted primarily through our direct sales force and our sales agents. Our agents do not sell any 

 
10 
TiO2 products other than KRONOS® branded products. In North America, our sales are made primarily through our direct 
sales force and supported by a network of distributors. We have increased our marketing efforts over the last several years 
in export markets and our sales are now made through our direct sales force, sales agents and distributors. In addition to 
our direct sales force and sales agents, many of our sales agents also act as distributors to service our customers in all 
regions. We offer customer and technical service to customers who purchase our products through distributors as well as 
to our larger customers serviced by our direct sales force. 
We sell to a diverse customer base with only one customer representing 10% or more of our net sales in 2024 
(Behr Process Corporation – 10%). Our largest ten customers accounted for approximately 39% of net sales in 2024. 
Neither our business as a whole nor any of our principal product groups is seasonal to any significant extent. 
However, TiO2 sales are generally higher in the second and third quarters of the year, due in part to the increase in coatings 
production in the spring to meet demand during the spring and summer painting seasons. We normally build inventories 
during the first and fourth quarters of each year in order to maximize our product availability during the higher demand 
periods normally experienced in the second and third quarters. 
Competition 
The TiO2 industry is highly competitive. We compete primarily on the basis of price, product quality, technical 
service and the availability of high-performance pigment grades. Since TiO2 is not traded through a commodity market, 
its pricing is largely a product of negotiation between suppliers and their respective customers. Price and availability are 
the most significant competitive factors along with quality and customer service for the majority of our product grades. 
Increasingly, we are focused on providing pigments that are differentiated to meet specific customer requests and specialty 
grades that are differentiated from our competitors’ products. During 2024, we had an estimated 7% share of worldwide 
TiO2 sales volume, and based on sales volume, we believe we are the leading seller of TiO2 in several countries, including 
Germany. 
Our principal competitors are LB Group Co. Ltd., The Chemours Company, Tronox Holdings PLC and Venator 
Materials PLC. The top five TiO2 producers (i.e., we and our four principal competitors) account for approximately 51% 
of the world’s production capacity. 
The following chart shows our estimate of worldwide production capacity in 2024: 
 
 
 
Worldwide production capacity - 2024 
LB Group 
     
13% 
Chemours 
 
13% 
Tronox 
  
12% 
Kronos 
  
7% 
Venator 
  
6% 
Other 
  
49% 
 
Chemours has approximately one-half of total North American TiO2 production capacity and is our principal 
North American competitor. LB Group previously announced it plans to add an additional 200,000 tons of chloride process 
capacity which we expect will be added incrementally over the next several years. However, several of our competitors 
have recently closed or announced plans to close facilities or otherwise reduce capacity, including Chemours which closed 
its Taiwan facility with an estimated 160,000 tons of chloride process capacity in 2023 and Venator which announced 
plans in 2024 to close its Duisburg, Germany facility with an estimated 50,000 tons of sulfate process capacity. In addition, 
in 2024 we closed our sulfate production line in Varennes, Canada. 
The TiO2 industry is characterized by high barriers to entry consisting of high capital costs, proprietary technology 
and significant lead times required to construct new facilities or to expand existing capacity. Therefore, over the past 
ten years, we and our competitors increased industry capacity through debottlenecking projects; however, this increase 
only partly compensated for the shut-down of various TiO2 plants throughout the world. Other than through 
debottlenecking projects and the LB Group expansion mentioned above, we do not expect any significant efforts will be 

 
11 
undertaken by us or our principal competitors to further increase capacity and we believe it is unlikely any new TiO2 plants 
will be constructed in Europe or North America for the foreseeable future. If actual developments differ from our 
expectations, the TiO2 industry and our performance could be unfavorably affected. 
Research and development 
We employ scientists, chemists, process engineers and technicians who are engaged in research and development, 
process technology and quality assurance activities in Leverkusen, Germany. These individuals have the responsibility for 
improving our chloride and sulfate production processes, improving product quality and strengthening our competitive 
position by developing new products and applications. Our expenditures for these activities were approximately 
$15 million in 2022, $18 million in 2023 and $14 million in 2024. We expect to spend approximately $15 million on 
research and development in 2025. 
We continually seek to improve the quality of our grades and have been successful in developing new grades for 
existing and new applications to meet the needs of our customers and increase product life cycles. Since the beginning of 
2020, we have added six new grades for pigments and other applications. 
Patents, trademarks, trade secrets and other intellectual property rights 
We have a comprehensive intellectual property protection strategy that includes obtaining, maintaining and 
enforcing our patents, primarily in the United States, Canada and Europe. We also register, maintain and protect our 
trademark rights. We maintain the secrecy of our trade secret rights and protect them by means of security protocols and 
confidentiality agreements. In some instances, we have entered into license agreements with third parties concerning 
various intellectual property matters. We have also from time to time been involved in disputes over intellectual property. 
Patents – We have obtained patents and have numerous patent applications pending that cover certain aspects of 
our products and the technology used in the manufacture of our products. Our patent strategy is important to us and our 
continuing business activities. In addition to maintaining our patent portfolio, we seek patent protection for our technical 
developments, principally in the United States, Canada and Europe. U.S. patents are generally in effect from the time that 
they issue as patents and then extend for 20 years from the date of filing. Our U.S. patent portfolio includes patents having 
remaining terms ranging from one year to 19 years. 
Trademarks – Our trademarks, including KRONOS®, are covered by issued and/or pending registrations, 
including in Canada and the United States. We protect the trademarks we use in connection with the products we 
manufacture and sell and have developed goodwill in connection with our long-term use of our trademarks.  
Trade secrets – We conduct research activities in secret and we protect the confidentiality of our trade secrets 
through reasonable measures, including confidentiality agreements and security procedures, including data security. We 
rely upon unpatented proprietary knowledge and continuing technological innovation and other trade secrets to develop 
and maintain our competitive position. Our proprietary chloride production process is an important part of our technology 
and our business could be harmed if we fail to maintain confidentiality of our trade secrets used in this technology. 
Regulatory and environmental matters 
Our operations and properties are governed by various environmental laws and regulations which are complex, 
change frequently and have tended to become stricter over time. These environmental laws govern, among other things, 
the generation, storage, handling, use and transportation of hazardous materials; the emission and discharge of hazardous 
materials into the ground, air, or water; and the health and safety of our employees. Certain of our operations are, or have 
been, engaged in the generation, storage, handling, manufacture or use of substances or compounds that may be considered 
toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other companies engaged 
in similar businesses, certain of our past and current operations and products have the potential to cause environmental or 
other damage. We have implemented and continue to implement various policies and programs in an effort to minimize 
these risks. Our policy is to comply with applicable environmental laws and regulations at all our facilities and to strive to 
improve our environmental performance and overall sustainability. It is possible that future developments, such as stricter 
requirements in environmental laws and enforcement policies, could adversely affect our operations, including production, 

 
12 
handling, use, storage, transportation, sale or disposal of hazardous or toxic substances or require us to make capital and 
other expenditures to comply, and could adversely affect our consolidated financial position and results of operations or 
liquidity.  
We have a history of identifying new ways to reduce consumption and waste by converting byproducts to 
co-products through our KRONOS ecochem® products. We have a published Safety, Environment, Energy and Quality 
Policy which is translated into local languages and distributed to all our employees and shared publicly via our website. 
We have implemented rigorous procedures for incident reporting and investigation, including root cause analysis of 
environmental and safety incidents and near misses. Because TiO2 production requires significant energy input, we are 
focused on energy efficiency at all production locations. Four of our six production facilities maintain certifications to the 
ISO 50001:2018 Energy Management standard and all locations have local energy teams in place. These teams are 
responsible for maintaining ISO 50001:2018 certifications (where applicable), performing regular reviews of local energy 
consumption, making recommendations regarding capital projects that reduce energy consumption and associated 
Greenhouse Gas (GHG) emissions or enhance efficiency. When possible, we look for opportunities to partner with local 
government authorities through grant opportunities to reduce energy consumption and associated GHG emissions. We 
also actively manage potential water-related risks, including flooding and water shortages. Our manufacturing facilities 
are strategically located adjacent to sources of water, which we use for process operations and for shipping and receiving 
raw materials and finished products. Water-critical processes are identified and ongoing efforts to minimize water use are 
incorporated into environmental planning. 
Our U.S. manufacturing operations are governed by federal, state and local environmental and worker health and 
safety laws and regulations. These include the Resource Conservation and Recovery Act, or RCRA, the Occupational 
Safety and Health Act, the Clean Air Act, the Clean Water Act, the Safe Drinking Water Act, the Toxic Substances Control 
Act and the Comprehensive Environmental Response, Compensation and Liability Act, as amended by the Superfund 
Amendments and Reauthorization Act, or CERCLA, as well as the state counterparts of these statutes. Some of these laws 
hold current or previous owners or operators of real property liable for the costs of cleaning up contamination, even if 
these owners or operators did not know of, and were not responsible for, such contamination. These laws also assess 
liability on any person who arranges for the disposal or treatment of hazardous substances, regardless of whether the 
affected site is owned or operated by such person. Although we have not incurred and do not currently anticipate any 
material liabilities in connection with such environmental laws, we may be required to make expenditures for 
environmental remediation in the future.  
While the laws regulating operations of industrial facilities in Europe vary from country to country, a common 
regulatory framework is provided by the European Union, or the EU. Germany and Belgium are members of the EU and 
follow its initiatives. Norway is not a member but generally patterns its environmental regulatory actions after those of the 
EU. 
From time to time, our facilities may be subject to environmental regulatory enforcement under local or national 
laws. Typically, we update our compliance programs to resolve these matters. Occasionally, we may pay penalties. To 
date, such penalties have not involved amounts having a material adverse effect on our consolidated financial position, 
results of operations or liquidity. We believe all of our facilities are in substantial compliance with applicable 
environmental laws.  
 
From time to time, new environmental, sustainability, health and safety regulations are passed or proposed in the 
countries in which we operate or sell our products, seeking to regulate our operations or to restrict, limit or classify TiO2. 
We believe we are in substantial compliance with laws applicable to the regulation of TiO2. However, increased regulatory 
scrutiny could affect consumer perception of TiO2 or limit the marketability and demand for TiO2 or products containing 
TiO2 and increase Kronos’ regulatory and compliance costs. 
On October 1, 2021, EU Regulation No. 1272/2008 classifying dry TiO2 and mixtures containing dry TiO2 as a 
suspected carcinogen via inhalation went into force. Our dry TiO2 products do not meet the criteria set forth in the 
regulation and therefore do not require classification labels. On November 23, 2022 the Court of Justice of the European 
Union annulled the classification of TiO2 as a suspected carcinogen in its entirety, which decision is currently under appeal. 

 
13 
Our capital expenditures related to ongoing environmental compliance, protection and improvement programs, 
including capital expenditures which are primarily focused on increasing operating efficiency but also result in improved 
environmental protection such as lower emissions from our manufacturing facilities, were $17 million in 2024 and are 
currently expected to be approximately $24 million in 2025.  
Environmental, Social and Governance (ESG) 
We seek to operate our businesses in line with sound ESG principles that include corporate governance, social 
responsibility, sustainability and cybersecurity. We believe ESG means conducting operations with high standards of 
environmental and social responsibility, practicing exemplary ethical standards, focusing on safety as a top priority, 
respecting human rights and supporting our local communities, and continuously developing our employees. At our 
facilities, we undertake various environmental sustainability programs, and we promote social responsibility and 
volunteerism through programs designed to support and give back to the local communities in which we operate. Each of 
our locations maintains site-specific safety programs and disaster response and business continuity plans. All 
manufacturing facilities have detailed, site-specific emergency response procedures we believe adequately address 
regulatory compliance, vulnerability to potential hazards, emergency response and action plans, employee training, alarms 
and warning systems and crisis communication. 
The U.S. government and various non-U.S. governmental agencies of countries in which we operate have adopted 
or are contemplating regulatory changes relating to certain ESG topics, such as the Corporate Social Responsibility 
Directive adopted by the European Union on November 28, 2022 (EU CSRD). We are evaluating and will continue to 
evaluate the applicability of the EU CSRD as regulatory guidance is issued and as the European countries in which we 
operate adopt implementing legislation and we will establish a compliance program to address any applicable 
requirements.   
In an effort to align our non-employee directors’ financial interests with those of our stockholders, our board of 
directors established share ownership guidelines for our non-management directors. In addition, we have adopted an 
insider trading policy that applies to both employees and non-employee directors. 
We have taken steps to integrate ESG considerations into operating decisions with other critical business factors. 
We periodically publish an ESG Report, which is available on our public website. The primary purpose of our ESG Report 
is to describe our policies and programs in the area of ESG, including certain internal metrics and benchmarks related to 
various aspects of ESG. We voluntarily developed these internal metrics and benchmarks, which we use to identify 
progress and opportunities for improvement. These metrics are not intended to be directly comparable to similar metrics 
utilized by other companies to track ESG performance, as the standards, methodologies and assumptions used to determine 
these metrics vary by subsidiary and jurisdiction.  
Human capital resources 
Employees – Our operating results depend in part on our ability to successfully manage our human capital 
resources, including attracting, identifying and retaining key talent. We have a well-trained labor force with a substantial 
number of long-tenured employees. We provide competitive compensation and benefits to our employees, some of which 
are offered under collective bargaining agreements. In addition to salaries, these programs, which vary by country/region, 
can include annual bonuses, a defined benefit pension plan, a defined contribution plan with employer matching 
opportunities, healthcare and insurance benefits, health savings and flexible spending accounts, paid time off, family leave, 
family care resources, employee assistance programs and tuition assistance.  
We recognize that everyone deserves respect and equal treatment. As a global company, we embrace diversity 
and collaboration in our workforce and our business initiatives. We are an equal opportunity employer and we base 
employment decisions on merit, competence and qualifications, without regard to race, color, national origin, gender, age, 
religion, disability, sex, sexual orientation or other characteristics protected by applicable law in the jurisdictions in which 
we operate. We promote a respectful, diverse and inclusive workplace in which all individuals are treated with respect and 
dignity. 

 
14 
As of December 31, 2024, we employed the following number of people: 
 
 
 
Europe 
     
 1,813 
Canada 
 
 364 
United States 
 
 347 
Total 
  
 2,524 
 
Certain employees at each of our production facilities are organized by labor unions. We strive to maintain good 
relationships with all our employees, including the unions and workers’ councils representing those employees. In Europe, 
our union employees are covered by master collective bargaining agreements for the chemical industry that are generally 
renewed annually. At December 31, 2024, approximately 75% of our worldwide workforce is organized under collective 
bargaining agreements. We did not experience any work stoppages during 2024, although it is possible that there could be 
future work stoppages or other labor disruptions that could materially and adversely affect our business, results of 
operations, financial position, or liquidity.  
Health and safety – Protecting the health and safety of our workforce, our customers, our business partners and 
the natural environment is one of our core values. We are committed to maintaining a strong safety culture where all 
workers meet or exceed required industry performance standards and continuously seek to improve occupational and 
process safety performance. We are conducting our businesses in ways that provide all personnel with a safe and healthy 
work environment and have established safety and environmental programs and goals to achieve such results. We expect 
our manufacturing facilities to produce our products safely and in compliance with local regulations, policies, standards 
and practices intended to protect the environment and people and have established global policies designed to promote 
such compliance. We require our employees to comply with such requirements. We provide our workers with the tools 
and training necessary to make the appropriate decisions to prevent accidents and injuries. Each of our operating facilities 
develops, maintains and implements safety programs encompassing key aspects of their operations. In addition, 
management reviews and evaluates safety performance throughout the year. We monitor conditions that could lead to a 
safety incident and keep track of injuries through reporting systems in accordance with laws in the jurisdictions in which 
we operate. With this data we calculate incident frequency rates to assess the quality of our safety performance. At the 
global level we also track overall safety performance. Each of our operating locations is subject to local laws and 
regulations that dictate what injuries are required to be recorded and reported, which may differ from location to location 
and result in different methods of injury rate calculation. For internal global tracking, benchmarking and identification of 
opportunities for improvement, we collect the location specific information and apply a U.S.-based injury rate calculation 
method to arrive at a global total frequency rate, which is expressed as the number of incidents at our operating locations 
per 200,000 hours. This internal safety metric may not be directly comparable to a recordable incident rate calculated 
under U.S. law. Our global total frequency rate aggregating information about employees and contractors was 1.01 in 2022 
(0.86 of the aggregate represents employees only), 0.95 in 2023 (0.74 of the aggregate represents employees only) and 
0.70 in 2024 (0.80 of the aggregate represents employees only). 
Website and other available information 
Our fiscal year ends December 31. Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current 
reports on Form 8-K and any amendments to those reports are available on our website at kronosww.com. These reports 
are available on the website, without charge, as soon as is reasonably practicable after we file or furnish them electronically 
with the Securities and Exchange Commission, or SEC. Additional information regarding us, including our Audit 
Committee Charter, Code of Business Conduct and Ethics and our Corporate Governance Guidelines, can also be found 
at this website. Information contained on our website is not part of this report. We will also provide free copies of such 
documents upon written request. Such requests should be directed to the Corporate Secretary at our address on the cover 
page of this Form 10-K. 
We are an electronic filer and the SEC maintains an internet website that contains reports, proxy and information 
statements and other information regarding issuers that file electronically with the SEC at www.sec.gov. 

 
15 
ITEM 1A. 
RISK FACTORS 
Below are certain risk factors associated with our business. See also certain risk factors discussed in 
Item 7- “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting 
Policies and Estimates.” In addition to the potential effect of these risk factors, any risk factor which could result in reduced 
earnings or operating losses, or reduced liquidity, could in turn adversely affect our ability to service our liabilities or pay 
dividends on our common stock or adversely affect the quoted market prices for our securities. 
Operational Risk Factors 
Demand for, and prices of, certain of our products are influenced by changing market conditions for our products, 
which may result in reduced earnings or in operating losses. 
Our sales and profitability are largely dependent on the TiO2 industry. In 2024, approximately 90% of our sales 
were attributable to sales of TiO2. TiO2 is used in many “quality of life” products for which demand historically has been 
linked to global, regional and local gross domestic product and discretionary spending, which can be negatively impacted 
by regional and world events or economic conditions. Such events are likely to cause a decrease in demand for our products 
and, as a result, may have an adverse effect on our results of operations and financial condition. 
Pricing within the global TiO2 industry over the long term is cyclical and changes in economic conditions 
worldwide can significantly impact our earnings and operating cash flows. Historically, the markets for many of our 
products have experienced alternating periods of increasing and decreasing demand. Relative changes in the selling prices 
for our products are one of the main factors that affect the level of our profitability. In periods of increasing demand, our 
selling prices and profit margins generally will tend to increase, while in periods of decreasing demand our selling prices 
and profit margins generally tend to decrease. In addition, pricing may affect customer inventory levels as customers may 
from time to time accelerate purchases of TiO2 in advance of anticipated price increases or defer purchases of TiO2 in 
advance of anticipated price decreases. Our ability to further increase capacity without additional investment in greenfield 
or brownfield capacity may be limited and as a result, our profitability may become even more dependent upon the selling 
prices of our products. 
The TiO2 industry is concentrated and highly competitive and we face price pressures in the markets in which we 
operate, which may result in reduced earnings or operating losses. 
The global market in which we operate our business is concentrated, with the top five TiO2 producers accounting 
for approximately 51% of the world’s production capacity and is highly competitive. Competition is based on a number 
of factors, such as price, product quality and service. We face significant competition from international and regional 
competitors, including TiO2 producers in China, who have significant sulfate production process capacity. Chinese 
producers have also continued to develop chloride process technology, and the risk of substitution of our products with 
products made by Chinese producers could increase if Chinese producers increase the use of chloride process technology 
and improve the quality of their sulfate and chloride products. Some of our competitors may be able to drive down prices 
for our products if their costs are lower than our costs, including our competitors with vertically integrated sources of raw 
materials for the chloride process who may have a competitive advantage during periods of high or rising raw material 
costs or who operate in regions with less stringent regulatory requirements. In addition, some of our competitors’ financial, 
technological and other resources may be greater than our resources and such competitors may be better able to withstand 
changes in market conditions. Our competitors may be able to respond more quickly than we can to new or emerging 
technologies and changes in customer requirements. Further, consolidation of our competitors or customers may result in 
reduced demand for our products or make it more difficult for us to compete with our competitors. The occurrence of any 
of these events could result in reduced earnings or operating losses. 
Higher costs or limited availability of our raw materials may reduce our earnings and decrease our liquidity. In 
addition, many of our raw material contracts contain fixed quantities we are required to purchase. 
The number of sources for and availability of certain raw materials is specific to the particular geographical region 
in which our facilities are located. Titanium-containing feedstocks suitable for use in our TiO2 facilities are available from 
a limited number of suppliers around the world. Political and economic instability or increased regulations in the countries 

 
16 
from which we purchase or mine our raw material supplies could adversely affect raw material availability. If we or our 
worldwide vendors are unable to meet our planned or contractual obligations and we are unable to obtain necessary raw 
materials, we could incur higher costs for raw materials or we may be required to reduce production levels. We experienced 
increases in feedstock costs in 2023 and 2024, for example, which affected our margins. We have also experienced higher 
operating costs such as energy costs. Future variations in the cost of energy, which primarily reflect market prices for oil 
and natural gas, and for raw materials may significantly affect our operating results and decrease liquidity as we may not 
always be able to increase our selling prices to offset the impact of any higher costs or reduced production levels.  
We have supply contracts that provide for our TiO2 feedstock requirements. While we believe we will be able to 
renew these contracts, as necessary, we do not know if we will be successful in renewing them or in obtaining long-term 
extensions to them prior to expiration. Our current agreements require us to purchase certain minimum quantities of 
feedstock with minimum purchase commitments aggregating approximately $542 million beginning in 2025 and extending 
through 2026. In addition, we have other long-term supply and service contracts that provide for various raw materials and 
services. These agreements require us to purchase certain minimum quantities or services with minimum purchase 
commitments aggregating approximately $67 million at December 31, 2024. Our commitments under these contracts could 
adversely affect our financial results if we significantly reduce our production and we are unable to modify the contractual 
commitments.  
Our recent acquisition of the remaining 50% interest in LPC may not generate benefits we anticipate and may otherwise 
affect our business and prospects. 
We recently completed the LPC acquisition in which we purchased the 50% ownership interest in LPC we did 
not previously own. If we experience unforeseen technological, operational or other difficulties in managing the integration 
of LPC as our wholly-owned subsidiary, we may not be able to implement the process innovations at the facility that we 
expect. In addition, we may not be able to achieve the synergies or improve efficiency and product quality that we expect. 
With or without such difficulties, the integration of the LPC facility into our operations may divert significant management 
time and attention from our other operations. If we fail to successfully integrate LPC into our operations, or if the LPC 
acquisition does not provide expected synergies or sales increases, or if LPC has unexpected legal, regulatory, or financial 
liabilities, our business, financial condition, results of operations and prospects could be adversely affected. 
Financial Risk Factors 
Our leverage may impair our financial condition or limit our ability to operate our businesses. 
We have a significant amount of debt, primarily related to our 9.50% Senior Secured Notes due 2029 and our 
3.75% Senior Secured Notes due 2025, our term loan from Contran, and borrowings on our global revolving credit facility 
(the “Global Revolver”). As of December 31, 2024, our total consolidated debt was approximately $507.4 million. Our 
level of debt could have important consequences to our stockholders and creditors, including:  
• 
making it more difficult for us to satisfy our obligations with respect to our liabilities; 
• 
increasing our vulnerability to adverse general economic and industry conditions; 
• 
requiring that a portion of our cash flows from operations be used for the payment of interest on our debt, 
which reduces our ability to use our cash flow to fund working capital, capital expenditures, dividends on 
our common stock, acquisitions or general corporate requirements; 
• 
limiting the ability of our subsidiaries to pay dividends to us; 
• 
limiting our ability to obtain additional financing to fund future working capital, capital expenditures, 
acquisitions or general corporate requirements; 
• 
limiting our flexibility in planning for, or reacting to, changes in our business and the industry in which we 
operate; and 
• 
placing us at a competitive disadvantage relative to other less leveraged competitors. 

 
17 
Indebtedness outstanding under our Global Revolver accrues interest at variable rates. To the extent market 
interest rates rise, the cost of our debt could increase, even if the amount borrowed remains the same, adversely affecting 
our financial condition, results of operations and cash flows. 
In addition to our indebtedness, we are party to various lease and other agreements (including feedstock purchase 
contracts and other long-term supply and service contracts, as discussed above) pursuant to which, along with our 
indebtedness, we are committed to pay approximately $701 million in 2025. Our ability to make payments on and refinance 
our debt and to fund planned capital expenditures depends on our ability to generate cash flow in the future. To some 
extent, this is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond 
our control. In addition, our ability to borrow funds under our Global Revolver in the future, in some instances, will depend 
in part on our ability to maintain specified financial ratios and satisfy certain financial covenants contained in the credit 
agreement governing the Global Revolver. 
Our business may not generate cash flows from operating activities sufficient to enable us to pay our debts when 
they become due and to fund our other liquidity needs. As a result, we may need to refinance all or a portion of our debt 
before maturity, as we have done in the past. We may not be able to refinance any of our debt in a timely manner on 
favorable terms, if at all, in the current credit markets. Any inability to generate sufficient cash flows or to refinance our 
debt on favorable terms could have a material adverse effect on our financial condition. 
Changes in currency exchange rates and interest rates can adversely affect our net sales, profits and cash flows. 
We operate our businesses in several different countries and sell our products worldwide. For example, during 
both 2023 and 2024, approximately 44% of our sales volumes were sold into European markets. The majority (but not all) 
of our sales from our operations outside the United States are denominated in currencies other than the United States dollar, 
primarily the euro, other major European currencies and the Canadian dollar. Therefore, we are exposed to risks related to 
the need to convert currencies we receive from the sale of our products into the currencies required to pay for certain of 
our operating costs and expenses and other liabilities (including indebtedness), all of which could result in future losses 
depending on fluctuations in currency exchange rates and affect the comparability of our results of operations between 
periods. 
Legal, Compliance and Regulatory Risk Factors 
We may be subject to litigation, the disposition of which could have a material adverse effect on our results of 
operations. 
The nature of our operations exposes us to possible litigation claims, including disputes with customers and 
suppliers and matters relating to, among other things, antitrust, product liability, intellectual property, employment and 
environmental claims. It is possible that judgments could be rendered against us in these or other types of cases for which 
we could be uninsured or not covered by indemnity, or which may be beyond the amounts that we currently have reserved 
or anticipate incurring for such matters. Some of the lawsuits may seek fines or penalties and damages in large amounts 
or seek to restrict our business activities. Because of the uncertain nature of litigation and coverage decisions, we cannot 
predict the outcome of these matters or whether insurance claims may mitigate any damages ultimately determined to be 
owed by us. Any liability we might incur in the future could be material. In addition, litigation is very costly, and the costs 
associated with defending litigation matters could have a material adverse effect on our results of operations. 
Environmental, health and safety laws and regulations may result in increased regulatory scrutiny which could 
decrease demand for our products, increase our manufacturing and compliance costs or obligations and result in 
unanticipated losses which could negatively impact our financial results or limit our ability to operate our business. 
From time to time, new environmental, health and safety regulations are passed or proposed in the countries in 
which we operate or sell our products, seeking to regulate our operations or to restrict, limit or classify TiO2, or its 
use. Increased regulatory scrutiny could affect consumer perception of TiO2 or limit the marketability and demand for 
TiO2 or products containing TiO2 or increase our manufacturing and regulatory compliance obligations and 
costs. Increased compliance obligations and costs or restrictions on operations, raw materials and certain TiO2 applications 

 
18 
could negatively impact our future financial results through increased costs of production, or reduced sales which may 
decrease our liquidity, operating income and results of operations. 
If some or all of our intellectual property were to be declared invalid, held to be unenforceable or copied by competitors 
or some or all of our confidential information become known to competitors, or if our competitors were to develop 
similar or superior intellectual property or technology, our ability to compete could be adversely impacted. 
Protection of our intellectual property rights, including patents, copyrights, trade secrets, confidential 
information, trademarks and tradenames, is important to our business and our competitive position. We endeavor to protect 
our intellectual property rights in key jurisdictions in which our products are produced, sold or used and in jurisdictions 
into which our products are imported. However, we may be unable to obtain protection for our intellectual property in key 
jurisdictions. Although we own and have applied for numerous patents and trademarks throughout the world, we may have 
to engage in judicial enforcement in order to protect our patent rights and other proprietary rights. Our patents and other 
intellectual property rights may be challenged, invalidated, circumvented, rendered unenforceable or otherwise 
compromised. A failure to protect, defend or enforce our intellectual property could have an adverse effect on our financial 
condition and results of operations. Similarly, third parties may assert claims against us and our customers and distributors 
alleging our products infringe upon third-party intellectual property rights. In the event that any such third-party prevails 
against us on such claims, there could be an adverse effect on our financial condition and results of operations. 
Although it is our practice to enter into confidentiality agreements with our employees and third parties to protect 
our proprietary expertise and other trade secrets, these agreements may not provide sufficient protection for our trade 
secrets or proprietary know-how, or adequate remedies for breaches of such agreements may not be available in the event 
of an unauthorized use or disclosure of such trade secrets and know-how. We also may not be able to readily detect 
breaches of such agreements. The failure of our confidentiality agreements to protect our proprietary technology, 
know-how or trade secrets could result in a material loss of our competitive position, which could lead to significantly 
lower revenues, reduced profit margins or loss of market share. 
If we must take legal action to protect, defend or enforce our intellectual property rights, any suits or proceedings 
could result in significant costs, including attorney’s fees and diversion of resources and management’s attention, and we 
may not prevail in any such suits or proceedings. 
Global climate change laws and regulations could negatively impact our financial results or limit our ability to operate 
our businesses. 
We operate production facilities in several countries and many of our facilities require large amounts of energy, 
including electricity and natural gas, in order to conduct operations. The U.S. government and various non-U.S. 
governmental agencies of countries in which we operate have determined the consumption of energy derived from fossil 
fuels is a major contributor to climate change and have adopted or are contemplating regulatory changes in response to the 
potential impact of climate change, including laws and regulations requiring enhanced reporting (such as the Corporate 
Social Responsibility Directive adopted by the European Union on November 28, 2022) as well as legislation regarding 
carbon emission costs, GHG emissions and renewable energy targets. International treaties or agreements may also result 
in increasing regulation of GHG emissions, including emissions permits and/or energy taxes or the introduction of carbon 
emissions trading mechanisms. To date, the existing GHG laws and regulations in effect in the various countries in which 
we operate have not had a material adverse effect on our financial results. Until the timing, scope and extent of any new 
or future regulation becomes known, we cannot predict the effect on our business, results of operations or financial 
condition. However, if further GHG laws and regulations were to be enacted in one or more countries, it could negatively 
impact our future results of operations through increased costs of production, particularly as it relates to our energy 
requirements or our need to obtain emissions permits. If such increased costs of production were to materialize, we may 
be unable to pass price increases on to our customers to compensate for increased production costs, which may decrease 
our liquidity, operating income and results of operations. In addition, any adopted future laws and regulations focused on 
climate change and/or GHG emissions could negatively impact our ability (or that of our customers and suppliers) to 
compete with companies situated in areas not subject to such laws and regulations.  

 
19 
General Risk Factors 
Operating as a global business presents risks associated with global and regional economic, political and regulatory 
environments. 
We manufacture and distribute our products globally. Revenue from non-U.S. markets accounted for 
approximately 68%, 66%, and 66% of our revenue for the years ended December 31, 2022, 2023, and 2024, respectively. 
We have significant international operations which, along with our customers and suppliers, could be substantially affected 
by a number of risks arising from operating a multi-national business, including: 
• 
global or regional economic downturns; 
• 
changes in tariffs, trade barriers, and regulatory requirements, such as the enactment of tariffs on goods 
imported into the U.S. including, but not limited to, the recently enacted tariff on goods imported from 
Canada where we manufacture a significant portion of the TiO2 we sell in North America. Tariffs could make 
our products more expensive which would reduce demand or require us to absorb the increased costs reducing 
our operating margins; 
• 
protectionist laws, policies, and business practices and nationalistic campaigns such as economic sanctions 
and exchange controls; 
• 
U.S. relations with the governments of the other countries in which we operate; 
• 
terrorism, armed conflict (such as the current conflicts between Russia and Ukraine and Israel and Hamas); 
• 
 natural disasters, pandemics or other health crises, climate change and other events beyond our control; 
• 
difficulties enforcing agreements or other legal rights; and 
• 
our effective tax rate may fluctuate based on the variability of geographic earnings and statutory rates. 
TiO2 production requires significant energy input, and economic sanctions or supply disruptions resulting from 
armed conflict could lead to additional volatility in global energy prices and energy supply disruptions. These risks, 
individually or in the aggregate, could have an adverse effect on our results of operations and financial condition. 
We are experiencing increasing competition from China. Chinese competition generally has lower operating costs 
due to less stringent regulatory and environmental compliance requirements and less expensive energy prices.  China has 
dumped lower cost sulfate process TiO2 into the markets we serve. In some cases, the TiO2 industry has been successful 
in getting anti-competitive duties enacted on Chinese imports such as the European duties enacted in 2024.   
The U.S. federal government has recently implemented tariffs on certain foreign goods and may implement 
additional tariffs on foreign goods. For example, on March 4, 2025, the U.S. government implemented a 25% tariff on all 
imports from Mexico and Canada into the U.S. As we currently manufacture a significant portion of our North American 
TiO2 in Canada, if sustained for an extended period of time, the 25% tariff on our imports into the U.S. from Canada, 
without exclusion, will make our products manufactured in Canada and sold into the U.S. more expensive. As a result, 
demand for these products could be reduced, or we could be required to absorb the increased costs or increase prices of 
such products.  Such tariffs and, if enacted, any further legislation or actions taken by the U.S. government that restrict 
trade, such as additional tariffs, trade barriers and other protectionist or retaliatory measures taken in response, could 
adversely impact our ability to sell our products in the U.S. or reduce our revenues and gross margins. These measures 
may also increase our costs of Canadian feedstock imported into the U.S. and could adversely impact our gross margins 
or require us to raise prices thereby making our products less competitive. Additional tariffs imposed by the U.S or any 
retaliatory or reciprocal tariffs imposed by other countries could also increase the cost of feedstock and other raw materials 
that go into making TiO2, the extent of which is unknown. The ultimate impact of any tariffs will depend on various 
factors, including the length of time tariffs are ultimately implemented and the amount, scope and nature of the tariffs.   

 
20 
Technology failures or cybersecurity breaches could have a material adverse effect on our operations. 
We rely on integrated information technology systems to manage, process and analyze data, including to facilitate 
the manufacture and distribution of products to and from our facilities, receive, process and ship orders, manage the billing 
of and collections from customers and manage payments to vendors. Although we have systems and procedures in place 
to protect our information technology systems, there can be no assurance that such systems and procedures will be 
sufficiently effective. Therefore, any of our information technology systems may be susceptible to outages, disruptions or 
destruction from power outages, telecommunications failures, employee error, cybersecurity breaches or attacks and other 
similar events. This could result in a disruption of our business operations, injury to people, harm to the environment or 
our assets, and/or the inability to access our information technology systems and could adversely affect our results of 
operations and financial condition. We have in the past experienced, and we expect to continue to experience, 
cyber-attacks, including phishing and other attempts to breach, or gain unauthorized access to, our systems, and 
vulnerabilities introduced into our systems by trusted third-party vendors who have experienced cyber-attacks. To date we 
have not suffered breaches in our systems, either directly or through a trusted third-party vendor, which have led to material 
losses. Due to the increase in global cybersecurity incidents it has become increasingly difficult to obtain insurance 
coverage on reasonable pricing terms to mitigate some risks associated with technology failures or cybersecurity breaches, 
and we are experiencing such difficulties in obtaining insurance coverage. 
Physical impacts of climate change could have a material adverse effect on our costs and operations. 
Climate change may increase both the frequency and severity of extreme weather conditions and natural disasters, 
such as hurricanes, thunderstorms, tornadoes, drought and snow or ice storms. Extreme weather conditions may increase 
our costs or cause damage to our facilities, and any damage resulting from extreme weather may not be fully insured. 
Climate change has also been associated with rising sea levels and many of our facilities are located near coastal areas or 
waterways where rising sea levels or flooding could disrupt our operations or adversely impact our facilities. Furthermore, 
periods of extended inclement weather or associated droughts or flooding may inhibit our facility operations and delay or 
hinder shipments of our products to customers. Any such events could have a material adverse effect on our costs or results 
of operations.  
 
ITEM 1B. 
UNRESOLVED STAFF COMMENTS 
None 
 
ITEM 1C. 
CYBERSECURITY 
We recognize the importance of proactively assessing, identifying and managing material risks associated with 
cybersecurity threats. These risks include, among other things: operational disruptions, intellectual property theft, fraud, 
extortion, harm to employees or customers and violation of data privacy or security laws. Our cybersecurity programs are 
built on both operational and compliance foundations. The operational component focuses on continuous detection, 
prevention, measurement, analysis and response to cybersecurity alerts and incidents, and on emerging threats. The 
compliance component establishes oversight of our cybersecurity programs by creating risk-based controls to protect the 
integrity, confidentiality, accessibility and availability of company data stored, processed or transferred. Our cybersecurity 
program is fully integrated into our enterprise-wide risk management framework. 
Our cybersecurity program is led by our chief information officer (CIO), who is responsible for developing and 
executing our overall information security strategy, policy, security engineering, operations and cyber threat detection and 
response. Our CIO has extensive information technology (IT) and program management experience and leads a team that 
has many years of experience with our organization. Our cybersecurity risks are also reviewed and tested annually through 
third party assessments and internal and external information technology audits. Our information technology team reviews 
cybersecurity risks at least annually, integrating findings into strategic risk assessments. Our CIO reports to our chief 
executive officer.  
We continually enhance our cyber defense strategy with the ultimate goal of preventing cybersecurity incidents 
to the extent feasible, while simultaneously bolstering our system resilience in an effort to minimize the business impact 
 
 

 
21 
should an incident occur. Third parties also play a role in our cybersecurity. We engage reputable third-party security firms 
for consultation on industry best practices and regulatory standards and to conduct routine evaluations of our cybersecurity, 
such as through penetration testing and security audits; these evaluations include testing both the design and operational 
effectiveness of security controls. All employees are required to complete cybersecurity training at least twice a year and 
have access to more frequent cybersecurity training through periodic updates. Employees in certain roles also receive 
additional role-based, specialized cybersecurity training. 
We have a Cybersecurity Incident Disclosure and Controls Committee (CIDAC) which is central to our response 
and evaluation of cybersecurity incidents. Our CIDAC is comprised of our CIO and other senior executives including our 
chief financial officer, chief operating officer and general counsel. Security events and data incidents are evaluated, ranked 
by severity and prioritized for response and remediation. Our IT team is responsible for categorizing cybersecurity 
incidents, and those deemed high-risk or critical are escalated to the CIDAC for review and response coordination. 
Incidents are evaluated to determine materiality and for operational, financial and reputational impact. Our CIDAC 
performs simulations and tabletop exercises at a management level to evaluate our readiness and response to cybersecurity 
incidents. As needed, we collaborate with external cybersecurity experts and legal advisors to help ensure a robust response 
strategy.  
Our board of directors oversees management’s processes for identifying and mitigating risks, including 
cybersecurity risks, to help align our risk exposure with our strategic objectives. Senior leadership, including our CIO and 
chief financial officer, provides regular updates to the board of directors on our cybersecurity posture, emerging threats 
and our risk mitigation efforts. Our board of directors is apprised of cybersecurity incidents deemed to have significant 
business impact, even if they are not material to us. The board has delegated some of its primary risk oversight to board 
committees, including that our audit committee facilitates the board’s process of oversight of our overall risk management 
approach. Our full board retains oversight of cybersecurity because of its importance to us and visibility with our 
customers.  
 
In the event of an incident, we follow a structured incident response playbook, which outlines clear and defined 
steps to be followed from incident detection to mitigation, recovery and notification, including notifying functional areas 
(such as legal and human resources), senior leadership and the board, as appropriate. We also conduct post-incident 
reviews to identify lessons learned and implement continuous improvements. 
We face a number of cybersecurity risks. To date, such risks have not materially affected us, including our 
business strategy, results of operations or financial condition. While we have not experienced any major breaches, we 
actively monitor and mitigate cyber threats, including phishing attempts, malware, and targeted attacks. Thus far all such 
incidents have been minor, isolated and promptly contained. For more information about the cybersecurity risks we face, 
see the risk factor entitled “Technology failures or cybersecurity breaches could have a material adverse effect on 
our operations.” in Item 1A- Risk Factors. 
ITEM 2. 
PROPERTIES 
Information on our properties is incorporated by reference to Item 1: Manufacturing, Operations and Properties 
above. Our corporate headquarters is located in Dallas, Texas. See Notes 1 and 7 to our Consolidated Financial Statements 
for information on our leases. 
ITEM 3. 
LEGAL PROCEEDINGS 
We are involved in various environmental, contractual, intellectual property, product liability and other claims 
and disputes incidental to our business. Information required for this Item is incorporated by reference to Note 15 to our 
Consolidated Financial Statements. 
ITEM 4. 
MINE SAFETY DISCLOSURES 
Not applicable 

 
22 
PART II 
ITEM 5. 
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER 
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 
Our common stock is listed and traded on the New York Stock Exchange (symbol: KRO). As of 
February 28, 2025, there were approximately 1,500 holders of record of our common stock. 
In December 2010, our board of directors authorized the repurchase of up to 2.0 million shares of our common 
stock in open market transactions, including block purchases, or in privately-negotiated transactions at unspecified prices 
and over an unspecified period of time. We have 1,017,518 shares available for repurchase under the stock repurchase 
program at December 31, 2024 after repurchasing 313,814 shares in 2023 and none in 2024. See Note 13 to our 
Consolidated Financial Statements. 
 
 

 
23 
Performance graph 
Set forth below is a table and line graph comparing the yearly change in our cumulative total stockholder return 
on our common stock against the cumulative total return of the S&P 500 Composite Stock Index and an index of a 
self-selected peer group of companies. The peer group index is comprised of The Chemours Company and 
Tronox Holdings PLC. The graph shows the value at December 31 of each year, assuming an original investment of $100 
at December 31, 2019 and reinvestment of cash dividends and other distributions to stockholders.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
2019 
    
2020 
    
2021 
    
2022 
    
2023 
    
2024 
Kronos Common Stock 
 $ 
 100  $ 
 118  $ 
 125  $ 
 83  $ 
 95  $ 
 98 
S&P 500 Composite Stock Index 
  
 100   
 118   
 152   
 125   
 158   
 197 
Peer Group 
   
 100   
 141   
 210    
 168    
 179    
 111 
 
The information contained in the performance graph shall not be deemed “soliciting material” or “filed” with the 
SEC, or subject to the liabilities of Section 18 of the Securities Exchange Act, except to the extent we specifically request 
that the material be treated as soliciting material or specifically incorporate this performance graph by reference into a 
document filed under the Securities Act or the Securities Exchange Act. 
Equity compensation plan information 
We have an equity compensation plan, which was approved by our stockholders, pursuant to which an aggregate 
of 200,000 shares of our common stock can be awarded to members of our board of directors. At December 31, 2024, 
87,800 shares are available for awards under this plan. See Note 13 to our Consolidated Financial Statements. 
ITEM 6. 
RESERVED 

 
24 
ITEM 7. 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
RESULTS OF OPERATIONS 
RESULTS OF OPERATIONS 
Business overview 
We are a leading global producer and marketer of value-added TiO2. TiO2 is used for a variety of manufacturing 
applications, including paints, plastics, paper and other industrial and specialty products. During 2024, 44% of our sales 
volumes were sold into European markets. We believe we are the largest chloride process producer of TiO2 in Europe with 
an estimated 14% share of European TiO2 sales volumes in 2024. In addition, we estimate we have a 17% share of North 
American TiO2 sales volumes in 2024. Our production facilities are located in Europe and North America. 
We consider TiO2 to be a “quality of life” product, with demand affected by gross domestic product, or GDP, and 
overall economic conditions in our markets located in various regions of the world. Over the long-term, we expect demand 
for TiO2 will grow by 2% to 3% per year, consistent with our expectations for the long-term growth in GDP. However, 
even if we and our competitors maintain consistent shares of the worldwide market, demand for TiO2 in any interim or 
annual period may not change in the same proportion as the change in GDP, in part due to relative changes in the TiO2 
inventory levels of our customers. We believe our customers’ inventory levels are influenced in part by their expectation 
for future changes in TiO2 selling prices as well as their expectation for future availability of product. Although certain of 
our TiO2 grades are considered specialty pigments, the majority of our grades and substantially all of our production are 
considered commodity pigment products with price and availability being the most significant competitive factors along 
with product quality and customer and technical support services. 
The factors having the most impact on our reported operating results are: 
• 
TiO2 selling prices, 
• 
TiO2 sales and production volumes, 
• 
Manufacturing costs, particularly raw materials such as third-party feedstock, maintenance and 
energy-related expenses, and 
• 
Currency exchange rates (particularly the exchange rate for the U.S. dollar relative to the euro, the Norwegian 
krone and the Canadian dollar and the euro relative to the Norwegian krone). 
Our key performance indicators are our TiO2 average selling prices, our TiO2 sales and production volumes and 
the cost of titanium-containing feedstock purchased from third parties. TiO2 selling prices generally follow industry trends 
and selling prices will increase or decrease generally as a result of competitive market pressures. 
Executive summary 
As previously reported, effective the Acquisition Date of July 16, 2024, we acquired the 50% joint venture interest 
in LPC previously held by Venator. Prior to the acquisition, we held a 50% joint venture interest in LPC through a 
wholly-owned subsidiary. LPC was operated as a manufacturing joint venture between us and Venator. Following the 
acquisition, LPC became a wholly-owned subsidiary of ours. We acquired the 50% joint venture interest that we did not 
already own for consideration of $185 million less a working capital adjustment. An additional earn-out payment of up to 
$15 million based on our aggregate consolidated net income before interest expense, income taxes and depreciation and 
amortization expense, or EBITDA, during a two-year period comprising calendar years 2025 and 2026 may be required. 
The acquisition was financed through borrowings of $132.1 million under our Global Revolver and the remainder paid 
with cash on hand. We accounted for the acquisition of the interest in LPC as a business combination. For financial 
reporting purposes, the assets acquired and liabilities assumed of LPC are included in our Consolidated Balance Sheet as 
of December 31, 2024, and the results of operations and cash flows of LPC are included in our Consolidated Statement of 
Operations and Cash Flows beginning as of the Acquisition Date. See Note 5 to our Consolidated Financial Statements. 
 
 

 
25 
We reported net income of $86.2 million, or $.75 per share, in 2024 compared to a net loss of $49.1 million, or 
$.43 per share, in 2023. Net income increased in 2024 as compared to 2023 primarily due to higher income from operations 
as a result of the effects of higher sales and production volumes and lower production costs (primarily energy and raw 
materials), partially offset by lower average TiO2 selling prices. Our results of operations in 2023 were significantly 
impacted by reduced demand for certain of our products occurring in all major markets and unabsorbed fixed production 
costs as a result of production curtailments in response to the sharp decline in demand. With improved demand in all of 
our major markets in 2024 compared to 2023 we increased production volumes, contributing to our improved profitability. 
Comparability of our results was also impacted by the effects of changes in currency exchange rates. 
We reported a net loss of $49.1 million, or $.43 per share, in 2023 compared to net income of $104.5 million, or 
$.90 per share, in 2022. Net income decreased in 2023 as compared to 2022 primarily due to lower income from operations 
as a result of lower sales volumes, lower average TiO2 selling prices and reduced production volumes. Beginning in the 
fourth quarter of 2022 and continuing through 2023, we implemented production curtailments in response to a sharp 
decline in demand for TiO2 products occurring in all major markets. In addition, throughout 2023 we implemented cost 
reduction initiatives and other strategies designed to improve our long-term cost structure and preserve liquidity. Through 
these actions we successfully reduced our finished goods inventory levels and maintained significant liquidity, although 
our results of operations were negatively impacted by certain cost reduction initiatives and the significant unabsorbed fixed 
production costs incurred due to the curtailments. Comparability of our results was also impacted by the effects of changes 
in currency exchange rates. 
Our net income in 2024 includes:  
• 
a non-cash, pre-tax gain of $64.5 million ($50.9 million, or $.44 per share, net of income tax expense) 
resulting from the remeasurement of our investment in LPC recognized in the third quarter, 
• 
a non-cash deferred income tax expense of $16.5 million ($.14 per share) related to final tax regulations on 
the treatment of certain currency translation gains and losses recognized in the fourth quarter, 
• 
a non-cash deferred income tax expense of $8.2 million ($.07 per share) related to the recognition of a 
deferred income tax asset valuation allowance related to our Belgian net deferred tax assets recognized in 
the fourth quarter, and 
• 
an aggregate charge of $1.5 million ($1.1 million, or $.01 per share, net of income tax benefit) related to a 
write-off of deferred financing costs. 
Our net loss in 2023 includes: 
• 
an aggregate $2.5 million ($2.0 million, or $.02 per share, net of income tax expense) pre-tax insurance 
settlement gain related to a business interruption insurance claim arising from Hurricane Laura in 2020, 
recognized in the first, second and third quarters, 
• 
recognition in the second quarter of a $1.3 million ($.9 million, or $.01 per share, net of income tax expense) 
settlement loss related to the termination and buy-out of our pension plan in the United Kingdom, 
• 
recognition in the fourth quarter of a $3.8 million ($2.8 million, or $.02 per share, net of income tax expense) 
fixed asset impairment related to the write-off of certain costs resulting from a capital project termination, 
and  
• 
recognition, primarily in the fourth quarter, of $5.8 million ($4.3 million, or $.04 per share, net of income 
tax expense) of restructuring costs related to workforce reductions. 
Our net income in 2022 includes the recognition of a pre-tax insurance settlement gain of $2.7 million recognized 
in the third quarter ($2.2 million, or $.02 per share, net of income tax expense) related to a business interruption insurance 
claim arising from Hurricane Laura in 2020. 

 
26 
Comparison of 2024 to 2023 Results of Operations 
 
 
Years ended December 31, 
 
 
     
2023 
    
2024 
 
 
 
(Dollars in millions) 
 
Net sales 
     $ 
 1,666.5      
 100 % $ 
 1,887.1      
 100 % 
Cost of sales 
  
 
 1,501.6 
 
 90  
  
 1,527.8 
 
 81  
Gross margin 
  
 
 164.9 
 
 10  
  
 359.3 
 
 19  
Selling, general and administrative expense 
  
 
 211.2 
 
 13  
  
 225.6 
 
 12  
Other operating income (expense): 
  
 
 
   
  
 
   
Currency transactions, net 
  
 
 1.4 
 
 -  
  
 1.6 
 
 -  
Other operating expense, net 
 
 (11.1)
 -  
 
 (12.4)
 -  
Income (loss) from operations 
 
 (56.0)
 (3) 
 
 122.9 
 7  
Corporate expense and trade interest income, net 
  
 
 16.2 
 
 1  
  
 18.1 
 
 1  
Segment profit (loss) (1) 
  $ 
 (39.8)
 
 (2) % $ 
 141.0 
 
 8 % 
 
 
 
 
 
 
 
   
 
 
% Change 
TiO2 operating statistics: 
   
  
 
   
  
  
 
   
Sales volumes* 
 
 
 419 
 
 
 
 504  
 20 %   
Production volumes* 
 
 
 401 
 
 
 
 535  
 33 %   
Percentage change in net sales: 
   
  
 
   
  
  
 
 
TiO2 sales volumes 
    
   
  
  
 
 20 % 
TiO2 product pricing 
    
 
   
  
  
 
 (5) 
TiO2 product mix/other 
    
 
   
  
  
 
 (2) 
Changes in currency exchange rates 
    
 
   
  
  
 
 -  
Total 
    
   
  
  
 
 13 % 
 
* Thousands of metric tons 
(1) The Company uses segment profit (loss) to assess the performance of the company’s TiO2 operations. Segment profit is defined as net income before 
income tax expense and certain general corporate items. These general corporate items include corporate expense and the components of other income 
(expense) except for trade interest income. 
Industry conditions and 2024 overview – We and the TiO2 industry experienced an extended period of 
significantly reduced demand reflected in our sales volumes beginning in the second half of 2022 and continuing 
throughout 2023.  While demand improved in 2024 resulting in increased sales volumes across all major markets compared 
to the prior year, overall demand remained below average historical levels. After improving in the first half of 2024, 
demand moderated in the second half of the year, which placed downward pressure on our TiO2 pricing with 2024 average 
TiO2 selling prices approximately 5% below the average TiO2 selling prices for 2023. 
We operated our production facilities at 72% of practical capacity utilization in 2023 in response to decreased 
demand and higher production costs. As a result of the increase in demand experienced in the fourth quarter of 2023 and 
the first quarter of 2024, along with more favorable production costs, we began increasing our production rates during the 
first quarter of 2024 and we operated at near practical capacity in the second, third and fourth quarters of 2024 resulting 
in 96% of practical capacity utilization in 2024. 

 
27 
The following table shows our capacity utilization rates during 2023 and 2024. 
 
 
 
 
 
 
    Production Capacity Utilization Rates 
 
    
2023 
     
2024 
First Quarter 
 
76%  
87% 
Second Quarter 
  
64%  
99% 
Third Quarter 
  
73%  
92% 
Fourth Quarter 
  
75%  
97% 
Overall 
  
72%  
96% 
Excluding the effect of changes in currency exchange rates, our cost of sales per metric ton of TiO2 sold in 2024 
was significantly lower as compared to 2023 primarily due to significant decreases in per metric ton production costs 
(primarily energy and raw materials).  
In response to the extended period of reduced demand in 2023, discussed above, we took measures to reduce our 
operating costs and improve our long-term cost structure such as the implementation of certain voluntary and involuntary 
workforce reductions during the second half of 2023 that primarily impacted our European operations. A substantial 
portion of our workforce reductions were accomplished through voluntary programs, for which eligible workforce 
reduction costs are recognized at the time both the employee and employer are irrevocably committed to the terms of the 
separation. These workforce reductions impacted approximately 100 employees. We recognized a total of approximately 
$6 million in charges primarily in the fourth quarter of 2023 related to workforce reductions we implemented during the 
second half of 2023. In the third quarter of 2024, we closed our sulfate process production line at our plant in Varennes, 
Canada. As a result of the process line closure, we recognized charges to cost of sales of approximately $2 million during 
2024 related to workforce reductions. We also recognized approximately $14 million in non-cash charges primarily related 
to accelerated depreciation in the second and third quarters of 2024. 
Net sales – Our net sales in 2024 increased 13%, or $220.6 million, compared to 2023 primarily due to the effects 
of a 20% increase in sales volumes due to improved overall demand across all major markets (which increased net sales 
by approximately $333 million) partially offset by a 5% decrease in average TiO2 selling prices (which decreased net sales 
by approximately $83 million). Changes in product mix negatively contributed to net sales, primarily due to changes in 
product sales mix in export markets in 2024 as compared to 2023. Additionally, we estimate that changes in currency 
exchange rates (primarily the euro) increased our net sales by approximately $5 million in 2024 as compared to 2023. TiO2 
selling prices will increase or decrease generally as a result of competitive market pressures and changes in the relative 
level of supply and demand as well as changes in raw material and other manufacturing costs. Incremental sales volumes 
resulting from the LPC acquisition did not significantly impact comparisons to the prior year. 
Cost of sales and gross margin – Cost of sales increased $26.2 million, or 2%, in 2024 compared to 2023 due to 
the net effects of a 20% increase in sales volumes, a 33% increase in production rates resulting in reduced unabsorbed 
fixed production costs, and lower production costs of approximately $115 million (primarily energy and raw materials). 
Our unabsorbed fixed production costs in 2024 were $12 million (incurred in the first quarter) compared to $96 million in 
2023 related to curtailments that began in 2022 and continued into the first quarter of 2024, as discussed above. Our cost 
of sales in 2024 include a charge of approximately $2 million related to workforce reductions and approximately 
$14 million in non-cash charges related to the closure of our sulfate process line in Canada discussed above. Sales and 
production volumes resulting from the LPC acquisition did not materially impact comparisons to the prior year. 
Our cost of sales as a percentage of net sales decreased to 81% in 2024 compared to 90% in 2023 primarily due 
to the favorable effects of increased sales, lower production costs and higher production volumes resulting in increased 
coverage of fixed production costs. 
Gross margin as a percentage of net sales increased to 19% in 2024 compared to 10% in 2023. As discussed and 
quantified above, our gross margin as a percentage of net sales increased primarily due to higher sales and production 
volumes as well as lower production costs, partially offset by lower average TiO2 selling prices. 

 
28 
Selling, general and administrative expense – Selling, general and administrative expense increased 
$14.4 million, or 7%, in 2024 compared to 2023. This increase was primarily due to higher distribution costs related to 
higher overall sales volumes compared to 2023. Our selling, general and administrative expense in 2024 also includes 
$2.2 million of transaction costs incurred in connection with the LPC acquisition. Selling, general and administrative 
expense also decreased due to lower costs related to workforce reductions in 2024 compared to 2023.  
Segment profit (loss) – We had segment profit of $141.0 million in 2024 compared to a segment loss of 
$39.8 million in 2023 as a result of the factors impacting gross margin discussed above. We recognized a gain of 
$2.5 million in 2023 related to cash received from the settlement of a business interruption insurance claim. See Note 17 
to our Consolidated Financial Statements. We estimate that changes in currency exchange rates increased our segment 
profit by approximately $10 million in 2024 as compared to 2023, as further discussed below. 
Other non-operating income (expense) – We recognized a gain on the remeasurement of our investment in LPC 
of $64.5 million in 2024 as a result of the acquisition. See Note 5 to our Consolidated Financial Statements. Interest 
expense in 2024 increased $25.8 million compared to 2023 primarily due to higher interest rates on the debt exchange and 
the issuance of new notes discussed below and higher average debt balances as a result of the LPC acquisition. As a result 
of the exchange, interest expense for 2024 also includes a charge of $1.5 million for the write-off of deferred financing 
costs. See Note 8 to our Consolidated Financial Statements. We recognized a gain of $1.2 million on the change in value 
of our marketable equity securities in 2024 compared to a loss of $1.0 million in 2023. See Note 6 to our Consolidated 
Financial Statements. Other components of net periodic pension and OPEB cost in 2024 decreased $4.1 million compared 
to 2023 primarily due to a higher expected return on plan assets, lower discount rates impacting interest costs and a 
non-recurring $1.3 million in settlement costs related to the termination and buy-out of our UK pension plan in the second 
quarter of 2023. See Note 10 to our Consolidated Financial Statements.  
Income tax expense (benefit) – We recognized income tax expense of $63.4 million in 2024 compared to an 
income tax benefit of $23.8 million in 2023. The difference is primarily due to higher earnings in 2024 and the 
jurisdictional mix of such earnings. Our earnings are subject to income tax in various U.S. and non-U.S. jurisdictions, and 
the income tax rates applicable to the pre-tax earnings (losses) of our non-U.S. operations are generally higher than the 
income tax rates applicable to our U.S. operations. We would generally expect our overall effective tax rate, excluding the 
effect of any increase or decrease in our deferred income tax asset valuation allowance or changes in our reserve for 
uncertain tax positions, to be higher than the U.S. federal statutory tax rate of 21% primarily because of our sizeable 
non-U.S. operations.  
Our income tax expense in 2024 includes a non-cash deferred income tax expense of $8.2 million, recognized in 
the fourth quarter, related to the recognition of a deferred income tax asset valuation allowance related to our Belgian net 
deferred tax assets. We continue to believe we will ultimately realize the full benefit of our Belgian NOL carryforwards, 
in part because of their indefinite carryforward period. However, our ability to reverse all or a portion of such valuation 
allowance in the future is dependent on the presence of sufficient positive evidence, such as the existence of cumulative 
profits in the most recent twelve consecutive quarters, and the ability to demonstrate future profitability for a sustainable 
period. Until such time as we are able to reverse the valuation allowance in full, to the extent we generate additional losses 
in Belgium in the intervening periods, our effective income tax rate will be negatively impacted because any further losses 
will effectively be recognized without the net income tax benefit. See Note 12 to our Consolidated Financial Statements. 
 On December 10, 2024, the Department of the Treasury and the Internal Revenue Service released final currency 
regulations under §987 and related rules (the “2024 Final Regulations”). The 2024 Final Regulations generally apply to 
tax years beginning after December 31, 2024, and include transition rules that require us to compute a pretransition gain 
or loss for currency translation related to the operations, assets and liabilities of our non-U.S. qualified business units. 
Pursuant to the 2024 Final Regulations, we have calculated a pretransition gain of $77.1 million and, accordingly, our 
income tax expense in 2024 includes a non-cash deferred income tax expense of $16.5 million recognized in the fourth 
quarter. See Note 12 to our Consolidated Financial Statements.  

 
29 
Comparison of 2023 to 2022 Results of Operations 
 
 
Years ended December 31, 
 
 
     
2022 
     
2023 
 
 
 
 
(Dollars in millions) 
 
Net sales 
     $ 
 1,930.2      
 100 % $ 
 1,666.5      
 100 % 
Cost of sales 
  
 1,539.1  
 80   
 
 1,501.6 
 
 90  
Gross margin 
   
 391.1   
 20  
 
 164.9 
 
 10  
Selling, general and administrative expense 
   
 231.3   
 12  
 
 211.2 
 
 13  
Other operating income (expense): 
   
  
   
 
 
   
Currency transactions, net 
   
 11.5   
 1  
 
 1.4 
 
 -  
Other operating expense, net 
 
 
 (11.7) 
 (1) 
 (11.1)
 -  
Income (loss) from operations 
 
 
 159.6  
 8  
 (56.0)
 (3) 
Corporate expense and trade interest income, net  
 
 16.3  
 1  
 16.2 
 1  
Segment profit (loss) (1) 
  $ 
 175.9   
 9 % $ 
 (39.8)
 
 (2)% 
 
 
 
 
 
 
 
 
   
 
 
 
% Change  
TiO2 operating statistics: 
   
  
   
  
    
   
Sales volumes* 
   
481 
 
  
419  
 (13)%  
Production volumes* 
   
492 
 
  
401  
 (19)%  
Percentage change in net sales: 
   
  
   
  
    
   
TiO2 product pricing 
    
 
   
  
    
 (13)% 
TiO2 sales volumes 
    
 
   
  
    
 (4) 
TiO2 product mix/other 
    
 
   
  
    
 2  
Changes in currency exchange rates 
    
 
   
  
    
 1  
Total 
    
 
   
  
    
 (14)% 
 
* Thousands of metric tons 
(1) The Company uses segment profit (loss) to assess the performance of the Company’s TiO2 operations. Segment profit  is defined as net income before 
income tax expense and certain general corporate items. The general corporate items include corporate expense and the components of other income 
(expense) except for trade interest income. 
Net sales – Our net sales in 2023 decreased 14%, or $263.7 million, compared to 2022 primarily due to a 13% 
decrease in sales volumes (which decreased net sales by approximately $251 million) and a 4% decrease in average TiO2  
selling prices (which decreased net sales by approximately $77 million). Changes in product mix positively contributed to 
net sales, primarily due to higher average selling prices and sales volumes in our complementary businesses which 
somewhat offset declines in TiO2 sales volumes. In addition to the impact of sales volumes and average TiO2 selling prices, 
we estimate that changes in currency exchange rates (primarily the euro) increased our net sales by approximately $10 
million in 2023 as compared to 2022. TiO2 selling prices will increase or decrease generally as a result of competitive 
market pressures, changes in the relative level of supply and demand as well as changes in raw material and other 
manufacturing costs. 
Our sales volumes decreased 13% in 2023 as compared to 2022 due to lower overall demand across all major 
markets noted above. The lower overall demand we began experiencing in the second half of 2022 continued throughout 
most of 2023. However, our sales volumes were 29% higher in the fourth quarter of 2023 as compared to the fourth quarter 
of 2022 due to strengthening demand for TiO2 in our primary markets of Europe and North America. 
Cost of sales and gross margin – Cost of sales decreased $37.5 million, or 2%, in 2023 compared to 2022 due to 
the net effects of a 13% decrease in sales volumes, a 19% decrease in production volumes at certain of our manufacturing 
facilities to align inventory levels to anticipated near-term customer demand (which resulted in  $96 million of unabsorbed 
fixed production costs) and higher production costs of approximately $65 million (primarily raw materials). Our cost of 
sales as a percentage of net sales increased to 90% in 2023 compared to 80% in 2022 primarily due to the unfavorable 
effects of higher production costs (primarily raw materials) and unabsorbed fixed production costs due to lower production 
volumes. 

 
30 
Gross margin as a percentage of net sales decreased to 10% in 2023 compared to 20% in 2022. As discussed and 
quantified above, our gross margin as a percentage of net sales decreased primarily due to lower production and sales 
volumes, lower average TiO2 selling prices, higher production costs and changes in currency exchange rates. 
Selling, general and administrative expense – Selling, general and administrative expense decreased 
$20.1 million, or 9%, in 2023 compared to 2022 primarily due to lower distribution costs related to lower overall sales 
volumes during the year. Selling, general and administrative expense as a percentage of net sales increased in 2023 
compared to 2022 as a result of lower net sales and $5.8 million in charges related to workforce reductions noted above. 
See Note 18 to our Consolidated Financial Statements. 
Segment profit (loss) – We had a segment loss of $39.8 million in 2023 compared to segment profit of 
$175.9 million in 2022 as a result of the factors impacting gross margin discussed above. We recognized a gain of 
$2.5 million in 2023 and a gain of $2.7 million in 2022 related to cash received from the settlement of a business 
interruption insurance claim related to Hurricane Laura. See Note 17 to our Consolidated Financial Statements. We 
estimate changes in currency exchange rates decreased our segment loss by approximately $16 million in 2023 as 
compared to 2022, as discussed in the Effects of currency exchange rates section below. 
Other non-operating income (expense) – We recognized unrealized losses of $1.0 million in each of 2023 and 
2022 on the change in value of our marketable equity securities. See Note 6 to our Consolidated Financial Statements. 
Other components of net periodic pension and OPEB cost in 2023 decreased $7.2 million compared to 2022 primarily due 
to the net effects of higher discount rates impacting interest cost, previously unrecognized actuarial losses and $1.3 million 
in settlement costs related to the termination and buy-out of our pension plan in the United Kingdom during the second 
quarter of 2023. See Note 10 to our Consolidated Financial Statements. Interest expense in 2023 was comparable to interest 
expense in 2022. See Note 8 to our Consolidated Financial Statements.  
Income tax expense (benefit) – We recognized an income tax benefit of $23.8 million in 2023 compared to income 
tax expense of $29.4 million in 2022. The difference is primarily due to lower earnings in 2023 and the jurisdictional mix 
of such earnings. 
Our earnings are subject to income tax in various U.S. and non-U.S. jurisdictions, and the income tax rates 
applicable to the pre-tax earnings (losses) of our non-U.S. operations are generally higher than the income tax rates 
applicable to our U.S. operations. We would generally expect our overall effective tax rate to be higher than the U.S. 
federal statutory rate of 21% primarily because of our sizeable non-U.S. operations. See Note 12 to our Consolidated 
Financial Statements for a tabular reconciliation of our statutory income tax provision to our actual tax provision. 
Effects of currency exchange rates 
We have substantial operations and assets located outside the United States (primarily in Germany, Belgium, 
Norway and Canada). The majority of our sales from non-U.S. operations are denominated in currencies other than the 
U.S. dollar, principally the euro, other major European currencies and the Canadian dollar. A portion of our sales generated 
from our non-U.S. operations is denominated in the U.S. dollar (and consequently our non-U.S. operations will generally 
hold U.S. dollars from time to time). Certain raw materials used in all our production facilities, primarily 
titanium-containing feedstocks, are purchased primarily in U.S. dollars, while labor and other production and 
administrative costs are incurred primarily in local currencies. Consequently, the translated U.S. dollar value of our 
non-U.S. sales and operating results are subject to currency exchange rate fluctuations which may favorably or unfavorably 
impact reported earnings and may affect the comparability of period-to-period operating results. In addition to the impact 
of the translation of sales and expenses over time, our non-U.S. operations also generate currency transaction gains and 
losses which primarily relate to (i) the difference between the currency exchange rates in effect when non-local currency 
sales or operating costs (primarily U.S. dollar denominated) are initially accrued and when such amounts are settled with 
the non-local currency and (ii) changes in currency exchange rates during time periods when our non-U.S. operations are 
holding non-local currency (primarily U.S. dollars). 

 
31 
Fluctuations in currency exchange rates had the following effects on our sales and income (loss) from operations 
for the periods indicated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Impact of changes in currency exchange rates - 2024 vs. 2023 
 
  
 
  
 
  
 
 Translation   
 
 
  
 
  
 
  
 
 
gains 
 Total currency
 
  
Transaction gains recognized 
 
impact of  
impact 
 
    
2023 
    
2024 
    Change     rate changes    2024 vs. 2023 
 
   
(In millions) 
Impact on: 
   
     
     
     
     
  
Net sales 
 $ 
 -  $ 
 -  $
 -  $ 
 5  $ 
 5 
Income (loss) from operations 
   
 1    
 2    
 1    
 9     
 10 
 
The $5 million increase in net sales (translation gains) was caused primarily by a weakening of the U.S. dollar 
relative to the euro, as our euro-denominated sales were translated into more U.S. dollars in 2024 as compared to 2023. 
The strengthening of the U.S. dollar relative to the Canadian dollar and the Norwegian krone in 2024 did not have a 
significant effect on our net sales, as a substantial portion of the sales generated by our Canadian and Norwegian operations 
is denominated in the U.S. dollar. 
The $10 million increase in income from operations was comprised of the following: 
• 
Higher net currency transaction gains of approximately $1 million primarily caused by relative changes in 
currency exchange rates at each applicable balance sheet date between the U.S. dollar and the euro, Canadian 
dollar and the Norwegian krone, and between the euro and the Norwegian krone, which causes increases or 
decreases, as applicable, in U.S. dollar-denominated receivables and payables and U.S. dollar currency held 
by our non-U.S. operations, and in Norwegian krone denominated receivables and payables held by our 
non-U.S. operations, and 
• 
Approximately $9 million from net currency translation gains primarily caused by a strengthening of the 
U.S. dollar relative to the Canadian dollar and Norwegian krone, as local currency-denominated operating 
costs were translated into fewer U.S. dollars in 2024 as compared to 2023. The effect of the weakening of 
the U.S. dollar relative to the euro caused additional net translation gains as the positive effects of the weaker 
U.S. dollar on euro-denominated sales more than offset the unfavorable effects on euro-denominated 
operating costs being translated into more U.S. dollars in 2024 as compared to 2023. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Impact of changes in currency exchange rates - 2023 vs. 2022 
 
  
 
  
 
  
 
 Translation   
 
 
  
 
  
 
  
 
 
gains 
 Total currency
 
  
Transaction gains recognized 
 
impact of  
impact 
 
    
2022 
    
2023 
    Change     rate changes    2023 vs. 2022 
 
  
(In millions) 
Impact on: 
   
     
     
     
     
  
Net sales 
 $ 
 -  $ 
 -  $
 -  $ 
 10  $ 
 10 
Income (loss) from operations 
   
 12    
 1    
 (11)   
 27    
 16 
 
The $10 million increase in net sales (translation gains) was caused primarily by a weakening of the U.S. dollar 
relative to the euro, as our euro-denominated sales were translated into more U.S. dollars in 2023 as compared to 2022. 
The strengthening of the U.S. dollar relative to the Canadian dollar and the Norwegian krone in 2023 did not have a 
significant effect on our net sales, as a substantial portion of the sales generated by our Canadian and Norwegian operations 
is denominated in the U.S. dollar. 

 
32 
The $16 million decrease in loss from operations was comprised of the following: 
• 
Lower net currency transaction gains of approximately $11 million primarily caused by relative changes in 
currency exchange rates at each applicable balance sheet date between the U.S. dollar and the euro, Canadian 
dollar and the Norwegian krone, and between the euro and the Norwegian krone, which causes increases or 
decreases, as applicable, in U.S. dollar-denominated receivables and payables and U.S. dollar currency held 
by our non-U.S. operations, and in Norwegian krone denominated receivables and payables held by our 
non-U.S. operations, and 
• 
Approximately $27 million from net currency translation gains primarily caused by a strengthening of the 
U.S. dollar relative to the Canadian dollar and Norwegian krone, as local currency-denominated operating 
costs were translated into fewer U.S. dollars in 2023 as compared to 2022. The effect of the weakening of 
the U.S. dollar relative to the euro was nominal in 2023 as compared to 2022. 
Outlook 
Overall customer demand improved in 2024 compared to the historical low demand we experienced during 2023, 
although demand levels remained below historical averages and customer demand moderated in the second half of the 
year as compared to the first half of the year across all major markets. We expect demand to improve in 2025, particularly 
in Europe where the European Commission enacted duties on Chinese imports of TiO2 in mid-2024; however, we expect 
overall demand will remain below historical levels due to continued global economic uncertainty caused, in part, by the 
potential implementation of tariffs by the U.S. and other countries. We believe customer inventory levels were low at the 
end of 2024 due to customer hesitancy to build inventory late in the year, and we are receiving customer orders on shorter 
notice than we experienced early in 2024 indicating that customers have a cautious demand outlook and are carefully 
managing inventory levels. TiO2 selling prices softened in the second half of 2024 in response to sluggish demand and 
competitive pressures. We expect these pricing pressures to be somewhat mitigated in 2025, particularly in Europe, as a 
result of the duties enacted on low-cost imports from China. We are operating our facilities at production rates in line with 
the current and expected near-term demand and believe our production rates for 2025 will be slightly above 2024 rates. 
We are focused on cost reduction initiatives designed to improve our long-term cost structure. In 2023, we 
implemented targeted workforce reductions and certain ongoing process improvement initiatives. In the third quarter of 
2024, we closed our Canadian sulfate process line to improve gross margins through the optimization of production of our 
purified grades. Raw material, energy and other input costs generally improved during 2024; however, energy costs in 
Europe have trended up in recent months and remain above historical levels. We expect raw material and other input costs 
will continue to moderate in 2025. Overall, primarily due to improved demand, we expect to report higher operating results 
for the full year of 2025 as compared to 2024, although we will need to achieve TiO2 selling price increases in order to 
recognize margins more in-line with historical levels.  
As noted above, we acquired full control of LPC in July 2024. We believe this acquisition is a unique opportunity 
to immediately add value to our customers and better serve the North American marketplace by allowing us to expand our 
product offerings and increase sales to new and existing customers while recognizing significant synergies, including 
commercial, overhead and supply chain optimization. We are in the process of fully integrating the additional LPC 
production capacity, and we expect the acquisition will have a positive impact on our earnings in 2025, although the 
potential positive impact will be limited by competitive pressures and by the additional debt service costs associated with 
the increase in borrowings to complete the transaction. With the increased borrowing availability under our Global 
Revolver, as well as cash on hand, we were able to finance the required working capital for the improvements needed to 
fully integrate the acquired LPC production capacity.  
Our expectations for the TiO2 industry and our operations are based on a number of factors outside our control. 
Our operations are affected by global and regional economic, political and regulatory factors, and we have experienced 
global market disruptions. As noted above, energy costs in Europe, which spiked when Russia invaded Ukraine, remain 
above historical levels. In addition, we operate a TiO2 facility in Canada, and the majority of production from that facility 
is currently sold into the U.S. The U.S. federal government’s recently enacted 25% tariff on our imports from Canada 
could harm our ability to compete and adversely impact our earnings and profitability if such tariffs are sustained for an 

 
33 
extended period of time without exclusion. We have begun to implement strategies to minimize the potential impacts. 
Future impacts on our operations will depend on, among other things, future energy costs, the effect newly enacted tariffs 
have on jurisdictions in which we or our customers and suppliers operate, our success in implementing mitigation 
strategies, and the impact economic conditions and geopolitical events have on our operations or our customers’ and 
suppliers’ operations, all of which remain uncertain and cannot be predicted.  
Operations outside the United States 
As discussed above, we have substantial operations located outside the United States for which the functional 
currency is not the U.S. dollar. As a result, the reported amount of our assets and liabilities related to our non-U.S. 
operations, and therefore our consolidated net assets, will fluctuate based upon changes in currency exchange rates. At 
December 31, 2024, we had substantial net assets denominated in the euro, Canadian dollar and Norwegian krone. 
Critical accounting policies and estimates 
Our significant accounting policies are more fully described in Note 1 to our Consolidated Financial Statements. 
Our Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted 
in the United States of America, or GAAP. The preparation of these financial statements requires us to make estimates 
and judgments that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities 
at the date of the financial statements and the reported amount of revenues and expenses during the reported period. On 
an ongoing basis we evaluate our estimates, including those related to the recoverability of long-lived assets, pension and 
other postretirement benefit obligations and the underlying actuarial assumptions related thereto, the realization of deferred 
income tax assets and accruals for litigation, income tax and other contingencies. We base our estimates on historical 
experience and on various other assumptions which we believe to be reasonable under the circumstances, the results of 
which form the basis for making judgments about the reported amounts of assets, liabilities, revenues and expenses. Actual 
results may differ significantly from previously-estimated amounts under different assumptions or conditions. 
We believe the most critical accounting policies and estimates involving significant judgment primarily relate to 
long-lived assets, defined benefit pension plans, income taxes and the acquisition of joint venture. We have discussed the 
development, selection and disclosure of our critical accounting estimates with the audit committee of our board of 
directors. 
• 
Long-lived assets – The net book value of our property and equipment totaled $694.1 million at 
December 31, 2024. We recognize an impairment charge associated with our long-lived assets, including 
property and equipment, whenever we determine that recovery of such long-lived asset is not probable. Such 
determination is based upon, among other things, estimates of the amount of future net cash flows to be 
generated by the long-lived asset and estimates of the current fair value of the asset. Significant judgment is 
required in estimating such cash flows. Adverse changes in such estimates of future net cash flows or 
estimates of fair value could result in an inability to recover the carrying value of the long-lived asset, thereby 
possibly requiring an impairment charge to be recognized in the future. We do not assess our property and 
equipment for impairment unless certain impairment indicators are present. We did not evaluate any 
long-lived assets for impairment during 2024 because no such impairment indicators were present.  
• 
Defined benefit pension plans – We participate in or maintain various defined benefit pension plans in the 
U.S., Europe and Canada. See Note 10 to our Consolidated Financial Statements. We recognized 
consolidated defined benefit pension plan expense of $24.1 million in 2022, $12.0 million in 2023 and $8.0 
million in 2024. The funding requirements for these defined benefit pension plans are generally based upon 
applicable regulations (such as ERISA in the U.S.) and will generally differ from pension expense for 
financial reporting purposes. We made contributions to all of our plans which aggregated $15.3 million in 
2022, $16.1 million in 2023 and $15.4 million in 2024. 
Under defined benefit pension plan accounting, defined benefit pension plan expense, pension assets and 
accrued pension costs are each recognized based on certain actuarial assumptions. These assumptions are 
principally the assumed discount rate, the assumed long-term rate of return on plan assets, the fair value of 
plan assets and the assumed increase in future compensation levels. We recognize the full funded status of 
our defined benefit pension plans as either an asset (for overfunded plans) or a liability (for underfunded 

 
34 
plans) on our Consolidated Balance Sheets. 
The discount rates we use for determining defined benefit pension expense and the related pension 
obligations are based on current interest rates earned on long-term bonds that receive one of the two highest 
ratings given by recognized rating agencies in the applicable country where the defined benefit pension 
benefits are being paid. In addition, we receive third-party advice about appropriate discount rates and these 
advisors may in some cases use their own market indices. We adjust these discount rates as of each 
December 31 valuation date to reflect then-current interest rates on such long-term bonds. We use these 
discount rates to determine the actuarial present value of the pension obligations as of December 31 of 
that year. We also use these discount rates to determine the interest component of defined benefit pension 
expense for the following year. 
At December 31, 2024, approximately 68%, 14%, 7% and 7% of the projected benefit obligations related to 
our plans in Germany, Canada, Norway and the U.S., respectively. We use several different discount rate 
assumptions in determining our consolidated defined benefit pension plan obligation and expense. This is 
because we maintain or participate in defined benefit pension plans in several different countries in Europe 
and North America and the interest rate environment differs from country to country. 
We used the following discount rates for our defined benefit pension plans: 
 
 
 
 
 
 
 
 
 
    
Discount rates used for: 
  
 
 
Obligations 
 
Obligations 
 
Obligations 
  
 
 at December 31, 2022 
at December 31, 2023 
at December 31, 2024 
 
    and expense in 2023     and expense in 2024     and expense in 2025  
Germany 
 
3.7%   
3.2%   
3.4%   
Canada 
  
5.1%   
4.6%   
4.6%   
Norway 
  
3.6%   
3.6%   
4.3%   
U.S. 
  
5.3%   
5.0%   
5.5%   
 
The assumed long-term rate of return on plan assets represents the estimated average rate of earnings 
expected to be earned on the funds invested or to be invested in the plans’ assets provided to fund the benefit 
payments inherent in the projected benefit obligations. Unlike the discount rate, which is adjusted each year 
based on changes in current long-term interest rates, the assumed long-term rate of return on plan assets will 
not necessarily change based upon the actual short-term performance of the plan assets in any given year. 
Defined benefit pension expense each year is based upon the assumed long-term rate of return on plan assets 
for each plan, the actual fair value of the plan assets as of the beginning of the year and an estimate of the 
amount of contributions to and distributions from the plan during the year. Differences between the expected 
return on plan assets for a given year and the actual return are deferred and amortized over future periods 
based either upon the expected average remaining service life of the active plan participants (for plans for 
which benefits are still being earned by active employees) or the average remaining life expectancy of the 
inactive participants (for plans for which benefits are not still being earned by active employees). 
At December 31, 2024, approximately 58%, 18%, 10% and 11% of the plan assets related to our plans in 
Germany, Canada, Norway and the U.S., respectively. We use several different long-term rates of return on 
plan asset assumptions in determining our consolidated defined benefit pension plan expense. This is because 
the plan assets in different countries are invested in a different mix of investments and the long-term rates of 
return for different investments differ from country to country. 
In determining the expected long-term rate of return on plan asset assumptions, we consider the long-term 
asset mix (e.g. equity vs. fixed income) for the assets for each of our plans and the expected long-term rates 
of return for such asset components. In addition, we receive third-party advice about appropriate long-term 
rates of return. We regularly review our actual asset allocation for each of our U.S. and non-U.S. plans and 

 
35 
will periodically rebalance the investments in each plan to more accurately reflect the targeted allocation 
when considered appropriate. 
Our assumed long-term rates of return on plan assets for 2022, 2023 and 2024 were as follows: 
 
 
 
 
 
 
 
 
     
2022 
     
2023 
 
2024 
Germany 
 
2.0%   
4.8%  
5.0% 
Canada 
 
3.8%   
4.4%  
4.9% 
Norway 
  
3.0%   
4.8%  
4.8% 
U.S. 
  
4.0%   
5.0%  
5.0% 
 
Our long-term rate of return on plan asset assumptions in 2025 used for purposes of determining our 2025 
defined benefit pension plan expense for Germany, Canada, Norway and the U.S. are 4.8%, 3.7%, 5.3% and 
5.0%, respectively. 
We follow ASC Topic 820, Fair Value Measurements and Disclosures, in determining the fair value of plan 
assets within our defined benefit pension plans. While we believe the valuation methods used to determine 
the fair value of plan assets are appropriate, the use of different methodologies or assumptions to determine 
the fair value of certain financial instruments could result in a different estimate of fair value at the reporting 
date. 
To the extent that a plan’s particular pension benefit formula calculates the pension benefit in whole or in 
part based upon future compensation levels, the projected benefit obligations and the pension expense will 
be based in part upon expected increases in future compensation levels. For all of our plans for which the 
benefit formula is so calculated, we generally base the assumed expected increase in future compensation 
levels upon average long-term inflation rates for the applicable country. 
In addition to the actuarial assumptions discussed above, the amount of recognized defined benefit pension 
expense and the amount of net pension asset and net pension liability will vary based upon relative changes 
in currency exchange rates.  
Based on the actuarial assumptions described above and our current expectation for what actual average 
currency exchange rates will be during 2025, we expect our defined benefit pension expense will approximate 
$8 million in 2025. In comparison, we expect to be required to contribute approximately $16 million to such 
plans during 2025. See Note 10 to our Consolidated Financial Statements for additional discussion of 
actuarial assumptions used in determining defined benefit pension assets, liabilities and expenses. 
As noted above, defined benefit pension expense and the amounts recognized as accrued pension costs are 
based upon the actuarial assumptions discussed above. We believe all of the actuarial assumptions used are 
reasonable and appropriate. However, if we had lowered the assumed discount rate by 25 basis points for all 
plans as of December 31, 2024, our aggregate projected benefit obligations would have increased by 
approximately $19.0 million at that date and our defined benefit pension expense would be expected to 
decrease by approximately $.1 million during 2025. Similarly, if we lowered the assumed long-term rate of 
return on plan assets by 25 basis points for all of our plans, our defined benefit pension expense would be 
expected to increase by approximately $1.2 million during 2025. 
• 
Income taxes – We operate globally and the calculation of our provision for income taxes and our deferred 
tax assets and liabilities involves the interpretation and application of complex tax laws and regulations in a 
multitude of jurisdictions across our global operations. Our effective tax rate is highly dependent upon the 
geographic distribution of our earnings or losses and the effects of tax laws and regulations in each 
tax-paying jurisdiction in which we operate. Significant judgments and estimates are required in determining 
our consolidated provision for income taxes due to the global nature of our operations. Our provision (benefit) 
for income taxes and deferred tax assets and liabilities reflects our best assessment of estimated current and 

 
36 
future taxes to be paid, including the recognition and measurement of deferred tax assets and liabilities. 
We recognize deferred taxes for future tax effects of temporary differences between financial and income 
tax reporting. Deferred income tax assets and liabilities for each tax-paying jurisdiction in which we operate 
are netted and presented as either a noncurrent deferred income tax asset or liability, as applicable. We record 
a valuation allowance to reduce our deferred income tax assets to the amount that is believed to be realized 
under the more-likely-than-not recognition criteria. While we have considered future taxable income and 
ongoing prudent and feasible tax planning strategies in assessing the need for a valuation allowance, it is 
possible that we may change our estimate of the amount of the deferred income tax assets that would 
more-likely-than-not be realized in the future, resulting in an adjustment to the deferred income tax asset 
valuation allowance that would either increase or decrease, as applicable, reported net income in the period 
such change in estimate was made. 
We periodically review our deferred tax assets (“DTA”) to determine if a valuation allowance is required. 
For example, at December 31, 2024, we have significant German corporate and trade net operating loss 
(NOL) carryforwards of $447.3 million (DTA of $70.8 million) and $40.1 million (DTA of $4.4 million), 
respectively; and Belgian corporate NOL carryforwards of $72.0 million (DTA of $18.0 million). Prior to 
December 31, 2024, and using all available evidence, we had concluded that no deferred income tax asset 
valuation allowance was required to be recognized with respect to such carryforwards, principally because 
(i) such carryforwards have lengthy carryforward periods (the German and Belgian carryforwards may be 
carried forward indefinitely), (ii) we have utilized a portion of such carryforwards during the most recent 
three-year period and (iii) we currently expect to utilize the remainder of such carryforwards over the long 
term. With respect to our Belgium carryforwards, at December 31, 2024, given our operating results during 
the fourth quarter of 2024 and our current expectations for 2025, we do not have sufficient positive evidence 
to overcome the significant negative evidence of having cumulative losses in the most recent twelve 
consecutive quarters in Belgium (even considering that the carryforward period of our Belgian NOL 
carryforwards is indefinite, one piece of positive evidence). Accordingly, at December 31, 2024, we 
concluded that we were required to recognize a non-cash deferred income tax asset valuation allowance of 
$8.2 million under the more-likely-than-not recognition criteria with respect to our Belgian net deferred tax 
assets. At December 31, 2024, we continue to conclude no valuation allowance is required to be recognized 
for our German DTAs although prior to the complete utilization of such carryforwards, if we were to generate 
additional losses in our German operations for an extended period of time, or if applicable laws were to 
change such that the carryforward periods were more limited, it is possible that we might conclude the benefit 
of such carryforwards would no longer meet the more-likely-than-not recognition criteria, at which point we 
would be required to recognize a valuation allowance against some or all of the then-remaining tax benefit 
associated with the carryforwards.   
The Organization for Economic Cooperation and Development (the “OECD”), the European Union and other 
countries have committed to enacting the OECD’s Pillar Two initiative that would provide a global minimum 
level of taxation for multinational companies to be applied on a country-by-country basis. Currently, many 
countries have enacted legislation to implement the Pillar Two rules effective for years beginning on or after 
December 31, 2023. Based on legislation currently enacted, we do not anticipate any material impact to our 
Consolidated Financial Statements; however, until all the jurisdictions we operate in enact legislation, the 
full impact of Pillar Two to us is unknown. 
• 
Acquisition of Joint Venture – During the third quarter of 2024, we acquired the 50% joint venture interest 
in LPC previously held by Venator. Prior to the acquisition we accounted for our interest in LPC under the 
equity method. The application of the purchase method of accounting for business combinations requires us 
to use significant estimates and assumptions in the determination of the estimated fair value of assets acquired 
and liabilities assumed. Our estimates of the fair values of assets acquired and liabilities assumed are based 
upon assumptions we believe are reasonable, and when appropriate, include assistance from independent 
third-party valuation advisors. See Note 5 to our Consolidated Financial Statements. 

 
37 
LIQUIDITY AND CAPITAL RESOURCES 
Consolidated cash flows 
Operating activities 
Trends in cash flows as a result of our operating activities (excluding the impact of significant asset dispositions 
and relative changes in assets and liabilities) are generally similar to trends in our earnings. In addition to the impact of 
the operating, investing and financing cash flows discussed below, changes in the amount of cash, cash equivalents and 
restricted cash we report from year to year can be impacted by changes in currency exchange rates, since a portion of our 
cash, cash equivalents and restricted cash is held by our non-U.S. subsidiaries. For example, during 2024, relative changes 
in currency exchange rates resulted in a $.1 million decrease in the reported amount of our cash, cash equivalents and 
restricted cash compared to a $1.0 million increase in 2023 and a $5.1 million decrease in 2022. 
Cash provided by operating activities was $72.5 million in 2024 compared to $5.5 million in 2023. This $67.0 
million increase in the amount of cash provided was primarily due to the net effect of the following: 
• 
higher income from operations in 2024 of $178.9 million, 
• 
higher amount of net cash used associated with relative changes in our inventories, receivables, payables and 
accruals in 2024 of $83.3 million,  
• 
higher cash paid for interest in 2024 of $22.4 million, 
• 
higher cash paid for taxes in 2024 of $17.2 million primarily due to higher earnings, 
• 
cash premium of $6.0 million on the issuance of senior notes, and 
• 
higher net contributions of $5.8 million to our TiO2 manufacturing joint venture in 2024 prior to the LPC 
acquisition. 
Cash provided by operating activities was $5.5 million in 2023 compared to $81.7 million in 2022. This 
$76.2 million decrease in the amount of cash provided was primarily due to the net effect of the following: 
• 
lower income from operations in 2023 of $215.6 million, 
• 
lower amount of net cash used associated with relative changes in our inventories, receivables, payables and 
accruals in 2023 of $109.5 million,  
• 
lower cash paid for income taxes of $20.0 million primarily due to decreased earnings in 2023, and 
• 
lower net contributions to our TiO2 manufacturing joint venture in 2023 of $13.6 million. 
Changes in working capital are affected by accounts receivable and inventory changes. As shown below: 
• 
Our average days sales outstanding, or DSO, decreased from December 31, 2023 to December 31, 2024, 
primarily due to relative changes in the timing of collections, and 
• 
Our average days sales in inventory, or DSI, increased from December 31, 2023 to December 31, 2024, 
primarily due to production volumes exceeding sales volumes in 2024 compared to 2023 when our sales 
volumes exceeded our production volumes. 
For comparative purposes, we have provided current and prior year numbers below. 
 
 
 
 
 
 
 
 
    December 31, 2022    December 31, 2023    December 31, 2024 
DSO 
 
  64 days 
 
66 days 
 
62 days 
DSI 
 
103 days 
 
65 days 
 
82 days 

 
38 
Investing activities 
We paid $156.8 million, net of cash acquired, for the remaining TiO2 manufacturing joint venture interest in LPC. 
See Note 5 to our Consolidated Financial Statements.  
Our capital expenditures were $29.5 million in 2024 compared to $47.4 million in 2023 and $63.2 million in 
2022. Capital expenditures are primarily incurred to maintain and improve the cost effectiveness of our manufacturing 
facilities. Our capital expenditures during the past three years include an aggregate of $45.8 million (including 
$17.0 million in 2024) for our ongoing environmental protection and compliance programs. 
During 2023 and 2022, we had no loans or collections under our unsecured revolving demand promissory note 
with Valhi, which was cancelled in February 2024. 
Financing activities 
During 2024, we: 
• 
paid dividends of $.48 per share to stockholders aggregating $55.2 million ($.19, $.19, $.05 and $.05 per 
share in the first, second, third and fourth quarters of 2024, respectively), and 
• 
exchanged €325 million of our Kronos International, Inc. (KII) 3.75% Senior Secured Notes due 
September 2025 (the “Old Notes”) for our newly issued €276.174 million 9.50% Senior Secured Notes due 
March 2029 (the “New Notes”) plus additional cash consideration of $52.6 million to certain eligible holders 
of the Old Notes and borrowed $53.7 million from Contran. In the third quarter we issued an additional 
€75 million principal amount of 9.50% Senior Secured Notes due 2029 (the Additional New Notes (as 
defined below) together with the Old Notes and the New Notes, the “Senior Secured Notes”). See Note 8 to 
our Consolidated Financial Statements. 
During 2023, we: 
• 
paid quarterly dividends of $.19 per share to stockholders aggregating $87.5 million, and 
• 
acquired 313,814 shares of our common stock in market transactions for an aggregate purchase price of 
$2.8 million. 
During 2022, we: 
• 
paid quarterly dividends of $.19 per share to stockholders aggregating $87.8 million, and 
• 
acquired 217,778 shares of our common stock in market transactions for an aggregate purchase price of 
$2.3 million. 
In February 2025, our board of directors declared a first quarter 2025 regular quarterly dividend of $.05 per share, 
payable March 20, 2025 to stockholders of record as of March 11, 2025. 
Outstanding debt obligations and borrowing availability 
At December 31, 2024, our consolidated debt comprised: 
• 
€351.174 million aggregate outstanding on our KII 9.5% Senior Secured Notes due 2029 plus €5.1 million 
of unamortized premium ($365.4 million carrying amount, net of unamortized debt issuance costs), 
• 
€75 million aggregate outstanding on our KII 3.75% Senior Secured Notes due 2025 ($78.3 million carrying 
amount), 
• 
$53.7 million outstanding on our subordinated, unsecured term loan from Contran due September 2029 (the 
“Contran Term Loan”), and 
• 
$10.0 million outstanding on our Global Revolver. 

 
39 
Availability under the Global Revolver is subject to a borrowing base calculation, as defined in the agreement. 
The borrowing base calculated as of December 31, 2024 was approximately $278 million. Effective July 17, 2024, we 
completed an amendment to our Global Revolver (the “Second Amendment”). Among other things, the Second 
Amendment increased the maximum borrowing amount from $225 million to $300 million, extended the maturity date to 
July 2029 and expanded the facility to include LPC and LPC’s receivables and certain of its inventories in the borrowing 
base. The LPC acquisition was financed through borrowings of $132.1 million under our Global Revolver with the 
remainder paid with cash on hand. On July 30, 2024, our wholly-owned subsidiary, KII, issued an additional €75 million 
principal amount of 9.50% Senior Secured Notes due 2029 (the “Additional New Notes”). The Additional New Notes 
were issued at a premium of 107.50% of their principal amount, plus accrued interest from February 12, 2024, resulting 
in net proceeds of approximately $90 million, after fees and expenses. The Additional New Notes are fungible with the 
New Notes, are treated as a single series with the New Notes, and have the same terms as the New Notes, other than their 
date of issuance and issue price. The proceeds from the Additional New Notes were used to pay down borrowings incurred 
under the Global Revolver. Subsequent to the issuance of the Additional New Notes, the Contran Term Loan was amended 
in August 2024 to change the interest rate from 11.5% (which had been determined by adding an additional spread of 2% 
to the final interest rate on the New Notes issued in February 2024) to 9.54% (determined by adding a spread of 2% to the 
effective interest rate of the Additional New Notes issued in July 2024). In each case, the spread used to determine the rate 
was based upon comparable debt transactions at the time of the issuance of the applicable notes. See Note 8 to our 
Consolidated Financial Statements.  
 
The Contran Term Loan is subordinated in right of payment to our Senior Secured Notes and our Global Revolver. 
Our Senior Secured Notes, the Contran Term Loan and our Global Revolver contain a number of covenants and restrictions 
which, among other things, restrict our ability to incur or guarantee additional debt, incur liens, pay dividends or make 
other restricted payments, or merge or consolidate with, or sell or transfer substantially all of our assets to, another entity, 
and contain other provisions and restrictive covenants customary in lending transactions of these types. Our credit 
agreements contain provisions which could result in the acceleration of indebtedness prior to their stated maturity for 
reasons other than defaults for failure to comply with typical financial or payment covenants. For example, the credit 
agreements allow the lender to accelerate the maturity of the indebtedness upon a change of control (as defined in the 
agreement) of the borrower. In addition, the credit agreements could result in the acceleration of all or a portion of the 
indebtedness following a sale of assets outside the ordinary course of business. The terms of all of our debt instruments 
are discussed in Note 8 to our Consolidated Financial Statements. We are in compliance with all of our debt covenants at 
December 31, 2024. We believe we will be able to continue to comply with the financial covenants contained in our credit 
facility through its maturity; however, if future operating results differ materially from our expectations we may be unable 
to maintain compliance. 
Our assets consist primarily of investments in operating subsidiaries, and our ability to service our obligations, 
including the Senior Secured Notes and the Contran Term Loan, depends in part upon the distribution of earnings of our 
subsidiaries, whether in the form of dividends, advances or payments on account of intercompany obligations or otherwise. 
Our Senior Secured Notes are collateralized by, among other things, a first priority lien on (i) 100% of the common stock 
or other ownership interests of each existing and future direct domestic subsidiary of KII and the guarantors, and (ii) 65% 
of the voting common stock or other ownership interests and 100% of the non-voting common stock or other ownership 
interests of each non-U.S. subsidiary that is directly owned by KII or any guarantor. Our Global Revolver is collateralized 
by, among other things, a first priority lien on the borrower’s trade receivables and inventories.  
Future cash requirements 
Liquidity 
Our primary source of liquidity on an ongoing basis is cash flows from operating activities which is generally 
used to (i) fund capital expenditures, (ii) repay any short-term indebtedness incurred for working capital purposes, 
(iii) provide for the payment of dividends and (iv) fund purchases of shares of our common stock under our stock 
repurchase program. From time-to-time we will incur indebtedness, generally to (i) fund short-term working capital needs, 
(ii) refinance existing indebtedness or (iii) fund major capital expenditures or the acquisition of other assets outside the 
ordinary course of business. We will also from time-to-time sell assets outside the ordinary course of business and use the 

 
40 
proceeds to (i) repay existing indebtedness, (ii) make investments in marketable and other securities, (iii) fund major 
capital expenditures or the acquisition of other assets outside the ordinary course of business or (iv) pay dividends. 
The TiO2 industry is cyclical, and changes in industry economic conditions significantly impact earnings and 
operating cash flows. Changes in TiO2 pricing, production volumes and customer demand, among other things, could 
significantly affect our liquidity. 
We routinely evaluate our liquidity requirements, alternative uses of capital, capital needs and availability of 
resources in view of, among other things, our dividend policy, our debt service, our capital expenditure requirements and 
estimated future operating cash flows. As a result of this process, we have in the past and may in the future seek to reduce, 
refinance, repurchase or restructure indebtedness, raise additional capital, repurchase shares of our common stock, modify 
our dividend policy, restructure ownership interests, sell interests in our subsidiaries or other assets, or take a combination 
of these steps or other steps to manage our liquidity and capital resources. Such activities have in the past and may in the 
future involve related companies. We may also from time to time engage in preliminary discussions with existing or 
potential investors regarding the timing or terms of any such refinancing or other potential transactions. In the normal 
course of our business, we may investigate, evaluate, discuss and engage in acquisition, joint venture, strategic relationship 
and other business combination opportunities in the TiO2 industry. In the event of any future acquisition or joint venture 
opportunity, we may consider using then-available liquidity, issuing our equity securities or incurring additional 
indebtedness. 
Based upon our expectation for the TiO2 industry and anticipated demands on cash resources, we expect to have 
sufficient liquidity to meet our short-term obligations (defined as the twelve-month period ending December 31, 2025) 
and our long-term obligations (defined as the five-year period ending December 31, 2029, our time period for long-term 
budgeting). With respect to the €75 million KII 3.75% Senior Secured Notes due 2025, we intend to satisfy this obligation 
through cash generated from operations or to the extent that is not sufficient, a combination of cash generated from 
operations and borrowings on the Global Revolver. If actual developments differ from our expectations, our liquidity could 
be adversely affected. 
Cash, cash equivalents, restricted cash and marketable securities 
At December 31, 2024 we had: 
 
 
 
 
 
 
 
 
 
 
 
   
Held by 
        
 
 
 
U.S.  
 
Non-U.S.    
 
 
     entities      entities      
Total 
 
 
(In millions) 
Cash and cash equivalents 
  $ 
 28.9  
$ 
 77.8  
$ 
 106.7 
Current restricted cash 
    
 1.3  
  
 2.0  
  
 3.3 
Noncurrent restricted cash 
    
 -  
  
 4.7  
  
 4.7 
Noncurrent marketable securities 
    
 3.4  
  
 -  
  
 3.4 
Following implementation of a territorial tax system under the 2017 Tax Act, repatriation of any cash and cash 
equivalents held by our non-U.S. subsidiaries would not be expected to result in any material income tax liability as a 
result of such repatriation. 
Stock repurchase program 
At December 31, 2024, we have 1,017,518 shares available for repurchase under a stock repurchase program 
authorized by our board of directors. See Note 13 to our Consolidated Financial Statements. 

 
41 
Capital expenditures 
We intend to spend approximately $55 million on capital expenditures during 2025 (including approximately 
$9 million contractually committed at December 31, 2024), primarily to maintain and improve our existing facilities. We 
estimate approximately $24 million of our 2025 capital expenditures will be in environmental compliance, protection and 
improvement programs which are primarily focused on increasing operating efficiency but also result in improved 
environmental protection, such as lower emissions from our manufacturing plants. Capital spending for 2025 is expected 
to be funded through cash on hand or borrowing under our existing credit facility. It is possible we will delay planned 
capital projects based on market conditions. 
Commitments and contingencies 
See Notes 5, 12 and 15 to our Consolidated Financial Statements for a description of certain income tax 
contingencies, certain legal proceedings and other commitments. 
As described in the Notes to the Consolidated Financial Statements, we are a party to various debt, lease, raw 
material supply and other agreements which contractually and unconditionally commit us to pay certain amounts in the 
future. See Notes 7, 8, 14 and 15 to our Consolidated Financial Statements. 
 
Recent accounting pronouncements 
See Note 19 to our Consolidated Financial Statements. 
ITEM 7A. 
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 
General 
We are exposed to market risk from changes in interest rates, currency exchange rates, equity security and raw 
material prices. 
Interest rates 
At December 31, 2024, our aggregate indebtedness was comprised primarily of our fixed-rate, euro-denominated 
KII 9.5% Senior Secured Notes due 2029 and KII 3.75% Senior Secured Notes due 2025. The fixed-rate debt instruments 
minimize earnings volatility that would result from changes in interest rates. Our Global Revolver is a variable-rate 
instrument. The following table presents principal amounts and weighted average interest rates for our aggregate 
outstanding indebtedness at December 31, 2024. Information shown below for our euro-denominated 9.50% and 3.75% 
Senior Secured Notes due 2029 and 2025, respectively, is presented in its U.S. dollar equivalent at December 31, 2024 
(net of unamortized debt issuance costs of $6.3 million, in addition to an unamortized bond premium of $5.3 million) using 
an exchange rate of U.S. $1.043 per euro. In addition, at December 31, 2024, we have a $53.7 million subordinated, 
unsecured term loan payable to a related party, Contran, due September 2029. See Notes 8 and 14 to our Consolidated 
Financial Statements. 
 
 
 
 
 
 
 
 
 
 
 
 
     
Indebtedness amount 
     Year-end      
   
 
 
Carrying  
 
Fair  
 
interest   
Maturity  
 
     
amount 
     
value 
     
rate 
     
date 
 
 
(In millions) 
 
 
 
 
Fixed-rate indebtedness: 
  
 
  
 
 
 
 
 
Kronos International, Inc. 9.50% Senior Secured 
 $ 
 365.4   
 403.4  
 9.50 % 
2029 
Kronos International, Inc. 3.75% Senior Secured 
  
 78.3   
 77.9  
 3.75 % 
2025 
Total fixed rate indebtedness 
 $ 
 443.7  $ 
 481.3  
 8.49 % 
Variable rate indebtedness: 
 
 
 
 
  
 
Revolving credit facility 
 
$ 
 10.0  
$ 
 10.0  
 6.25 %  
2029 
Currency exchange rates 
We are exposed to market risk arising from changes in currency exchange rates as a result of manufacturing and 
selling our products worldwide. Earnings are primarily affected by fluctuations in the value of the U.S. dollar relative to 

 
42 
the euro, the Canadian dollar, the Norwegian krone and to a lesser extent the United Kingdom pound sterling and the value 
of the euro relative to the Norwegian krone. 
The majority of our sales from non-U.S. operations are denominated in currencies other than the U.S. dollar, 
principally the euro, other major European currencies and the Canadian dollar. A portion of our sales generated from our 
non-U.S. operations is denominated in the U.S. dollar (and consequently our non-U.S. operations will generally hold U.S. 
dollars from time to time). Certain raw materials used in all our production facilities, primarily titanium-containing 
feedstocks, are purchased primarily in U.S. dollars, while labor and other production and administrative costs are incurred 
primarily in local currencies. Consequently, the translated U.S. dollar value of our non-U.S. sales and operating results are 
subject to currency exchange rate fluctuations which may favorably or unfavorably impact reported earnings. In addition 
to the impact of the translation of sales and expenses over time, our non-U.S. operations also generate currency transaction 
gains and losses which primarily relate to (i) the difference between the currency exchange rates in effect when non-local 
currency sales or operating costs (primarily U.S. dollar denominated) are initially accrued and when such amounts are 
settled with the non-local currency and (ii) changes in currency exchange rates during time periods when our non-U.S. 
operations are holding non-local currency (primarily U.S. dollars). 
We periodically use currency forward contracts to manage a very nominal portion of currency exchange rate risk 
associated with trade receivables denominated in a currency other than the holder’s functional currency or similar exchange 
rate risk associated with future sales. We have not entered into these contracts for trading or speculative purposes in the 
past. However, we may enter into such contracts in the future to manage our currency exchange rate risk. We are not party 
to any currency forward contracts at December 31, 2024. 
Also, we are subject to currency exchange rate risk associated with our Senior Secured Notes due 2025 and 2029, 
as such indebtedness is denominated in euros. At December 31, 2024, we had the equivalent of $365.4 million outstanding 
under our euro-denominated KII 9.5% Senior Secured Notes due 2029 (exclusive of unamortized bond premium and debt 
issuance costs) and $78.3 million outstanding under our euro-dominated KII 3.75% Senior Secured Notes due 2025 
(exclusive of unamortized debt issuance costs). The potential increase in the U.S. dollar equivalent of such indebtedness 
resulting from a hypothetical 10% adverse change in exchange rates at December 31, 2024 would be approximately $45 
 
million. 
Raw materials 
We are exposed to market risk from changes in commodity prices relating to our raw materials. As discussed in 
Item 1 we generally enter into long-term supply agreements for certain of our raw material requirements. Many of our raw 
material contracts contain fixed quantities we are required to purchase or specify a range of quantities within which we 
are required to purchase. Raw material pricing under these agreements is generally negotiated quarterly or semi-annually 
depending upon the suppliers. For certain raw material requirements we do not have long-term supply agreements either 
because we have assessed the risk of the unavailability of those raw materials and/or the risk of a significant change in the 
cost of those raw materials to be low, or because long-term supply agreements for those raw materials are generally not 
available. 
Other 
We believe there may be a certain amount of incompleteness in the sensitivity analyses presented above. For 
example, the hypothetical effect of changes in exchange rates discussed above ignores the potential effect on other 
variables which affect our results of operations and cash flows, such as demand for our products, sales volumes and selling 
prices and operating expenses. Accordingly, the amounts presented above are not necessarily an accurate reflection of the 
potential losses we would incur assuming the hypothetical changes in exchange rates were actually to occur. 
The above discussion and estimated sensitivity analysis amounts include forward-looking statements of market 
risk which assume hypothetical changes in currency exchange rates. Actual future market conditions will likely differ 
materially from such assumptions. Accordingly, such forward-looking statements should not be considered to be 
projections by us of future events, gains or losses. 

 
43 
ITEM 8. 
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 
The information called for by this Item is contained in a separate section of this Annual Report. See “Index of 
Financial Statements” (page F-1). 
ITEM 9. 
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND 
FINANCIAL DISCLOSURE 
None 
ITEM 9A. 
CONTROLS AND PROCEDURES 
Evaluation of disclosure controls and procedures 
We maintain disclosure controls and procedures which, as defined in Exchange Act Rule 13a-15(e), means 
controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we 
file or submit to the SEC under the Securities Exchange Act of 1934, as amended (the Act), is recorded, processed, 
summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and 
procedures include, without limitation, controls and procedures designed to ensure that information we are required to 
disclose in the reports we file or submit to the SEC under the Act is accumulated and communicated to our management, 
including our principal executive officer and our principal financial officer, or persons performing similar functions, as 
appropriate to allow timely decisions to be made regarding required disclosure. Each of James M. Buch, our President and 
Chief Executive Officer and Tim C. Hafer, our Executive Vice President and Chief Financial Officer, have evaluated the 
design and effectiveness of our disclosure controls and procedures as of December 31, 2024. Based upon their evaluation, 
these executive officers have concluded that our disclosure controls and procedures are effective as of the date of such 
evaluation. 
Management’s report on internal control over financial reporting 
Our management is responsible for establishing and maintaining adequate internal control over financial reporting 
which, as defined by Exchange Act Rule 13a-15(f) means a process designed by, or under the supervision of, our principal 
executive and principal financial officers, or persons performing similar functions, and effected by the board of directors, 
management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the 
preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and 
includes those policies and procedures that: 
• 
Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions 
and dispositions of our assets, 
• 
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial 
statements in accordance with GAAP, and that receipts and expenditures are being made only in accordance 
with authorizations of management and directors and 
• 
Provide reasonable assurance regarding prevention or timely detection of an unauthorized acquisition, use or 
disposition of assets that could have a material effect on our Consolidated Financial Statements. 
Our evaluation of the effectiveness of internal control over financial reporting is based upon the criteria 
established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the 
Treadway Commission in 2013 (commonly referred to as the “2013 COSO” framework). Based on our evaluation under 
that framework, we have concluded that our internal control over financial reporting was effective as of 
December 31, 2024. 
PricewaterhouseCoopers LLP, the independent registered public accounting firm that has audited our 
Consolidated Financial Statements included in this Annual Report, has audited the effectiveness of our internal control 
 
 

 
44 
over financial reporting as of December 31, 2024, as stated in their report, which is included in this Annual Report on 
Form 10-K. 
Other 
As permitted by the SEC, our assessment of internal control over financial reporting excludes (i) internal control 
over the preparation of any financial statement schedules which would be required by Article 12 of Regulation S-X and 
(ii) internal control over financial reporting as it relates to our newly-consolidated subsidiary LPC (as discussed in Note 5 
to our Consolidated Financial Statements, which represents approximately 19% of our total assets at December 31, 2024).  
Changes in internal control over financial reporting 
There has been no change to our internal control over financial reporting during the quarter ended 
December 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over 
financial reporting. 
Certifications 
Our chief executive officer is required to annually file a certification with the New York Stock Exchange, or 
NYSE, certifying our compliance with the corporate governance listing standards of the NYSE. During 2024, our chief 
executive officer filed such annual certification with the NYSE. The 2024 certification was unqualified. 
Our chief executive officer and chief financial officer are also required to, among other things, file quarterly 
certifications with the SEC regarding the quality of our public disclosures, as required by Section 302 of the 
Sarbanes-Oxley Act of 2002. The certifications for the quarter ended December 31, 2024 have been filed as Exhibits 31.1 
and 31.2 to this Annual Report on Form 10-K. 
 
ITEM 9B. 
OTHER INFORMATION 
Not applicable 
 
ITEM 9C. 
DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 
Not applicable. 

 
45 
PART III 
ITEM 10. 
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 
The information required by this Item is incorporated by reference to our 2025 definitive proxy statement to be 
filed with the SEC pursuant to Regulation 14A within 120 days after the end of the fiscal year covered by this report. 
ITEM 11. 
EXECUTIVE COMPENSATION 
The information required by this Item is incorporated by reference to our 2025 proxy statement. 
ITEM 12. 
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 
AND RELATED STOCKHOLDER MATTERS 
The information required by this Item is incorporated by reference to our 2025 proxy statement. 
ITEM 13. 
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR 
INDEPENDENCE 
The information required by this Item is incorporated by reference to our 2025 proxy statement. See also Note 14 
to our Consolidated Financial Statements. 
ITEM 14. 
PRINCIPAL ACCOUNTING FEES AND SERVICES 
The information required by this Item is incorporated by reference to our 2025 proxy statement. 
 
 

 
46 
PART IV 
ITEM 15. 
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 
(a) and (c)    Financial Statements 
 
The Registrant 
 The Consolidated Financial Statements of the Registrant listed on the accompanying Index of Financial
Statements (see page F-1) are filed as part of this Annual Report.  
50%-or-less owned persons  
We are not required to provide any consolidated financial statements pursuant to Rule 3-09 of Regulation 
S-X. 
(b)
 
Exhibits 
 
Included as exhibits are the items listed in the Exhibit Index. We will furnish a copy of any of the exhibits
listed below upon payment of $4.00 per exhibit to cover our costs to furnish the exhibits. Pursuant to Item
601(b)(4)(iii) of Regulation S-K, any instrument defining the rights of holders of long-term debt issues 
and other agreements related to indebtedness which do not exceed 10% of consolidated total assets as of
December 31, 2024 will be furnished to the Commission upon request. 
 
 
 
 
Item No. 
    
Exhibit Index 
3.1+ 
 Restated First Amended and Restated Certificate of Incorporation of Kronos Worldwide, Inc., as amended
on May 12, 2011 – incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on
Form 8-K filed on May 12, 2011. 
3.2 
 Amended and Restated Bylaws of Kronos Worldwide, Inc. as of October 25, 2023 – incorporated by 
reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed with the U.S. Securities and
Exchange Commission on October 25, 2023. 
4.1 
 Description of the Registrant’s Capital Stock – incorporated by reference to Exhibit 4.1 to the Registrant’s
Annual Report on Form 10-K for the year ended December 31, 2019. 
10.1 
 Tax Agreement between Valhi, Inc. and Kronos Worldwide, Inc. dated as of January 1, 2020 –
incorporated by reference to Exhibit 10.1 to the Registrant’s Annual Report on Form 10-K for the year 
ended December 31, 2019. 
10.2 
 Intercorporate Services Agreement by and between Contran Corporation and Kronos Worldwide, Inc.,
effective as of January 1, 2004 – incorporated by reference to Exhibit 10.1 to the Quarterly Report on
Form 10-Q of the Registrant for the quarter ended March 31, 2004. 
10.3* 
 Kronos Worldwide, Inc. 2012 Director Stock Plan – incorporated by reference to Exhibit 4.4 of the
Registration statement on Form S-8 of the Registrant. 
10.4 
 Lease Contract, dated June 21, 1952, between Farbenfabriken Bayer Aktiengesellschaft and
Titangesellschaft mit beschrankter Haftung (German language version and English translation thereof)-
incorporated by reference to Exhibit 10.14 to the Annual Report on Form 10-K (File No. 001-00640) of 
NL Industries, Inc. for the year ended December 31, 1985. (P) 
10.5 
 Form of Assignment and Assumption Agreement, dated as of January 1, 1999, between Kronos Inc.
(formerly known as Kronos (USA), Inc.) and Kronos International, Inc. – incorporated by reference to 
Exhibit 10.9 to Kronos International, Inc.’s Registration Statement on Form S-4 (File No. 333-100047). 
(P) 
 
 

 
47 
Item No. 
    
Exhibit Index 
10.6 
 Form of Cross License Agreement, effective as of January 1, 1999, between Kronos Inc. (formerly known
as Kronos (USA), Inc.) and Kronos International, Inc. – incorporated by reference to Exhibit to Kronos
International, Inc.’s Registration Statement on Form S-4 (File No. 333-100047). (P) 
10.7 
 Second Amended and Restated Agreement Regarding Shared Insurance among CompX International Inc.,
Contran Corporation, Kronos Worldwide, Inc., NL Industries, Inc., and Valhi, Inc. dated January 25, 
2019 – incorporated by reference to Exhibit 10.16 to the Registrant’s Annual Report on Form 10-K for the 
year ended December 31, 2018. 
10.8 
 Restated and Amended Agreement by and between Richards Bay Titanium (Proprietary) Limited (acting
through its sales agent Rio Tinto Iron & Titanium Limited) and Kronos (US), Inc. effective
January 1, 2016 – incorporated by reference to Exhibit 10.26 to the Registrant’s Annual Report on
Form 10-K for the year ended December 31, 2015. 
10.9 
 Indenture, dated as of September 13, 2017, among Kronos International, Inc., the guarantors named
therein, and Deutsche Bank Trust Company Americas, as trustee, collateral agent, paying agent, transfer
agent and registrar – incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K dated 
September 13, 2017 and filed by the Registrant on September 13, 2017. 
10.9.1 
 Supplemental Indenture No. 1, dated as of February 12, 2024, among Kronos International, Inc., the
guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee, collateral agent,
paying agent, transfer agent and registrar – incorporated by reference to Exhibit 4.1 to the Current Report
on Form 8-K filed by the Registrant on February 12, 2024. 
10.9.2 
 Supplemental Indenture No. 2, dated as of August 8, 2024, among Louisiana Pigment Company, L.P. and
Kronos LPC, LLC (as new guarantors under the Indenture dated as of September 13, 2017, as amended), 
Kronos International, Inc., and Deutsche Bank Trust Company Americas, as trustee, collateral agent,
paying agent, transfer agent and registrar – incorporated by reference to Exhibit 10.1 to the Registrant’s 
Quarterly Report on Form 10-Q for the quarter ended September 30, 2024.  
10.10 
 Indenture, dated as of February 12, 2024, among Kronos International, Inc., the guarantors named therein,
and Deutsche Bank Trust Company Americas, as trustee, collateral agent, paying agent, transfer agent and
registrar – incorporated by reference to Exhibit 4.2 to the Current Report on Form 8 K filed by the 
Registrant on February 12, 2024. 
10.10.1 
 First Supplemental Indenture dated as of July 30, 2024, by and among Kronos International, Inc., the
guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee, collateral agent,
paying agent, transfer agent and registrar – incorporated by reference to Exhibit 10.1 to the Current Report
on Form 8-K filed by the Registrant on July 30, 2024. 
10.10.2 
 Second Supplemental Indenture dated as of August 8, 2024, among Louisiana Pigment Company, L.P. and
Kronos LPC, LLC (as new guarantors under the Indenture dated as of February 12, 2024, as amended), 
Kronos International, Inc., and Deutsche Bank Trust Company Americas, as trustee, collateral agent,
paying agent, transfer agent and registrar – incorporated by reference to Exhibit 10.2 to the Registrant’s 
Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. 
10.11 
 Pledge Agreement, dated as of September 13, 2017, among Kronos International, Inc., the guarantors
named therein and Deutsche Bank Trust Company Americas, as collateral agent – incorporated by 
reference to Exhibit 4.2 to the Current Report on Form 8-K dated September 13, 2017, and filed by the 
Registrant on September 13, 2017. 
 
 

 
48 
Item No. 
    
Exhibit Index 
10.11.1 
 Additional Notes Priority Joinder Agreement dated February 12, 2024, executed by Deutsche Bank Trust
Company Americas, as trustee and collateral agent for the holders of Kronos International, Inc.’s 9.50%
Senior Secured Notes due 2029 and as existing agent under the Pledge Agreement dated September 13, 
2017 entered into in connection with Kronos International Inc.’s 3.75% Senior Secured Notes due 2025 –
incorporated by reference to Exhibit 4.4 to the Current Report on Form 8 K filed by the Registrant on
February 12, 2024. 
10.11.2 
 Additional Notes Priority Joinder Agreement dated July 30, 2024, executed by Deutsche Bank Trust
Company Americas, as trustee and collateral agent – incorporated by reference to Exhibit 10.2 to the
Current Report on Form 8-K filed by the Registrant on July 30, 2024. 
10.11.3 
 Joinder No. 1 dated as of August 8, 2024, to the Pledge Agreement dated as of September 13, 2017, joining 
Louisiana Pigment Company, L.P. and Kronos LPC, LLC to the Pledge Agreement – incorporated by 
reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended 
September 30, 2024. 
10.11.4 
 Pledge Amendment dated as of August 8, 2024, to the Pledge Agreement dated as of September 13, 2017, 
executed by Kronos Louisiana, Inc. and Kronos LPC, LLC regarding additional pledged securities –
incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter 
ended September 30, 2024. 
10.12 
 Credit Agreement dated as of April 20, 2021, by and among the Company, Kronos Louisiana, Inc., Kronos
(US), Inc., Kronos Canada, Inc., Kronos Europe NV, Kronos Titan GmbH and Wells Fargo Bank, National
Association as administrative agent and lender – incorporated by reference to Exhibit 10.1 to the Registrant’s
Quarterly Report on Form 10-Q for the quarter ended March 31, 2021. 
10.12.1 
 First Amendment to Credit Agreement dated May 8, 2023, among Kronos Worldwide, Inc., Kronos
Louisiana, Inc., Kronos (US), Inc., Kronos Canada, Inc., Kronos Europe NV, Kronos Titan GmbH, Wells
Fargo Bank, National Association, as administrative agent, and the lenders a party thereto – incorporated 
by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed with the U.S. Securities
and Exchange Commission on May 9, 2023. 
10.12.2 
 Second Amendment to Credit Agreement dated July 17, 2024 among Kronos Worldwide, Inc.,  Kronos
Louisiana, Inc., Kronos (US), Inc., Kronos Canada, Inc., Kronos Europe NV, Kronos Titan GmbH, Wells
Fargo Bank, National Association as administrative agent and the lenders a party thereto – incorporated 
by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by the Registrant on July 17, 2024. 
10.12.3 
 Third Amendment to Credit Agreement dated December 19, 2024 among Kronos Worldwide, Inc., Kronos
Louisiana, Inc., Kronos (US), Inc., Kronos Canada, Inc., Kronos Europe NV, Kronos Titan GmbH, Wells
Fargo Bank, National Association, as administrative agent, and the lenders a party thereto – incorporated 
by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Registrant on
December 19, 2024. 
10.13 
 Guaranty and Security Agreement dated as of April 20, 2021, by and among the Company, Kronos
Louisiana, Inc., Kronos (US), Inc., Kronos Canada, Inc., Kronos International, Inc. and Wells Fargo Bank,
National Association as administrative agent and lender – incorporated by reference to Exhibit 10.2 to the
Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021. 
10.13.1 
 First Amendment to Guaranty and Security Agreement, entered into as of July 17, 2024, by and among 
Kronos Worldwide, Inc., Kronos Louisiana, Inc., Kronos (US), Inc., Kronos International, Inc. and Wells
Fargo Bank, National Association as administrative agent and lender, amending Guaranty and Security
Agreement dated as of April 20, 2021 – incorporated by reference to Exhibit 10.5 to the Registrant’s 
Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. 
 
 

 
49 
Item No. 
    
Exhibit Index 
10.13.2 
 Joinder No. 1 dated as of August 7, 2024, joining Louisiana Pigment Company, L.P. and Kronos LPC,
LLC to the Guaranty and Security Agreement dated as of April 20, 2021, as amended – incorporated by 
reference to Exhibit 10.6 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended 
September 30, 2024. 
10.14 
 Unsecured Subordinated Term Promissory Note dated February 12, 2024, in the principal amount of
$53,705,000 executed by Kronos Worldwide, Inc. and the guarantors named therein and payable to the
order of Contran Corporation – incorporated by reference to Exhibit 4.5 to the Current Report on Form 8 
K filed by the Registrant on February 12, 2024. 
10.14.1 
 First Amendment to Unsecured Subordinated Term Promissory Note dated February 12, 2024, executed 
by Kronos Worldwide, Inc. and Contran Corporation as of August 7, 2024 – incorporated by reference to 
Exhibit 10.6 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. 
10.15 
 Purchase and Sale Agreement dated July 16, 2024 by and between Kronos Louisiana, Inc., Kronos
Worldwide, Inc., Venator Investments, Ltd. and Venator Materials PLC – incorporated by reference to 
Exhibit 10.1 to the Current Report on Form 8-K filed by the Registrant on July 17, 2024. 
10.15.1 
 Amendment to Purchase and Sale Agreement dated August 13, 2024, by and between Kronos Louisiana,
Inc., Kronos Worldwide, Inc., Venator Investments, Ltd., Venator Materials PLC. and Louisiana Pigment
Company, L.P, amending Purchase Agreement dated as of July 16, 2024 – incorporated by reference to 
Exhibit 10.7 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024.
19.1** 
 Kronos Worldwide, Inc. Insider Trading Policy 
21.1** 
 Subsidiaries. 
23.1** 
 Consent of PricewaterhouseCoopers LLP. 
31.1** 
 Certification. 
31.2** 
 Certification. 
32.1** 
 Certification. 
97* 
 Policy of the Recovery of Erroneously Awarded Compensation incorporated by reference to the
Registrant’s Annual Report on Form 10-K for the year ended December 31, 2023. 
101.INS**  Inline XBRL Instance - the instance document does not appear in the Interactive Data File because its
XBRL tags are embedded within the Inline XBRL document. 
101.SCH**  Inline XBRL Taxonomy Extension Schema 
101.CAL**  Inline XBRL Taxonomy Extension Calculation Linkbase 
101.DEF**  Inline XBRL Taxonomy Extension Definition Linkbase 
101.LAB**  Inline XBRL Taxonomy Extension Label Linkbase 
101.PRE**  Inline XBRL Taxonomy Extension Presentation Linkbase 
104 
 Cover page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) 
 
+ 
Exhibit 3.1 is restated for the purposes of the disclosure requirements of Item 601 of Regulation S-K promulgated by 
the U.S. Securities and Exchange Commission and does not represent a restated certificate of incorporation that has 
been filed with the Delaware Secretary of State. 
* 
Management contract, compensatory plan or arrangement 
** Filed herewith 
(P) Paper exhibits 

 
50 
SIGNATURES 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has 
duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 
 
 
 
 
Kronos Worldwide, Inc. 
 
(Registrant) 
 
 
 
 
 
 
 
 
 
 
By: /s/ James M. Buch 
 
 
James M. Buch, March 6, 2025 
 
 
(President and Chief Executive Officer) 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the 
following persons on behalf of the Registrant and in the capacities and on the dates indicated: 
 
 
 
/s/ Loretta J. Feehan 
     /s/ John E. Harper 
Loretta J. Feehan, March 6, 2025 
 
John E. Harper, March 6, 2025 
(Chair of the Board (non-executive)) 
 
(Director) 
 
 
 
 
 
 
 
 
 
/s/ Michael S. Simmons 
 
/s/ Kevin B. Kramer 
Michael S. Simmons, March 6, 2025 
 
Kevin B. Kramer, March 6, 2025 
(Vice Chairman of the Board) 
 
(Director) 
 
 
 
 
 
 
 
 
 
/s/ James M. Buch 
 
/s/ Meredith W. Mendes 
James M. Buch, March 6, 2025 
 
Meredith W. Mendes, March 6, 2025 
(President and Chief Executive Officer) 
 
(Director) 
 
 
 
 
 
 
 
 
 
/s/ Tim C. Hafer 
 
/s/ Cecil H. Moore, Jr. 
Tim C. Hafer, March 6, 2025 
 
Cecil H. Moore, Jr., March 6, 2025 
(Executive Vice President and Chief Financial Officer,  
 
(Director) 
Principal Financial Officer) 
 
 
 
 
 
 
 
 
/s/ Bryan S. Bell 
 
/s/ R. Gerald Turner 
Bryan S. Bell, March 6, 2025 
 
R. Gerald Turner, March 6, 2025 
(Vice President and Controller, Global Finance) 
 
(Director) 
 
 
 

(This page has been left blank intentionally.)

 
F-1 
KRONOS WORLDWIDE, INC. 
Annual Report on Form 10-K 
Items 8, 15(a) and 15(c) 
Index of Financial Statements 
 
 
 
Financial Statements 
Page 
Report of Independent Registered Public Accounting Firm (PCAOD ID 238) 
F-2
Consolidated Balance Sheets – December 31, 2023 and 2024 
F-5
Consolidated Statements of Operations –  
Years ended December 31, 2022, 2023 and 2024 
F-7
Consolidated Statements of Comprehensive Income (Loss) –   
Years ended December 31, 2022, 2023 and 2024 
F-8
Consolidated Statements of Stockholders’ Equity –   
Years ended December 31, 2022, 2023 and 2024 
F-9
Consolidated Statements of Cash Flows –   
Years ended December 31, 2022, 2023 and 2024 
F-10
Notes to Consolidated Financial Statements 
F-12
 
All financial statement schedules have been omitted either because they are not applicable or required, or the 
information that would be required to be included is disclosed in the Notes to the Consolidated Financial Statements. 
 
 

PricewaterhouseCoopers LLP, 2121 North Pearl Street, Suite 2000, Dallas, Texas 75201 
T: (214) 999 1400, www.pwc.com/us 
Report of Independent Registered Public Accounting Firm 
To the Board of Directors and Stockholders of Kronos Worldwide, Inc. 
Opinions on the Financial Statements and Internal Control over Financial 
Reporting 
We have audited the accompanying consolidated balance sheets of Kronos Worldwide, Inc. and 
its subsidiaries (the "Company") as of December 31, 2024 and 2023, and the related consolidated 
statements of operations, of comprehensive income (loss), of stockholders’ equity and of cash 
flows for each of the three years in the period ended December 31, 2024, including the related 
notes (collectively referred to as the "consolidated financial statements"). We also have audited 
the Company's internal control over financial reporting as of December 31, 2024, based on 
criteria established in Internal Control - Integrated Framework (2013) issued by the Committee 
of Sponsoring Organizations of the Treadway Commission (COSO). 
In our opinion, the consolidated financial statements referred to above present fairly, in all 
material respects, the financial position of the Company as of December 31, 2024 and 2023, and 
the results of its operations and its cash flows for each of the three years in the period ended 
December 31, 2024 in conformity with accounting principles generally accepted in the United 
States of America. Also in our opinion, the Company maintained, in all material respects, effective 
internal control over financial reporting as of December 31, 2024, based on criteria established in 
Internal Control - Integrated Framework (2013) issued by the COSO. 
Basis for Opinions 
The Company's management is responsible for these consolidated financial statements, for 
maintaining effective internal control over financial reporting, and for its assessment of the 
effectiveness of internal control over financial reporting, included in Management’s report on 
internal control over financial reporting appearing under Item 9A. Our responsibility is to express 
opinions on the Company’s consolidated financial statements and on the Company's internal 
control over financial reporting based on our audits. We are a public accounting firm registered 
with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required 
to be independent with respect to the Company in accordance with the U.S. federal securities laws 
and the applicable rules and regulations of the Securities and Exchange Commission and the 
PCAOB. 
We conducted our audits in accordance with the standards of the PCAOB. Those standards 
require that we plan and perform the audits to obtain reasonable assurance about whether the 
consolidated financial statements are free of material misstatement, whether due to error or 
fraud, and whether effective internal control over financial reporting was maintained in all 
material respects. 
Our audits of the consolidated financial statements included performing procedures to assess the 
risks of material misstatement of the consolidated financial statements, whether due to error or 
fraud, and performing procedures that respond to those risks. Such procedures included 
examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated 
financial statements. Our audits also included evaluating the accounting principles used and 
significant estimates made by management, as well as evaluating the overall presentation of the 
consolidated financial statements. Our audit of internal control over financial reporting included 
obtaining an understanding of internal control over financial reporting, assessing the risk that a 
material weakness exists, and testing and evaluating the design and operating effectiveness of 
F-2

 
internal control based on the assessed risk. Our audits also included performing such other 
procedures as we considered necessary in the circumstances. We believe that our audits provide a 
reasonable basis for our opinions. 
As described in Management’s report on internal control over financial reporting, management 
has excluded Louisiana Pigment Company, L.P. (“LPC”) from its assessment of internal control 
over financial reporting as of December 31, 2024, because it was acquired by the Company in a 
purchase business combination during 2024. We have also excluded LPC from our audit of 
internal control over financial reporting. LPC is a wholly-owned subsidiary whose total assets and 
total revenues excluded from management’s assessment and our audit of internal control over 
financial reporting represent 19% and less than 1%, respectively, of the related consolidated 
financial statement amounts as of and for the year ended December 31, 2024. 
Definition and Limitations of Internal Control over Financial Reporting 
A company’s internal control over financial reporting is a process designed to provide reasonable 
assurance regarding the reliability of financial reporting and the preparation of financial 
statements for external purposes in accordance with generally accepted accounting principles. A 
company’s internal control over financial reporting includes those policies and procedures that (i) 
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the 
transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that 
transactions are recorded as necessary to permit preparation of financial statements in 
accordance with generally accepted accounting principles, and that receipts and expenditures of 
the company are being made only in accordance with authorizations of management and 
directors of the company; and (iii) provide reasonable assurance regarding prevention or timely 
detection of unauthorized acquisition, use, or disposition of the company’s assets that could have 
a material effect on the financial statements. 
Because of its inherent limitations, internal control over financial reporting may not prevent or 
detect misstatements. Also, projections of any evaluation of effectiveness to future periods are 
subject to the risk that controls may become inadequate because of changes in conditions, or that 
the degree of compliance with the policies or procedures may deteriorate. 
Critical Audit Matters 
The critical audit matter communicated below is a matter arising from the current period audit of 
the consolidated financial statements that was communicated or required to be communicated to 
the audit committee and that (i) relates to accounts or disclosures that are material to the 
consolidated financial statements and (ii) involved our especially challenging, subjective, or 
complex judgments. The communication of critical audit matters does not alter in any way our 
opinion on the consolidated financial statements, taken as a whole, and we are not, by 
communicating the critical audit matter below, providing a separate opinion on the critical audit 
matter or on the accounts or disclosures to which it relates. 
Income Taxes 
As described in Note 12 to the consolidated financial statements, the Company recorded a 
provision for income taxes of $63.4 million and recorded noncurrent deferred tax asset and 
deferred tax liability amounts of $55.1 million and $24.5 million, respectively, for the year ended 
December 31, 2024. As disclosed by management, the Company operates globally and the 
calculation of the Company's provision for income taxes and its deferred tax assets and liabilities 
involves the interpretation and application of complex tax laws and regulations in a multitude of 
jurisdictions across the Company's global operations. The Company’s effective tax rate is highly 
dependent upon the geographic distribution of its earnings or losses and the effects of tax laws 
F-3

 
and regulations in each tax-paying jurisdiction in which the Company operates. Significant 
judgments and estimates are required by management in determining the consolidated provision 
for income taxes due to the global nature of the Company’s operations. The Company's provision 
for income taxes and deferred tax assets and liabilities reflect management's best assessment of 
estimated current and future taxes to be paid, including the recognition and measurement of 
deferred tax assets and liabilities. 
The principal considerations for our determination that performing procedures relating to income 
taxes is a critical audit matter are the significant judgment by management when developing the 
estimate of current and future taxes to be paid, including the recognition and measurement of 
deferred tax assets and liabilities. This in turn led to a high degree of auditor judgment, 
subjectivity, and effort in performing procedures and evaluating evidence related to the 
recognition and measurement of deferred tax assets and liabilities and management's assessment 
of the estimated current and future taxes to be paid, including evaluating management’s 
interpretation of tax laws and regulations.  
Addressing the matter involved performing procedures and evaluating audit evidence in 
connection with forming our overall opinion on the consolidated financial statements. These 
procedures included testing the effectiveness of controls relating to accounting for income taxes, 
including controls over the identification, completeness, and recognition of permanent and 
temporary differences within jurisdictions, the recognition and measurement of deferred tax 
assets and liabilities, the application of tax laws and regulations in the various jurisdictions in 
which the Company operates, the rate reconciliation and the provision to tax return 
reconciliation. These procedures also included, among others, (i) evaluating the provision for 
income taxes, including the accuracy of the underlying information used in the calculation by 
jurisdiction, as well as the reasonableness of management's judgments and estimates in the 
application of tax laws and regulations; (ii) testing the current and deferred income tax provision, 
including evaluating permanent and temporary differences within certain jurisdictions and 
management's assessment of the technical merits of the differences; (iii) performing procedures 
over the Company's rate reconciliation; and (iv) testing the reconciliation of the provision to the 
tax returns. 
Dallas, Texas 
March 6, 2025 
We have served as the Company’s auditor since 1997. 
F-4

 
F-5 
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES 
CONSOLIDATED BALANCE SHEETS 
(In millions, except per share data) 
 
 
 
 
 
 
 
ASSETS 
 
December 31,  
 
     
2023 
     
2024 
Current assets: 
  
 
    
 
  
Cash and cash equivalents 
 
$ 
 194.7  
$ 
 106.7 
Restricted cash 
 
  
 2.2  
  
 3.3 
Accounts and other receivables, net 
 
  
 295.2  
  
 291.0 
Receivables from affiliates 
 
 
 17.3  
 
 .6 
Inventories, net 
 
  
 564.6  
  
 656.7 
Prepaid expenses and other 
 
  
 43.4  
  
 47.0 
 
 
  
 
  
Total current assets 
 
  
 1,117.4  
  
 1,105.3 
 
 
  
 
  
Other assets: 
 
  
   
  
  
Investment in TiO2 manufacturing joint venture 
 
  
 111.0  
  
 - 
Restricted cash 
 
  
 5.2  
  
 4.7 
Marketable securities 
 
  
 2.2  
  
 3.4 
Operating lease right-of-use assets 
 
  
 22.7  
  
 20.6 
Deferred income taxes 
 
  
 83.3  
  
 55.1 
Goodwill 
 
 
 -  
 
 2.6 
Other 
 
  
 13.3  
  
 27.7 
 
 
  
 
  
Total other assets 
 
  
 237.7  
  
 114.1 
 
 
  
 
  
Property and equipment: 
 
  
   
  
  
Land 
 
  
 44.7  
  
 74.2 
Buildings 
 
  
 236.8  
  
 253.9 
Equipment 
 
  
 1,172.0  
  
 1,306.5 
Mining properties 
 
  
 130.5  
  
 115.8 
Construction in progress 
 
  
 22.9  
  
 41.1 
 
 
  
 1,606.9  
  
 1,791.5 
Less accumulated depreciation and amortization 
 
  
 1,124.0  
  
 1,097.4 
 
 
  
 
  
Net property and equipment 
 
  
 482.9  
  
 694.1 
 
 
  
 
  
Total assets 
 
$ 
 1,838.0  
$ 
 1,913.5 
 

 
F-6 
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES 
CONSOLIDATED BALANCE SHEETS (CONTINUED) 
(In millions, except per share data) 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY 
 
December 31,  
 
     
2023 
     
2024 
Current liabilities: 
  
 
    
 
  
Current maturities of long-term debt 
 
$ 
 -  
$ 
 78.3 
Accounts payable and accrued liabilities 
 
  
 324.1  
  
 358.3 
Payables to affiliates 
 
 
 31.3  
 
 18.0 
Income taxes 
 
  
 15.4  
  
 22.0 
 
 
  
 
  
Total current liabilities 
 
  
 370.8  
  
 476.6 
 
 
  
 
  
Noncurrent liabilities: 
 
  
   
  
  
Long-term debt 
 
  
 440.9  
  
 429.1 
Accrued pension costs 
 
  
 150.0  
  
 117.5 
Payable to affiliate - income taxes 
 
  
 18.6  
  
 - 
Operating lease liabilities 
 
  
 18.6  
  
 17.1 
Deferred income taxes 
 
  
 9.0  
  
 24.5 
Other 
 
  
 21.8  
  
 31.7 
 
 
  
 
  
Total noncurrent liabilities 
 
  
 658.9  
  
 619.9 
 
 
  
 
  
Stockholders’ equity: 
 
  
   
  
  
Common stock, $.01 par value; 240.0 shares authorized; 
   115.0 shares issued and outstanding 
 
  
 1.2  
  
 1.2 
Additional paid-in capital 
 
  
 1,390.2  
  
 1,390.3 
Retained deficit 
 
  
 (242.0) 
  
 (211.0)
Accumulated other comprehensive loss 
 
  
 (341.1) 
  
 (363.5)
 
 
  
 
  
Total stockholders’ equity 
 
  
 808.3  
  
 817.0 
 
 
  
 
  
Total liabilities and stockholders’ equity 
 
$ 
 1,838.0  
$ 
 1,913.5 
 
Commitments and contingencies (Notes 5, 12 and 15) 
See accompanying Notes to Consolidated Financial Statements. 
 
 

 
F-7 
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES 
CONSOLIDATED STATEMENTS OF OPERATIONS 
(In millions, except per share data) 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
    
2022 
     
2023 
     
2024 
Net sales 
 $ 
 1,930.2  
$ 
 1,666.5  
$ 
 1,887.1 
Cost of sales 
   
 1,539.1  
  
 1,501.6  
  
 1,527.8 
 
   
 
  
 
  
Gross margin 
   
 391.1  
  
 164.9  
  
 359.3 
 
   
 
  
 
  
Selling, general and administrative expense 
   
 231.3  
  
 211.2  
  
 225.6 
Other operating income (expense): 
   
   
  
   
  
  
Currency transactions, net 
   
 11.5  
  
 1.4  
  
 1.6 
Other income, net 
  
 3.4  
 
 3.3  
 
 2.4 
Corporate expense 
   
 (15.1) 
  
 (14.4) 
  
 (14.8)
 
   
 
  
 
  
Income (loss) from operations 
   
 159.6  
  
 (56.0) 
  
 122.9 
 
   
 
  
 
  
Other income (expense): 
   
   
  
   
  
  
Gain on remeasurement of investment in  
  TiO2 manufacturing joint venture 
 
 
 -  
 
 -  
 
 64.5 
Interest and dividend income 
   
 5.1  
  
 6.9  
  
 5.5 
Marketable equity securities 
   
 (1.0) 
  
 (1.0) 
  
 1.2 
Other components of net periodic pension and OPEB cost 
   
 (12.9) 
  
 (5.7) 
  
 (1.6)
Interest expense 
   
 (16.9) 
  
 (17.1) 
  
 (42.9)
 
   
 
  
 
  
Income (loss) before income taxes 
   
 133.9  
  
 (72.9) 
  
 149.6 
 
   
 
  
 
  
Income tax expense (benefit) 
   
 29.4  
  
 (23.8) 
  
 63.4 
 
   
 
  
 
  
Net income (loss) 
 $ 
 104.5  
$ 
 (49.1) 
$ 
 86.2 
 
   
 
  
 
  
Net income (loss) per basic and diluted share 
 $ 
 .90  
$ 
 (.43) 
$ 
 .75 
 
   
 
   
 
   
Weighted average shares used in the calculation of  
     net income (loss) per share 
 
  
 115.5  
  
 115.1  
  
 115.0 
 
See accompanying Notes to Consolidated Financial Statements. 
 
 

 
F-8 
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES 
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) 
(In millions) 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
Net income (loss) 
 
$ 
 104.5  
$ 
 (49.1) 
$ 
 86.2 
 
 
  
 
  
 
  
Other comprehensive income (loss), net of tax: 
 
  
   
  
   
  
  
Currency translation 
 
  
 (28.8) 
  
 3.7  
  
 (34.5)
Defined benefit pension plans 
 
  
 100.2  
  
 (12.9) 
  
 12.2 
Other postretirement benefit plans 
 
  
 1.2  
  
 (.4) 
  
 (.1)
 
 
  
 
  
 
  
Total other comprehensive income (loss), net 
 
  
 72.6  
  
 (9.6) 
  
 (22.4)
 
 
  
 
  
 
  
Comprehensive income (loss) 
 
$ 
 177.1  
$ 
 (58.7) 
$ 
 63.8 
 
See accompanying Notes to Consolidated Financial Statements. 
 
 

 
F-9 
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES 
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY 
Years ended December 31, 2022, 2023 and 2024 
(In millions) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
  
 
 Accumulated   
 
  
 
 
  
 
 Additional   
 
 
other 
  
 
  
 
 
 Common  
paid-in 
 Retained  comprehensive  Treasury   
 
 
     stock     
capital     deficit     
loss 
    
stock     Total 
Balance at December 31, 2021 
 
$ 
 1.2  $  1,395.4  $  (122.1) $ 
 (404.1) $ 
 (.2) $ 870.2 
 
 
  
   
   
   
   
   
Net income 
 
  
 -    
 -     104.5    
 -    
 -     104.5 
Other comprehensive income, net of tax  
  
 -    
 -    
 -    
 72.6    
 -     72.6 
Issuance of common stock 
 
  
 -    
 .2    
 -    
 -    
 -    
 .2 
Dividends paid - $.76 per share 
 
  
 -    
 -     (87.8)   
 -    
 -     (87.8)
Treasury stock acquired 
 
 
 -    
 -    
 -    
 -    
 (2.5)    (2.5)
Treasury stock retired 
 
 
 -    
 (1.3)   
 -    
 -    
 1.3    
 - 
 
 
  
   
   
   
   
   
Balance at December 31, 2022 
 
  
 1.2     1,394.3     (105.4)   
 (331.5)   
 (1.4)    957.2 
 
 
  
   
   
   
   
   
Net loss 
 
  
 -    
 -     (49.1)   
 -    
 -     (49.1)
Other comprehensive loss, net of tax 
 
  
 -    
 -    
 -    
 (9.6)   
 -     (9.6)
Issuance of common stock 
 
  
 -    
 .1    
 -    
 -    
 -    
 .1 
Dividends paid - $.76 per share 
 
  
 -    
 -     (87.5)   
 -    
 -     (87.5)
Treasury stock acquired 
 
  
 -    
 -    
 -    
 -    
 (2.8)    (2.8)
Treasury stock retired 
 
  
 -    
 (4.2)   
 -    
 -    
 4.2    
 - 
 
 
  
   
   
   
   
   
Balance at December 31, 2023 
 
  
 1.2     1,390.2     (242.0)   
 (341.1)   
 -     808.3 
 
 
  
   
   
   
   
   
Net income 
 
  
 -    
 -    
 86.2    
 -    
 -     86.2 
Other comprehensive loss, net of tax 
 
  
 -    
 -    
 -    
 (22.4)   
 -     (22.4)
Issuance of common stock 
 
  
 -    
 .1    
 -    
 -    
 -    
 .1 
Dividends paid - $.48 per share 
 
  
 -    
 -     (55.2)   
 -    
 -     (55.2)
 
 
  
   
   
   
   
   
Balance at December 31, 2024 
 
$ 
 1.2  $  1,390.3  $  (211.0) $ 
 (363.5) $ 
 -  $ 817.0 
 
See accompanying Notes to Consolidated Financial Statements. 
 
 

 
F-10 
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES 
CONSOLIDATED STATEMENTS OF CASH FLOWS 
(In millions) 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
Cash flows from operating activities: 
   
     
     
  
Net income (loss) 
 
$ 
 104.5  
$ 
 (49.1) 
$ 
 86.2 
Depreciation 
 
  
 51.7  
  
 48.6  
  
 60.4 
Amortization of operating lease right-of-use assets 
 
  
 4.5  
  
 4.5  
  
 4.0 
Gain on remeasurement of investment in  
   TiO2 manufacturing joint venture 
 
 
 -  
 
 -  
 
 (64.5)
Premium on issuance of senior secured notes 
 
 
 -  
 
 -  
 
 6.0 
Deferred income taxes 
 
  
 (1.4) 
  
 (39.3) 
  
 31.3 
Benefit plan expense greater (less) than cash funding 
 
  
 8.7  
  
 (5.1) 
  
 (8.3)
Marketable equity securities 
 
  
 1.0  
  
 1.0  
  
 (1.2)
Distributions from (contributions to) TiO2 manufacturing joint 
venture, net 
 
  
 (10.5) 
  
 3.1  
  
 (2.7)
Fixed asset impairment 
 
 
 -  
 
 3.8  
 
 - 
Other, net 
 
  
 3.5  
  
 1.8  
  
 3.6 
Change in assets and liabilities: 
 
  
 
  
 
  
Accounts and other receivables, net 
 
  
 85.7  
  
 (43.9) 
  
 (8.4)
Inventories, net 
 
  
 (198.4) 
  
 56.3  
  
 (43.1)
Prepaid expenses 
 
  
 (12.5) 
  
 6.3  
  
 (5.6)
Accounts payable and accrued liabilities 
 
  
 36.7  
  
 33.9  
  
 11.6 
Income taxes 
 
  
 (.1) 
  
 8.2  
  
 8.9 
Accounts with affiliates 
 
  
 8.7  
  
 (26.0) 
  
 (6.7)
Other noncurrent assets 
 
  
 .3  
  
 .8  
  
 (.2)
Other noncurrent liabilities 
 
  
 (.7) 
  
 .6  
  
 1.2 
 
 
  
 
  
 
  
Net cash provided by operating activities 
 
  
 81.7  
  
 5.5  
  
 72.5 
 
 
  
 
  
 
  
Cash flows from investing activities: 
 
  
 
  
 
  
Capital expenditures 
 
  
 (63.2) 
  
 (47.4) 
  
 (29.5)
Acquisition of remaining TiO2 manufacturing  
   joint venture interest, net of cash acquired 
 
 
 -  
 
 -  
 
 (156.8)
Other 
 
 
 .1  
 
 -  
 
 - 
 
 
 
 
 
 
 
Net cash used in investing activities 
 
  
 (63.1) 
  
 (47.4) 
  
 (186.3)
 
 
  
 
  
 
  
Cash flows from financing activities: 
 
  
   
  
   
  
  
Revolving credit facility: 
 
 
 
 
 
 
Borrowings 
 
 
 -  
 
 -  
 
 158.6 
Payments 
 
 
 -  
 
 -  
 
 (148.9)
Payments on long-term debt 
 
  
 (1.3) 
  
 (1.1) 
  
 (52.6)
Proceeds from issuance of senior secured notes 
 
 
 -  
 
 -  
 
 80.2 
Loan from Contran 
 
 
 -  
 
 -  
 
 53.7 
Deferred financing fees 
 
  
 (.1) 
  
 (.1) 
  
 (9.3)
Dividends paid 
 
  
 (87.8) 
  
 (87.5) 
  
 (55.2)
Treasury stock acquired 
 
  
 (2.3) 
  
 (2.9) 
  
 - 
 
 
  
 
  
 
  
Net cash provided by (used in) financing activities 
 
  
 (91.5) 
  
 (91.6) 
  
 26.5 

 
F-11 
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES 
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED) 
(In millions) 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
Cash, cash equivalents and restricted cash - net change from: 
   
     
     
  
Operating, investing and financing activities 
 
$ 
 (72.9) 
$ 
 (133.5) 
$ 
 (87.3)
Effect of currency exchange rate changes on cash 
 
  
 (5.1) 
  
 1.0  
  
 (.1)
 
 
  
 
  
 
  
Net change for the year 
 
  
 (78.0) 
  
 (132.5) 
  
 (87.4)
 
 
  
 
  
 
  
Balance at beginning of year 
 
  
 412.6  
  
 334.6  
  
 202.1 
 
 
  
 
  
 
  
Balance at end of year 
 
$ 
 334.6  
$ 
 202.1  
$ 
 114.7 
 
 
  
 
  
 
  
Supplemental disclosures: 
 
  
   
  
   
  
  
Cash paid for: 
 
  
   
  
   
  
  
Interest, net of amount capitalized 
 
$ 
 15.7  
$ 
 15.8  
$ 
 38.2 
Income taxes 
 
  
 37.3  
  
 17.3  
  
 34.5 
Change in accruals for capital expenditures 
 
  
 6.6  
  
 1.1  
  
 6.6 
 
See accompanying Notes to Consolidated Financial Statements. 
 
 

 
F-12 
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
December 31, 2024 
Note 1 – Summary of significant accounting policies: 
Organization and basis of presentation – At December 31, 2024, Valhi, Inc. (NYSE: VHI) held approximately 
50% of our outstanding common stock and a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL) held 
approximately 31% of our common stock. Valhi owned approximately 83% of NL’s outstanding common stock and a 
wholly-owned subsidiary of Contran Corporation held approximately 91% of Valhi’s outstanding common stock. A 
majority of Contran’s outstanding voting stock is held directly by Lisa K. Simmons and by family stockholders (Thomas 
C. Connelly (the husband of Ms. Simmons’ late sister), a family-owned entity and various family trusts established for the 
benefit of Ms. Simmons, Mr. Connelly and their children) who are required to vote their shares of Contran voting stock in 
the same manner as Ms. Simmons. Such voting rights are personal to Ms. Simmons and last through April 22, 2030. The 
remainder of Contran’s outstanding voting stock is held by another trust (the “Family Trust”), which was established for 
the benefit of Ms. Simmons and her late sister and their children and for which a third-party financial institution serves as 
trustee. Consequently, at December 31, 2024, Ms. Simmons and the Family Trust may be deemed to control Contran, and 
therefore may be deemed to indirectly control the wholly-owned subsidiary of Contran, Valhi, NL and us. 
Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and 
its subsidiaries, taken as a whole. 
Management’s estimates – In preparing our financial statements in conformity with accounting principles 
generally accepted in the United States of America (GAAP) we are required to make estimates and assumptions that affect 
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial 
statements, and the reported amount of revenues and expenses during the reporting period. Actual results may differ 
significantly from previously estimated amounts under different assumptions or conditions. 
Principles of consolidation – The Consolidated Financial Statements include our accounts and those of our 
majority-owned subsidiaries. We have eliminated all material intercompany accounts and balances. 
Translation of currencies – We translate the assets and liabilities of our subsidiaries whose functional currency 
is other than the U.S. dollar at year-end exchange rates, while we translate our revenues and expenses at average exchange 
rates prevailing during the year. We accumulate the resulting translation adjustments in stockholders’ equity as part of 
accumulated other comprehensive loss, net of related deferred income taxes. We recognize currency transaction gains and 
losses in income currently. 
Derivatives and hedging activities – We recognize derivatives as either assets or liabilities measured at fair value.  
We recognize the effect of changes in the fair value of derivatives either in net income (loss) or other comprehensive 
income (loss), depending on the intended use of the derivative.  
Cash and cash equivalents – We classify bank time deposits and highly-liquid investments, including 
government and commercial notes and bills, with original maturities of three months or less as cash equivalents. 
Restricted cash – We classify cash that has been segregated or is otherwise limited in use as restricted. Such 
restrictions or limitations relate primarily to financial assurance for landfill closure obligations at our Belgium facility, 
certain Norwegian payroll tax and employee benefit obligations and certain employee benefit obligations at our U.S. 
operating facility. To the extent the restricted amount relates to a recognized liability, we classify such restricted amount 
as either a current or noncurrent asset to correspond with the classification of the liability. To the extent the restricted  
 
 

 
F-13 
amount does not relate to a recognized liability, we classify restricted cash as a current asset. Restricted cash classified as 
a current asset and restricted cash classified as a noncurrent asset are presented separately on our Consolidated Balance 
Sheets. 
Marketable securities and securities transactions – We carry marketable securities at fair value. Accounting 
Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, establishes a consistent 
framework for measuring fair value and (with certain exceptions) this framework is generally applied to all financial 
statement items required to be measured at fair value. The standard requires fair value measurements to be classified and 
disclosed in one of the following three categories: 
• 
Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, 
unrestricted assets or liabilities; 
• 
Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or 
indirectly, for substantially the full term of the assets or liability; and 
• 
Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value 
measurement and unobservable. 
We classify all of our marketable securities as available-for-sale. Unrealized gains or losses on the marketable 
equity securities are recognized in other income (expense) - marketable equity securities on our Consolidated Statements 
of Operations. We accumulate unrealized gains and losses on marketable debt securities as part of accumulated other 
comprehensive income (loss), net of related deferred income taxes. We base realized gains and losses upon the specific 
identification of the securities sold. See Notes 6 and 10. 
Accounts receivable – We provide an allowance for doubtful accounts for known and estimated potential losses 
arising from sales to customers based on a periodic review of these accounts. See Note 3. 
Inventories and cost of sales – We state inventories at the lower of cost or net realizable value, net of allowance 
for obsolete and slow-moving inventories. We generally base inventory costs for all inventory categories on average cost 
that approximates the first-in, first-out method. Inventories include the costs for raw materials, the cost to manufacture the 
raw materials into finished goods and overhead. Depending on the inventory’s stage of completion, our manufacturing 
costs can include the costs of packing and finishing, utilities, maintenance, depreciation and salaries and benefits associated 
with our manufacturing process. We allocate fixed manufacturing overhead costs based on normal production capacity. 
Unallocated overhead costs resulting from periods with abnormally low production levels are charged to expense as 
incurred. As inventory is sold to third parties, we recognize the cost of sales in the same period that the sale occurs. We 
periodically review our inventory for estimated obsolescence or instances when inventory is no longer marketable for its 
intended use, and we record any write-down equal to the difference between the cost of inventory and its estimated net 
realizable value based on assumptions about alternative uses, market conditions and other factors. See Note 4. 
Investment in TiO2 manufacturing joint venture – We accounted for our investment in Louisiana Pigment 
Company, L.P. (“LPC”), a 50%-owned manufacturing joint venture, by the equity method before our acquisition of the 
remaining 50% joint venture interest in July 2024. Distributions received from LPC are classified for statement of cash 
flow purposes using the “nature of distribution” approach under ASC Topic 320. See Note 5. 
Leases – We enter into various arrangements (or leases) that convey the rights to use and control identified 
underlying assets for a period of time in exchange for consideration. We lease various manufacturing facilities, land and 
equipment. From time to time, we may also enter into an arrangement in which the right to use and control an identified 
underlying asset is embedded in another type of contract. 
We determine if an arrangement is a lease (including leases embedded in another type of contract) at inception. 
All of our leases are classified as operating leases. Operating leases are included in operating lease right-of-use assets, 
current operating lease liabilities and noncurrent operating lease liabilities on our Consolidated Balance Sheets. See Note 9. 
As permitted by ASC Topic 842, Leases, we elected the practical expedients related to nonlease components (in which 

 
F-14 
nonlease components associated with a lease and paid by us to the lessor, such as property taxes, insurance and 
maintenance, are treated as a lease component and considered part of minimum lease rental payments), and short-term 
leases (in which leases with an original maturity of 12 months or less are excluded from the recognition requirements of 
ASC 842). 
Right-of-use assets represent our right to use an underlying asset for the lease term and operating lease liabilities 
represent our obligation to make lease payments arising from the lease. The right-of-use operating lease assets and 
liabilities are recognized based on the estimated present value of lease payments over the lease term as of the respective 
lease commencement dates. 
We use an estimated incremental borrowing rate to determine the present value of lease payments (unless we can 
determine the rate implicit in the lease, which is generally not the case). Our incremental borrowing rate for each of our 
leases is derived from available information, including our current debt and credit facility and U.S. and European yield 
curves as well as publicly available data for instruments with similar characteristics, adjusted for factors such as 
collateralization and term. 
Our leases generally do not include termination or purchase options. Certain of our leases include an option to 
renew the lease after expiration of the initial lease term, but we have not included such renewal periods in our lease term 
because it is not reasonably certain that we would exercise the renewal option. Our leases generally have fixed lease 
payments, with no contingent or incentive payments. Certain of our leases include variable lease payments that depend on 
a specified index or rate. Our lease agreements do not contain any residual value guarantees. 
Property and equipment and depreciation – We state property and equipment at cost, including capitalized 
interest on borrowings during the actual construction period of major capital projects. Capitalized interest costs were 
$1.2 million in 2022, $1.5 million in 2023 and $.6 in 2024. We compute depreciation of property and equipment for 
financial reporting purposes (including mining equipment) principally by the straight-line method over the estimated useful 
lives of the assets as follows: 
 
 
 
Asset 
     
Useful lives 
Buildings and improvements 
 
10 to 40 years 
Machinery and equipment 
  
3 to 20 years 
Mine development costs 
  
units-of-production 
 
We use the Alternative Depreciation System (“ADS”) method for income tax purposes. Upon the sale or 
retirement of an asset, we remove the related cost and accumulated depreciation from the accounts and recognize any gain 
or loss in income currently. 
We expense costs incurred for maintenance, repairs and minor renewals (including planned major maintenance) 
while we capitalize expenditures for major improvements. 
We have a governmental concession with an unlimited term to operate our ilmenite mine in Norway. Mining 
properties consist of buildings and equipment used in our Norwegian ilmenite mining operations. While we own the land 
and ilmenite reserves associated with the mining operations, such land and reserves were acquired for nominal value and 
we have no material asset recognized for the land and reserves related to our mining operations. 
We perform impairment tests when events or changes in circumstances indicate the carrying value may not be 
recoverable. We consider all relevant factors. We perform the impairment test by comparing the estimated future 
undiscounted cash flows (exclusive of interest expense) associated with the asset to the asset’s net carrying value to 
determine if a write-down to fair value is required. During the fourth quarter of 2023, we recorded a fixed asset impairment 
of $3.8 million related to the write-off of certain costs resulting from a capital project termination. Excluding this project, 
we did not evaluate any long-lived assets for impairment during 2023 or 2024 because no such impairment indicators were 
present.  

 
F-15 
Long-term debt – We state long-term debt net of any unamortized original issue premium, discount or deferred 
financing costs (other than deferred financing costs associated with revolving credit facilities, which are recognized as an 
asset). We classify amortization of all deferred financing costs and any premium or discount associated with the issuance 
of indebtedness as interest expense and compute such amortization by either the interest method or the straight-line method 
over the term of the applicable issue. See Note 8. 
Employee benefit plans – Accounting and funding policies for our defined benefit pension and defined 
contribution retirement plans are described in Note 10. We also provide certain postretirement benefits other than pensions 
(“OPEB”), consisting of health care and life insurance benefits, to certain U.S. and Canadian retired employees, which are 
not material. See Note 11. 
Income taxes – We, Valhi and our qualifying subsidiaries are members of Contran’s consolidated U.S. federal 
income tax group (the “Contran Tax Group”) and we and certain of our qualifying subsidiaries also file consolidated 
income tax returns with Contran in various U.S. state jurisdictions. As a member of the Contran Tax Group, we are jointly 
and severally liable for the federal income tax liability of Contran and the other companies included in the Contran Tax 
Group for all periods in which we are included in the Contran Tax Group. See Note 14. As a member of the Contran Tax 
Group, we are a party to a tax sharing agreement which provides that we compute our provision for U.S. income taxes on 
a separate-company basis using the tax elections made by Contran. Pursuant to the tax sharing agreement, we make 
payments to or receive payments from Valhi in amounts we would have paid to or received from the U.S. Internal Revenue 
Service or the applicable state tax authority had we not been a member of the Contran Tax Group. We made net payments 
of income taxes to Valhi of $15.9 million, $11.8 million and $17.8 million in 2022, 2023 and 2024, respectively. 
We recognize deferred income tax assets and liabilities for the expected future tax consequences of temporary 
differences between the income tax and financial reporting carrying amounts of assets and liabilities, including investments 
in our subsidiaries and affiliates who are not members of the Contran Tax Group and undistributed earnings of non-U.S. 
subsidiaries which are not deemed to be permanently reinvested. At December 31, 2024, we continue to assert indefinite 
reinvestment as it relates to our outside basis difference attributable to our investments in our non-U.S. subsidiaries, other 
than post-1986 undistributed earnings of our European subsidiaries and all undistributed earnings of our Canadian 
subsidiary, which are not subject to permanent reinvestment plans. It is not practical for us to determine the amount of the 
unrecognized deferred income tax liability related to our investments in our non-U.S. subsidiaries which are permanently 
reinvested due to the complexities associated with our organizational structure, changes in the Tax Cuts and Jobs Act 
(“2017 Tax Act”), and the U.S. taxation of such investments in the states in which we operate. Deferred income tax assets 
and liabilities for each tax-paying jurisdiction in which we operate are netted and presented as either a noncurrent deferred 
income tax asset or liability, as applicable. We periodically evaluate our deferred tax assets in the various taxing 
jurisdictions in which we operate and adjust any related valuation allowance based on the estimate of the amount of such 
deferred tax assets that we believe does not meet the more-likely-than-not recognition criteria. 
The 2017 Tax Act imposed a tax on global intangible low-taxed income (“GILTI”). We record GILTI tax as a 
current-period expense when incurred under the period cost method. While our future global operations depend on a 
number of different factors, we do expect to have future U.S. inclusions in taxable income related to GILTI. 
We account for the tax effects of a change in tax law as a component of the income tax provision related to 
continuing operations in the period of enactment, including the tax effects of any deferred income taxes originally 
established through a financial statement component other than continuing operations (i.e., other comprehensive income 
(loss)). Changes in applicable income tax rates over time as a result of changes in tax law, or times in which a deferred 
income tax asset valuation allowance is initially recognized in one year and subsequently reversed in a later year, can give 
rise to “stranded” tax effects in accumulated other comprehensive income in which the net accumulated income tax 
expense (benefit) remaining in accumulated other comprehensive income does not correspond to the then-applicable 
income tax rate applied to the pre-tax amount which resides in accumulated other comprehensive income (loss). As 
permitted by GAAP, our accounting policy is to remove any such stranded tax effect remaining in accumulated other 
comprehensive income by recognizing an offset to our provision for income taxes related to continuing operations, only 
at the time when there is no remaining pre-tax amount in accumulated other comprehensive income. For accumulated other 
comprehensive income related to currency translation, this would occur only upon the sale or complete liquidation of one 

 
F-16 
of our non-U.S. subsidiaries. For defined pension benefit plans and OPEB plans, this would occur whenever one of our 
subsidiaries which previously sponsored a defined benefit pension or OPEB plan had terminated such a plan and had no 
future obligation or plan asset associated with such a plan. 
We record a reserve for uncertain tax positions for tax positions where we believe that it is more-likely-than-not 
our position will not prevail with the applicable tax authorities. The amount of the benefit associated with our uncertain 
tax positions that we recognize is limited to the largest amount for which we believe the likelihood of realization is greater 
than 50%. We accrue penalties and interest on the difference between tax positions taken on our tax returns and the amount 
of benefit recognized for financial reporting purposes. We classify our reserves for uncertain tax positions in a separate 
current or noncurrent liability, depending on the nature of the tax position. See Note 12. 
Net sales – Our sales involve single performance obligations to ship our products pursuant to customer purchase 
orders. In some cases, the purchase order is supported by an underlying master sales agreement, but our purchase order 
acceptance generally evidences the contract with our customer by specifying the key terms of product and quantity ordered, 
price and delivery and payment terms. In accordance with Revenues from Contracts with Customers, (ASC 606), we record 
revenue when we satisfy our performance obligation to our customers by transferring control of our products to them, 
which generally occurs at point of shipment or upon delivery. Such transfer of control is also evidenced by transfer of 
legal title and other risks and rewards of ownership (giving the customer the ability to direct the use of, and obtain 
substantially all of the benefits of, the product), and our customers becoming obligated to pay us and it is probable we will 
receive payment. In certain arrangements we provide shipping and handling activities after the transfer of control to our 
customer (e.g., when control transfers prior to delivery) that are considered fulfillment activities, and accordingly, such 
costs are accrued when the related revenue is recognized. Sales arrangements with consignment customers occur when our 
product is shipped to a consignment customer location but we maintain control until the product is used in the customer’s 
manufacturing process. In these instances, we recognize sales when the consignment customer uses our product, as control 
of our product has not passed to the customer until that time and all other revenue recognition criteria have been satisfied. 
Revenue is recorded in an amount that reflects the net consideration we expect to receive in exchange for our 
products. Prices for our products are based on terms specified in published list prices and purchase orders, which generally 
do not include financing components, noncash consideration or consideration paid to our customers. As our standard 
payment terms are less than one year, we have elected the practical expedient under ASC 606 and have not assessed 
whether a contract has a significant financing component. We state sales net of price, early payment and distributor 
discounts and volume rebates (collectively, variable consideration). Variable consideration, to the extent present, is 
recognized as the amount to which we are most-likely to be entitled, using all information (historical, current and 
forecasted) that is reasonably available to us, and only to the extent that a significant reversal in the amount of the 
cumulative revenue recognized is not probable of occurring in a future period. Differences, if any, between estimates of 
the amount of variable consideration to which we will be entitled and the actual amount of such variable consideration 
have not been material in the past. Amounts received or receivable from our customers with respect to variable 
consideration we expect to refund to our customers is recognized as a current liability and classified as accrued sales 
discounts and rebates. See Note 9. We report any tax assessed by a governmental authority that we collect from our 
customers that is both imposed on and concurrent with our revenue-producing activities (such as sales, use, value added 
and excise taxes) on a net basis (meaning we do not recognize these taxes either in our revenues or in our costs and 
expenses). 
Frequently, we receive orders for products to be delivered over dates that may extend across reporting periods. 
We invoice for each delivery upon shipment and recognize revenue for each distinct shipment when all sales recognition 
criteria for that shipment have been satisfied. As scheduled delivery dates for these orders are within a one-year period, 
under the optional exemption provided by ASC 606, we do not disclose sales allocated to future shipments of partially 
completed contracts. 
ASC 606 requires a disaggregation of our sales into categories that depict how the nature, amount, timing and 
uncertainty of revenue and cash flows are affected by economic factors. We have determined such disaggregation of our 
sales is the same as the disclosure of our sales by place of manufacture (point of origin) and to the location of the customer 
(point of destination). See Note 2. 

 
F-17 
Selling, general and administrative expense; distribution costs – Selling, general and administrative expense 
includes costs related to marketing, sales, distribution (shipping and handling), research and development, legal and 
administrative functions such as accounting, treasury and finance, and includes costs for salaries and benefits not 
associated with our manufacturing process, travel and entertainment, promotional materials and professional fees. We 
include distribution costs (shipping and handling) in selling, general and administrative expense and these costs were 
$122 million in 2022, $101 million in 2023 and $115 million in 2024. We expense research and development costs as 
incurred, and these costs were $15 million in 2022, $18 million in 2023 and $14 million in 2024. We expense advertising 
costs as incurred and these costs were not material in any year presented.  
 
Note 2 – TiO2 segment and geographic information: 
We have one operating segment – the manufacture and sale of titanium dioxide pigments (“TiO2”) and related 
by-products. We are a leading global producer and marketer of TiO2 in North America and Europe and the leading seller 
of TiO2 in several countries, including Germany. TiO2 is a white inorganic pigment used in a wide range of products for 
its exceptional durability and its ability to impart whiteness, brightness and opacity. TiO2 is a critical component of 
everyday applications, such as coatings, plastics and paper, as well as many specialty products such as inks, cosmetics and 
pharmaceuticals. We are managed on a global basis by our Vice Chairman of the Board, who we have determined is our 
chief operating decision maker (“CODM”) and makes the key operating decisions, allocates resources and assesses our 
performance. Our CODM evaluates the segment’s operating performance based on net income and segment profit 
(a non-GAAP measure), which we define as net income before income tax expense and certain general corporate items. 
These general corporate items include corporate expense and the components of other income (expense) except for trade 
interest income. The CODM considers current-period net income and segment profit (loss) compared to plan and prior-
period on a monthly and/or quarterly basis for evaluating performance of the TiO2 segment and making decisions about 
allocating capital and other resources.  
 
TiO2 segment accounting policies are the same as those described in Note 1.  Differences between segment profit 
(loss) and the amounts included in consolidated net income (loss) are highlighted within the table below. Asset information, 
including investments in equity method investees and expenditures for additions of long-lived assets, is not regularly 
provided to the CODM and therefore is not considered to be used by the CODM in making key operating decisions, 
allocating resources or assessing TiO2 segment performance. Trade interest income included in the calculation of segment 
profit (loss) is $1.2 million, $1.8 million, and $3.3 million in 2022, 2023 and 2024, respectively. Depreciation and 
amortization amounts included in the calculation of segment profit are $51.7 million, $48.6 million and $60.4 million for 
the periods ended December 31, 2022, 2023 and 2024, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
 
 
(In millions) 
Net sales 
 
$ 
 1,930.2  
$ 
 1,666.5  
$ 
 1,887.1 
 
 
 
 
 
 
 
Segment profit (loss) 
 
$ 
 175.9  
$ 
 (39.8) 
$ 
 141.0 
Gain on remeasurement of investment in TiO2 manufacturing 
    joint venture 
 
  
 -  
  
 -  
  
 64.5 
Corporate expense 
 
 
 (15.1) 
 
 (14.4) 
  
 (14.8)
Interest and dividend income - corporate 
 
 
 3.9  
 
5.1  
 
2.2 
Marketable equity securities gain (loss) 
 
  
 (1.0) 
  
 (1.0) 
  
 1.2 
Other components of net periodic pension and OPEB cost 
 
 
 (12.9) 
  
 (5.7) 
  
 (1.6)
Interest expense 
 
  
 (16.9) 
  
 (17.1) 
  
 (42.9)
Income tax (expense) benefit 
 
  
 (29.4) 
  
 23.8  
  
 (63.4)
Net income (loss) 
 
$ 
 104.5  
$ 
 (49.1) 
$ 
 86.2 
See the Consolidated Financial Statements for other financial information regarding the Company’s operating 
segment.  

 
F-18 
Geographic information. We attribute net sales to the place of manufacture (point of origin) and to the location 
of the customer (point of destination); we attribute property and equipment to their physical location. 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
 
 
(In millions) 
Net sales - point of origin: 
  
  
  
United States 
 $  1,226.6  $  1,029.2  $  1,178.4 
Germany 
   
 895.4    
 726.4    
 826.6 
Canada 
   
 389.4    
 351.0    
 351.5 
Norway 
   
 273.5    
 252.1    
 278.6 
Belgium 
   
 306.5    
 217.1    
 237.8 
Eliminations 
    (1,161.2)   
 (909.3)   
 (985.8)
Total 
 $  1,930.2  $  1,666.5  $  1,887.1 
 
   
   
   
Net sales - point of destination: 
   
     
     
  
Europe 
 $ 
 878.3  $ 
 737.8  $ 
 841.5 
North America 
   
 695.7    
 618.1    
 698.3 
Other 
   
 356.2    
 310.6    
 347.3 
Total 
 $  1,930.2  $  1,666.5  $  1,887.1 
 
 
 
 
 
 
 
 
 
 
December 31,  
 
    
2023 
    
2024 
 
 
(In millions) 
Identifiable assets - net property and equipment: 
   
     
  
United States 
 $ 
 5.7  $ 
 270.2 
Germany 
  
 207.7   
 187.4 
Belgium 
   
 97.9    
 88.2 
Norway 
   
 82.7    
 73.2 
Canada 
   
 81.9    
 68.3 
Other 
   
 7.0    
 6.8 
Total 
 $ 
 482.9  $ 
 694.1 
At December 31, 2024, the United States net property and equipment includes the acquired assets of LPC.   
 
At December 31, 2023 and 2024, the net assets of non-U.S. subsidiaries included in consolidated net assets 
approximated $443 million and $286 million, respectively. 
 
 
Note 3 – Accounts and other receivables, net: 
 
 
 
 
 
 
 
 
 
December 31,  
 
    
2023 
    
2024 
 
 
(In millions) 
Trade receivables 
 $ 
 273.6  $ 
 269.2 
Recoverable VAT and other receivables 
   
 23.8    
 24.3 
Refundable income taxes 
   
 1.9    
 1.3 
Allowance for doubtful accounts 
   
 (4.1)   
 (3.8)
Total 
 $ 
 295.2  $ 
 291.0 
 
 

 
F-19 
Note 4 – Inventories, net: 
 
 
 
 
 
 
 
 
 
December 31,  
 
     
2023 
     
2024 
 
 
(In millions) 
Raw materials 
 
$ 
 188.3  
$ 
 176.9 
Work in process 
 
  
 30.8  
  
 52.5 
Finished products 
 
  
 249.6  
  
 307.5 
Supplies 
 
  
 95.9  
  
 119.8 
Total 
 
$ 
 564.6  
$ 
 656.7 
 
Note 5 – Acquisition of joint venture interest in LPC: 
Effective July 16, 2024 (“Acquisition Date”), we acquired the 50% joint venture interest in LPC previously held 
by Venator Investments, Ltd. (“Venator”). Prior to the acquisition, we held a 50% joint venture interest in LPC and LPC 
was operated as a manufacturing joint venture between us and Venator. We acquired the 50% joint venture interest in LPC 
for consideration of $185 million less a working capital adjustment. An additional earn-out payment of up to $15 million 
may be required if our aggregate consolidated net income before interest expense, income taxes and depreciation and 
amortization expense, or EBITDA, during a two-year period comprising calendar years 2025 and 2026 exceed certain 
thresholds as described below. We accounted for the acquisition of the interest in LPC as a business combination and, as 
a result of obtaining full control, LPC became a wholly-owned subsidiary of ours. Obtaining control of LPC and its 
estimated additional 78,000 metric tons annually of TiO2 production volume allows us to better serve the North American 
TiO2 marketplace. The acquisition was financed through a borrowing of $132.1 million under our Global Revolver and 
the remainder paid with cash on hand.  
For financial reporting purposes, the assets acquired and liabilities assumed of LPC have been included in our 
Consolidated Balance Sheet as of December 31, 2024, and the results of operations and cash flows of LPC have been 
included in our Consolidated Statement of Operations and Cash flows beginning as of the Acquisition Date. We incurred 
$2.2 million of transaction costs in connection with the acquisition. These costs were primarily associated with legal and 
professional services and were expensed in accordance with ASC 805 and are included in selling, general and 
administrative expense in our Consolidated Statement of Operations.    
 
The potential earn-out payment of up to $15 million is based on our aggregate consolidated EBITDA tiers for 
2025 and 2026 of $650 million and $730 million, with $5 million of the earn-out payable if we achieve $650 million in 
aggregate consolidated EBITDA, and a maximum of $15 million payable if aggregate EBITDA is $730 million or greater 
for the period. If we achieve aggregated consolidated EBITDA between $650 million and $730 million, the payment of 
the additional $10 million is prorated between the two targets. The earn-out is payable at the earliest in April 2027. The 
estimated fair value of the earn-out at the Acquisition Date was $4.2 million and was determined using a weighted 
probability of potential outcomes based on estimated future EBITDA and volatility factors, among other variables and 
estimates. The earn-out liability is included in other noncurrent liabilities on the Consolidated Balance Sheet and is part of 
the line item captioned “Earn-out liability” in Note 11. The fair value measurement is based on significant inputs not 
observable in the market and therefore represents a Level 3 measurement as defined in ASC 820. The earn-out liability 
will be re-measured at fair value on a recurring basis and the change to the liability, if any, would be recorded in other 
income (expense) in our Consolidated Statements of Operations. See Note 16.    
We remeasured our existing ownership interest in LPC to its estimated fair value at the Acquisition Date in 
accordance with ASC 805-10-25, for a business combination achieved in stages (because we previously had an ownership 
interest in LPC). As a result of such remeasurement, we recognized a pre-tax gain of approximately $64.5 million in the 
third quarter of 2024, representing the difference between the $178.2 million estimated fair value of our existing ownership 
interest in LPC at the Acquisition Date and its aggregate $113.7 million carrying value at the Acquisition Date. Such 
pre-tax gain is disclosed as gain on remeasurement of investment in TiO2 manufacturing joint venture and is included in 
other income (expense) in our Consolidated Statement of Operations. 

 
F-20 
The following table summarizes the aggregate fair value of the consideration transferred to gain control of LPC, 
the current estimate for the fair value of our existing ownership interest in LPC, and the amounts assigned to the identifiable 
assets acquired and liabilities assumed at the Acquisition Date. The estimated purchase price allocation is based upon 
management’s estimate of the fair value of the acquired assets and assumed liabilities using independent third-party 
appraiser valuation techniques including income, cost and market approaches. The total consideration was allocated to the 
assets acquired and liabilities assumed, with the excess of the consideration over the estimated fair value of the net assets 
acquired recorded as goodwill. Subject to final determination, which is expected to occur within 12 months of the 
Acquisition Date, the provisional fair values of the assets acquired and liabilities assumed in the acquisition are as follows: 
 
 
 
 
 
 
 
Amount 
 
     
(In millions) 
Consideration: 
 
  
Cash consideration 
 
$ 
 185.0 
Working capital adjustment 
 
 (11.0)
Earn-out liability 
 
 4.2 
Total fair value of consideration 
 
 
 178.2 
 
 
  
Fair value of investment in TiO2 manufacturing  
   joint venture 
 
 178.2 
Total 
 
$ 
 356.4 
 
 
  
Allocation of purchase price to identifiable  
    assets acquired and liabilities assumed: 
 
  
Cash and cash equivalents 
 
$ 
 21.3 
Restricted cash 
 
 1.3 
Accounts and other receivables, net 
 
 .2 
Inventories, net 
 
 82.0 
Prepaid expenses and other 
 
 .6 
Other assets 
 
 10.7 
Property and equipment 
 
 268.5 
Accounts payable and accrued liabilities 
 
 (21.7)
Other noncurrent liabilities 
 
 (6.4)
Deferred tax liability 
 
 (2.7)
Total net identifiable assets acquired 
 353.8 
Goodwill 
 
 2.6 
Total 
 
$ 
 356.4 
 
Property and equipment will be depreciated over useful lives of 5 years to 20 years. Goodwill is related to the 
benefits expected as a result of the acquisition, and of the $2.6 million recorded as goodwill, $.1 million is expected to be 
deductible for tax purposes. 
 
 
 

 
F-21 
Prior to the Acquisition Date, we and Venator were both required to purchase one-half of the TiO2 produced by 
LPC, unless we and Venator agreed otherwise. Because we operated LPC on a break-even basis, we reported no equity in 
earnings of LPC. Each owner’s acquisition transfer price for its share of the TiO2 produced was equal to its share of the 
joint venture’s production costs and interest expense, if any. Our share of net cost was reported as cost of sales as the 
related TiO2 acquired from LPC was sold. We reported distributions we received from LPC, which generally related to 
excess cash generated by LPC from its non-cash production costs, and contributions we made to LPC, which generally 
related to cash required by LPC when it built working capital, as part of our cash flows from operating activities in our 
Consolidated Statements of Cash Flows. The components of our net cash distributions from (contributions to) LPC are 
shown in the table below. 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     2024(1) 
 
 
(In millions) 
Distributions from LPC 
 
$ 
 58.3  
$ 
 52.8  
$ 
 31.2 
Contributions to LPC 
 
  
 (68.8) 
  
 (49.7) 
  
 (33.9)
Net distributions (contributions) 
 
$ 
 (10.5) 
$ 
 3.1  
$ 
 (2.7)
 
(1) Reflects distributions and contributions from/to LPC prior to the Acquisition Date. 
The summary balance sheet for LPC for the annual period prior to the Acquisition Date is shown below: 
 
 
 
 
 
    December 31, 2023
 
 
(In millions) 
ASSETS 
  
  
Current assets 
 $ 
 118.5 
Property and equipment, net 
   
 148.4 
Total assets 
 $ 
 266.9 
 
   
LIABILITIES AND PARTNERS’ EQUITY 
   
  
Other liabilities, primarily current 
 $ 
 42.1 
Partners’ equity 
   
 224.8 
Total liabilities and partners’ equity 
 $ 
 266.9 
 
Summary income statements for LPC for the annual periods prior to the Acquisition Date are shown below: 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
 
 
(In millions) 
Revenues and other income: 
 
 
 
 
Kronos 
 
$ 
 225.6  
$ 
 231.7 
Venator 
 
  
 225.9  
  
 231.7 
Total revenues and other income 
 
  
 451.5  
  
 463.4 
 
 
  
 
  
Cost and expenses: 
 
  
   
  
  
Cost of sales 
 
  
 451.1  
  
 463.0 
General and administrative 
 
  
 .4  
  
 .4 
Total costs and expenses 
 
  
 451.5  
  
 463.4 
Net income 
 
$ 
 -  
$ 
 - 
 
Prior to the acquisition, we had certain related party transactions with LPC, as more fully described in Note 14. 
 
 

 
F-22 
The pro forma impact of combining LPC’s results of operations assuming the LPC transaction had occurred as 
of January 1, 2023 would result in no net increase to earnings. The additional interest expense and depreciation expense 
that would have occurred during the comparable period is not material. The pro forma impact is not necessarily indicative 
of either future results of operations or results of operations that might have been achieved had the acquisition occurred as 
of January 1, 2023. The incremental finished goods offtake produced resulting from our additional 50% interest acquired 
in LPC has not materially impacted our revenue and earnings from Acquisition Date through the end of the year. 
 
Note 6 – Marketable securities: 
Our marketable securities consist of an investment in the publicly-traded shares of Valhi, a related party. All of 
our marketable securities are accounted for as available-for-sale securities, which are carried at fair value using quoted 
market prices in active markets for each marketable security and represent a Level 1 input within the fair value hierarchy. 
Unrealized gains or losses on equity securities are recognized in other income (expense) - marketable equity securities on 
our Consolidated Statements of Operations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Fair value       
 
      
 
      
 
 
 measurement  
Market 
 
Cost 
 Unrealized 
Marketable security 
     
level 
     
value 
     
basis 
     gain (loss) 
 
 
 
  
(In millions) 
December 31, 2023: 
     
   
     
     
  
Valhi common stock 
  
1 
 
$ 
 2.2  
$ 
 3.2  
$ 
 (1.0)
 
 
 
 
  
 
  
 
  
December 31, 2024: 
 
 
 
  
   
  
   
  
  
Valhi common stock 
  
1 
 
$ 
 3.4  
$ 
 3.2  
$ 
 .2 
At December 31, 2023 and 2024, we held approximately 144,000 shares of Valhi’s common stock. The per share 
quoted market price of Valhi’s common stock was $15.19 and $23.39 at December 31, 2023 and 2024, respectively. 
The Valhi common stock we own is subject to the restrictions on resale pursuant to certain provisions of the 
Securities and Exchange Commission (“SEC”) Rule 144. In addition, as a majority-owned subsidiary of Valhi we cannot 
vote our shares of Valhi common stock under Delaware General Corporation Law, but we do receive dividends from Valhi 
on these shares, when declared and paid. 
 
Note 7 – Leases: 
We enter into various operating leases for manufacturing facilities, land and equipment. Our operating leases are 
included in operating lease right-of-use assets, current operating lease liabilities and noncurrent operating lease liabilities 
on our Consolidated Balance Sheets. See Note 9. Our principal German operating subsidiary leases the land under its 
Leverkusen TiO2 production facility pursuant to a lease that expires in 2050. The Leverkusen facility itself, which we own 
and which represents approximately 29% of our current TiO2 production capacity, is located within an extensive 
manufacturing complex. 
During 2022, 2023 and 2024, our operating lease expense approximated $5.5 million, $5.6 million and 
$5.2 million, respectively (which approximates the amount of cash paid during each year for our operating leases included 
in the determination of our cash flows from operating activities). During 2022, 2023 and 2024, variable lease expense and 
short-term lease expense were not material. During 2022, 2023 and 2024, we entered into new operating leases which 
resulted in the recognition of $6.6 million, $4.6 million and $2.8 million, respectively, in right-of-use operating lease assets 
and corresponding liabilities on our Consolidated Balance Sheets. At December 31, 2023 and 2024, the weighted average 
remaining lease term of our operating leases was approximately 14 years and the weighted average discount rate associated 
with such leases was approximately 5.0% in 2023 and approximately 6.0% in 2024. Such average remaining lease term is 
weighted based on each arrangement’s lease obligation, and such average discount rate is weighted based on each 
arrangement’s total remaining lease payments. 

 
F-23 
At December 31, 2024, maturities of our operating lease liabilities were as follows: 
 
 
 
 
Years ending December 31,  
     
Amount 
 
 
(In millions) 
2025 
 
$ 
 4.4 
2026 
 
  
 4.0 
2027 
 
  
 2.8 
2028 
 
  
 2.3 
2029 
 
  
 2.0 
2030 and thereafter 
 
  
 14.6 
Total remaining lease payments 
 
  
 30.1 
Less imputed interest 
 
  
 9.5 
Total lease obligations 
 
  
 20.6 
Less current obligations 
 
  
 3.5 
Long term lease obligations 
 
$ 
 17.1 
 
With respect to our land lease associated with our Leverkusen facility, we periodically establish the amount of 
rent for such land lease for periods of at least two years at a time. The lease agreement provides for no formula, index or 
other mechanism to determine changes in the rent of such land lease; rather, any change in the rent is subject solely to 
periodic negotiation. As such, we will account for any change in the rent associated with such lease as a lease modification. 
Of the $20.6 million total lease obligations at December 31, 2024, $6.8 million relates to our Leverkusen facility land 
lease. 
At December 31, 2024, we have no significant lease commitments that have not yet commenced. 
Note 8 – Long-term debt: 
 
 
 
 
 
 
 
 
 
December 31,  
 
     
2023 
     
2024 
 
 
(In millions) 
Kronos International, Inc. 9.50% Senior Secured Notes due 2029 
 $ 
 -  $ 
 365.4 
Kronos International, Inc. 3.75% Senior Secured Notes due 2025 
 
  
 440.9  
 
 78.3 
Subordinated, Unsecured Term Loan from Contran 
 
  
 -  
  
 53.7 
Revolving credit facility 
 
 
 -  
 
 10.0 
Total debt 
 
  
 440.9  
  
 507.4 
Less current maturities 
 
  
 -  
  
 78.3 
Total long-term debt 
 
$ 
 440.9  
$ 
 429.1 
9.50% Senior Secured Notes due 2029 – On February 12, 2024, for certain eligible holders of existing 3.75% 
Senior Secured Notes due September 2025 (the “Old Notes”), Kronos International, Inc. (“KII”) executed an exchange of 
€325 million principal amount of the outstanding Old Notes for newly issued €276.174 million aggregate outstanding KII 
9.50% Senior Secured Notes due March 2029 (the “New Notes” and together with the Old Notes and the Additional New 
Notes (as defined below), the “Senior Secured Notes”) plus additional cash consideration of €48.75 million ($52.6 million). 
Holders of the Old Notes received for each €1,000 principal amount of Old Notes exchanged, €850 in principal amount of 
New Notes, plus a cash payment in an amount equal to €150. Following the exchange, Old Notes totaling €75 million 
principal amount that were not exchanged continue to remain outstanding. In connection with the exchange, the indenture 
governing the Old Notes was amended to conform to the restrictive covenants in the indenture governing the New Notes 
and to make other conforming changes. KII did not receive any cash proceeds from the issuance and delivery of the New 
Notes in connection with the exchange. We also entered into a $53.7 million unsecured term loan from Contran 
Corporation (described below) in connection with the exchange.   
On July 30, 2024, KII issued an additional €75 million principal amount of 9.50% Senior Secured Notes due 2029 
(the “Additional New Notes” and together with the New Notes the “9.50% Senior Secured Notes due 2029”). The 

 
F-24 
Additional New Notes are additional notes to the existing €276.174 million aggregate principal amount of New Notes 
issued on February 12, 2024. The Additional New Notes were issued at a premium of 107.50% of their principal amount, 
plus accrued interest from February 12, 2024, resulting in net proceeds of approximately $90 million after fees and 
estimated expenses. The Additional New Notes are fungible with the New Notes, are treated as a single series with the 
New Notes and have the same terms as the New Notes, other than their date of issuance and issue price. The proceeds 
from the Additional New Notes were used to pay down borrowings under the $300 million global revolving credit facility 
(the “Global Revolver”).  
The 9.50% Senior Secured Notes due 2029: 
• 
bear interest at 9.50% per annum, payable semi-annually on March 15 and September 15 of each year, 
payments began on September 15, 2024; 
• 
have a maturity date of March 15, 2029. Prior to March 15, 2026, we may redeem some or all of the 9.50% 
Senior Secured Notes due 2029 at a price equal to 100% of the principal amount thereof, plus an applicable 
premium as of the date of the redemption as described in the indenture governing our 9.50% Senior Secured 
Notes due 2029 plus accrued and unpaid interest. On or after March 15, 2026, we may redeem the 9.50% 
Senior Secured Notes due 2029 at redemption prices ranging from 104.75% of the principal amount, 
declining to 100% on or after March 15, 2028, plus accrued and unpaid interest. In addition, on or before 
March 15, 2026, we may redeem up to 40% of the 9.50% Senior Secured Notes due 2029 with the net 
proceeds of certain public or private equity offerings at 109.50% of the principal amount, plus accrued and 
unpaid interest, provided that following the redemption at least 50% of the 9.50% Senior Secured Notes due 
2029 remain outstanding. If we or our subsidiaries experience certain change of control events, as outlined 
in the indenture governing our 9.50% Senior Secured Notes due 2029, we would be required to make an offer 
to purchase the 9.50% Senior Secured Notes due 2029 at 101% of the principal amount thereof, plus accrued 
and unpaid interest. We would also be required to make an offer to purchase a specified portion of the 9.50% 
Senior Secured Notes due 2029 at par value, plus accrued and unpaid interest, in the event that we and our 
subsidiaries generate a certain amount of net proceeds from the sale of assets outside the ordinary course of 
business, and such net proceeds are not otherwise used for specified purposes within a specified time 
period as described in the indenture governing our 9.50% Senior Secured Notes due 2029; 
• 
are fully and unconditionally guaranteed, jointly and severally, on a senior secured basis by Kronos 
Worldwide, Inc. and each of our direct and indirect domestic, wholly-owned subsidiaries; 
• 
are collateralized by a first priority lien on (i) 100% of the common stock or other ownership interests of 
each existing and future direct domestic subsidiary of KII and the guarantors, and (ii) 65% of the voting 
common stock or other ownership interests and 100% of the non-voting common stock or other ownership 
interests of each non-U.S. subsidiary that is directly owned by KII or any guarantor; 
• 
contain a number of covenants and restrictions which, among other things, restrict our ability to incur or 
guarantee additional debt, incur liens, pay dividends or make other restricted payments, or merge or 
consolidate with, or sell or transfer substantially all of our assets to, another entity, and contain other 
provisions and restrictive covenants customary in lending transactions of this type (however, there are no 
ongoing financial maintenance covenants); and 
• 
contain customary default provisions, including a default under any of our other indebtedness in excess 
of $50.0 million. 
At December 31, 2024, the carrying value of the 9.50% Senior Secured Notes due 2029 (€351.174 million 
aggregate principal amount outstanding plus €5.1 million of unamortized premium) is stated net of unamortized debt 
issuance costs of $6.3 million. As a result of the note exchange, in the first quarter of 2024 we recognized a non-cash 
pre-tax interest charge of $1.5 million included in interest expense related to the write-off of the deferred financing costs 
associated with the Old Notes. As of December 31, 2024, we have capitalized $7.4 million in debt issuance costs associated 
with the 9.50% Senior Secured Notes due 2029. 

 
F-25 
3.75% Senior Secured Notes due 2025 – At December 31, 2024, the carrying value of our remaining Old 
Notes (€75 million aggregate principal amount outstanding) is $78.3 million. In connection with the issuance of the New 
Notes in February 2024, the indenture governing the Old Notes was amended to conform to the restrictive covenants in 
the indenture governing the New Notes and to make other conforming changes. 
Subordinated, Unsecured Term Loan from Contran – As part of the refinancing of a majority of our Old Notes 
discussed above, we borrowed $53.7 million (€50.0 million) from Contran through the issuance of an unsecured, 
subordinated term promissory note dated February 12, 2024 (the “Contran Term Loan”). The Contran Term Loan is 
guaranteed by certain of our domestic wholly-owned subsidiaries. Our obligations under the Contran Term Loan, and the 
obligations of the guarantors under the related guaranties, are unsecured and subordinated in right of payment to our Senior 
Secured Notes and our Global Revolver. Interest on the Contran Term Loan is payable in cash. Subsequent to the issuance 
of the Additional New Notes the Contran Term Loan was amended in August 2024 to change the interest rate from 11.5% 
(which had been determined by adding an additional spread of 2% to the final interest rate on the New Notes issued in 
February 2024) to 9.54% (determined by adding a spread of 2% to the effective interest rate of the Additional New Notes 
issued in July 2024). In each case, the spread used to determine the rate was based upon comparable debt transactions at 
the time of the issuance of the applicable notes. The Contran Term Loan matures on demand (but no earlier than 
September 2029), is not subject to any amortization payments and is prepayable at par beginning in March 2026. The 
restrictive covenants in the Contran Term Loan are substantially similar to those contained in the indenture governing our 
9.50% Senior Secured Notes due 2029. In accordance with our related party transaction policy, the audit committee of our 
board of directors, comprised of the independent directors, approved the terms and conditions of the original Contran Term 
Loan and its amendment in August 2024. 
Revolving credit facility – Effective July 17, 2024, we completed an amendment to our Global Revolver (the 
“Second Amendment”). Among other things, the Second Amendment increased the maximum borrowing amount from 
$225 million to $300 million, extended the maturity date to July 2029 and expanded the agreement to include LPC and 
LPC’s receivables and certain of its inventories in the borrowing base. See Note 5. Available borrowings are based on 
formula-determined amounts of eligible trade receivables and inventories, as defined in the agreement, less any borrowings 
outstanding and outstanding letters of credit issued under the Global Revolver. Borrowings by our Canadian, Belgian and 
German subsidiaries are limited to U.S. $35 million, €30 million and €60 million, respectively. Any amounts outstanding 
under the Global Revolver bear interest, at our option, at the applicable non-base rate (SOFR, adjusted CORRA or 
EURIBOR, depending on the currency of the borrowing) plus a margin ranging from 1.5% to 2.0%, or at the applicable 
base rate, as defined in the agreement, plus a margin ranging from .5% to 2.0%. U.S. Dollar or Canadian Dollar non-base 
rate loans, as well as euro non-base rate and euro base rate loans are subject to a 0.25% floor, plus the applicable 
margin. The Global Revolver is collateralized by, among other things, a first priority lien on the borrowers’ trade 
receivables and inventories. The facility contains a number of covenants and restrictions customary in lending transactions 
of this type which, among other things, restrict the borrowers’ ability to incur additional debt, incur liens, pay additional 
dividends or merge or consolidate with, or sell or transfer all or substantially all of their assets to another entity and, under 
certain conditions, requires the maintenance of a fixed charge coverage ratio, as defined in the agreement, of at least 1.0 to 
1.0. During 2024, we borrowed $157.8 million and repaid $147.8 million under our Global Revolver. The average interest 
rate on outstanding borrowings for 2024 was 7.21%, and at December 31, 2024, the interest rate on the outstanding 
borrowings was 6.25%. The borrowing base calculated as of December 31, 2024 was approximately $278 million.  
During 2023, we had no borrowings or repayments under our Global Revolver. 
 
 

 
F-26 
Aggregate maturities and other – Aggregate maturities of debt at December 31, 2024 are presented in the table 
below. 
 
 
 
 
Years ending December 31,  
     
Amount 
 
 
(In millions) 
2025 
 
$ 
 78.3 
2026 
 
  
 - 
2027 
 
  
 - 
2028 
 
  
 - 
2029 
 
  
 430.1 
2030 and thereafter 
 
  
 - 
Gross maturities 
 
  
 508.4 
Less net amounts representing original issue premium and debt 
issuance costs 
 
  
 1.0 
Total 
 
$ 
 507.4 
 
We are in compliance with all of our debt covenants at December 31, 2024. 
Note 9 – Accounts payable and accrued liabilities: 
 
 
 
 
 
 
 
 
 
December 31,  
 
     
2023 
     
2024 
 
 
(In millions) 
Accounts payable 
 
$ 
 218.7  
$ 
 232.4 
Accrued sales discounts and rebates 
 
  
 22.5  
  
 27.6 
Employee benefits 
 
  
 24.7  
  
 27.6 
Operating lease liabilities 
 
  
 3.9  
  
 3.5 
Other 
 
  
 54.3  
  
 67.2 
Total 
 
$ 
 324.1  
$ 
 358.3 
 
 
Note 10 – Defined contribution and defined benefit retirement plans: 
Defined contribution plans – We maintain various defined contribution pension plans with our contributions 
based on matching or other formulas. Defined contribution plan expense approximated $3.9 million in 2022, $4.1 million 
in 2023 and $4.0 million in 2024. 
Defined benefit pension plans – We participate in or maintain various defined benefit pension plans. Certain 
non-U.S. employees are covered by plans in their respective countries. Our U.S. plan, which has been maintained and 
administered by NL since prior to our spinoff from NL in 2003, was closed to new participants in 1996, and existing 
participants no longer accrue any additional benefits after that date. The benefits under all of our defined benefit pension 
plans are based upon years of service and employee compensation. Our funding policy is to contribute annually the 
minimum amount required under ERISA (or equivalent non-U.S.) regulations plus additional amounts as we deem 
appropriate. We recognize an asset or liability for the over or under funded status of each of our individual defined benefit 
pension plans on our Consolidated Balance Sheets. Changes in the funded status of these plans are recognized either in 
net income, to the extent they are reflected in periodic benefit cost, or through other comprehensive income (loss). 
As a result of the LPC acquisition in July 2024 (see Note 5), we acquired the LPC defined benefit pension plan, 
which had a net pension asset of $10.6 million on the Acquisition Date. Prior to the LPC acquisition, LPC’s defined benefit 
pension plan had been frozen for all employees with benefits based on years of service and employee compensation. 
Effective December 31, 2024, the LPC defined benefit pension plan was merged into our U.S. defined benefit pension 
plan. See Note 14. 

 
F-27 
We expect to contribute the equivalent of approximately $16 million to all of our defined benefit pension plans 
during 2025. Benefit payments to plan participants out of plan assets are expected to be the equivalent of: 
 
 
 
 
Years ending December 31,  
     
Amount 
 
 
(In millions) 
2025 
 
$ 
 27.0 
2026 
 
  
 27.6 
2027 
 
  
 29.7 
2028 
 
  
 34.5 
2029 
 
  
 33.1 
Next 5 years 
 
  
 162.4 
 
The funded status of our non-U.S. defined benefit pension plans is presented in the table below. 
 
 
 
 
 
 
 
 
 
December 31,  
 
     
2023 
     
2024 
 
 
(In millions) 
Change in projected benefit obligations ("PBO"): 
  
 
    
 
  
Benefit obligations at beginning of the year 
 
$ 
 502.8  
$ 
 563.7 
Service cost 
 
  
 6.3  
  
 6.6 
Interest cost 
 
  
 19.7  
  
 18.9 
Participant contributions 
 
  
 1.8  
  
 1.8 
Actuarial (gains) losses 
 
  
 44.7  
  
 (16.2)
Settlements 
 
  
 (3.1) 
  
 (1.9)
Change in currency exchange rates 
 
  
 14.0  
  
 (36.8)
Benefits paid 
 
  
 (22.5) 
  
 (22.8)
Benefit obligations at end of the year 
 
  
 563.7  
  
 513.3 
 
 
  
 
  
Change in plan assets: 
 
  
   
  
  
Fair value of plan assets at beginning of the year 
 
  
 383.6  
  
 422.6 
Actual return on plan assets 
 
  
 37.9  
  
 20.0 
Employer contributions 
 
  
 15.6  
  
 14.9 
Participant contributions 
 
  
 1.8  
  
 1.8 
Settlements 
 
  
 (3.1) 
  
 (1.9)
Change in currency exchange rates 
 
  
 9.3  
  
 (29.7)
Benefits paid 
 
  
 (22.5) 
  
 (22.8)
Fair value of plan assets at end of year 
 
  
 422.6  
  
 404.9 
Funded status 
 
$ 
 (141.1) 
$ 
 (108.4)
 
 
  
 
  
Amounts recognized in the balance sheet: 
 
  
   
  
  
Noncurrent pension asset 
 
$ 
 8.1  
$ 
 9.1 
Noncurrent accrued pension costs 
 
  
 (149.2) 
  
 (117.5)
Total 
 
$ 
 (141.1) 
$ 
 (108.4)
 
 
  
 
  
Amounts recognized in accumulated other comprehensive loss: 
 
  
   
  
  
Actuarial losses 
 
$ 
 106.8  
$ 
 88.8 
Prior service cost 
 
  
 .3  
  
 .3 
Total 
 
$ 
 107.1  
$ 
 89.1 
 
 
  
 
  
Accumulated benefit obligations ("ABO") 
 
$ 
 549.8  
$ 
 499.7 
The total net underfunded status of our non-U.S. defined benefit pension plans decreased from $141.1 million at 
December 31, 2023 to $108.4 million at December 31, 2024 due to the change in our PBO during 2024 exceeding the 

 
F-28 
change in plan assets during 2024. The decrease in our PBO in 2024 was primarily attributable to higher actuarial gains 
due primarily to the increase in discount rates in Germany from the end of 2023 and favorable currency fluctuations, 
primarily from the strengthening of the U.S. dollar relative to the euro. The decrease in our plan assets in 2024 was 
primarily attributable to unfavorable currency fluctuations (primarily from the strengthening of the U.S. dollar relative to 
the euro) offsetting positive plan asset returns and employer contributions in 2024. 
The components of our net periodic defined benefit pension cost for our non-U.S. defined benefit pension plans 
are presented in the table below. The amounts shown below for the amortization of prior service cost and recognized 
actuarial losses for 2022, 2023 and 2024 were recognized as components of our accumulated other comprehensive loss at 
December 31, 2021, 2022 and 2023, respectively, net of deferred income taxes. 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
 
 
(In millions) 
Net periodic pension cost (income): 
 
 
     
     
  
Service cost 
 
$ 
 11.3  
$ 
 6.3  
$ 
 6.6 
Interest cost 
 
  
 10.5  
  
 19.7  
  
 18.9 
Expected return on plan assets 
 
  
 (11.0) 
  
 (18.2) 
  
 (19.9)
Amortization of prior service cost 
 
 
 .1  
 
 .1  
 
 .1 
Recognized actuarial losses 
 
  
 12.5  
  
 1.8  
  
 1.9 
Settlements 
 
 
 .3  
 
 1.6  
 
 .4 
Total 
 
$ 
 23.7  
$ 
 11.3  
$ 
 8.0 
 
Information concerning certain of our non-U.S. defined benefit pension plans (for which the ABO exceeds the 
fair value of plan assets as of the indicated date) is presented in the table below.  
 
 
 
 
 
 
 
 
 
December 31,  
 
     
2023 
     
2024 
 
 
(In millions) 
Plans for which the ABO exceeds plan assets: 
   
    
 
  
PBO 
 
$ 
 463.1  
$ 
 397.1 
ABO 
 
  
 452.9  
  
 387.1 
Fair value of plan assets 
 
  
 313.8  
  
 279.5 
 
The weighted-average rate assumptions used in determining the actuarial present value of benefit obligations for 
our non-U.S. defined benefit pension plans as of December 31, 2023 and 2024 are presented in the table below. 
 
 
 
 
 
 
 
December 31,  
Rate 
     
2023 
    
2024 
Discount rate 
  
3.4%  
3.6% 
Increase in future compensation levels 
  
2.7%  
2.8% 
 
The weighted-average rate assumptions used in determining the net periodic pension cost for our non-U.S. defined 
benefit pension plans for 2022, 2023 and 2024 are presented in the table below. 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
Rate 
     
2022 
     
2023 
     
2024 
Discount rate 
  
1.5%  
3.9%  
3.4% 
Increase in future compensation levels 
  
2.6%  
2.7%  
2.7% 
Long-term return on plan assets 
  
2.5%  
4.6%  
4.9% 
 
Variances from actuarially assumed rates will result in increases or decreases in accumulated pension obligations, 
pension expense and funding requirements in future periods. 

 
F-29 
The funded status of our U.S. defined benefit pension plan, including the acquired LPC plan, is presented in the 
table below. 
 
 
 
 
 
 
 
 
 
December 31,  
 
     
2023 
     
2024 
 
 
(In millions) 
Change in PBO: 
  
 
    
 
  
Benefit obligations at beginning of the year 
 
$ 
 13.2  
$ 
 13.3 
Interest cost 
 
  
 .7  
  
 1.3 
Actuarial (gains) losses 
 
  
 .5  
  
 (1.8)
Benefits paid 
 
  
 (1.1) 
  
 (1.7)
Acquisition 
 
 
 -  
 
 27.5 
Benefit obligations at end of the year 
 
  
 13.3  
  
 38.6 
 
 
  
 
  
Change in plan assets: 
 
  
   
  
  
Fair value of plan assets at beginning of the year 
 
  
 12.0  
  
 12.5 
Actual return on plan assets 
 
  
 1.1  
  
 (.5)
Employer contributions 
 
  
 .5  
  
 .5 
Benefits paid 
 
  
 (1.1) 
  
 (1.7)
Acquisition 
 
 
 -  
 
 38.1 
Fair value of plan assets at end of year 
 
  
 12.5  
  
 48.9 
Funded status 
 
$ 
 (.8) 
$ 
 10.3 
 
 
  
 
  
Amounts recognized in the balance sheet: 
 
  
   
  
  
Noncurrent pension asset 
 
$ 
 -  
$ 
 10.3 
Noncurrent accrued pension costs 
 
  
 (.8) 
  
 - 
Total 
 
$ 
 (.8) 
$ 
 10.3 
 
 
  
 
  
Amounts recognized in accumulated other comprehensive loss – actuarial losses 
 
$ 
 8.5  
$ 
 8.6 
 
 
  
 
  
ABO 
 
$ 
 13.3  
$ 
 38.6 
 
The components of our net periodic defined benefit pension cost for our U.S. defined benefit pension plan is 
presented in the table below. The amounts shown below for recognized actuarial losses for 2022, 2023 and 2024 were 
recognized as components of our accumulated other comprehensive loss at December 31, 2021, 2022 and 2023 
respectively, net of deferred income taxes. 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
 
 
(In millions) 
Net periodic pension cost (income): 
   
     
     
  
Interest cost 
 
$ 
 .4  
$ 
 .7  
$ 
 1.3 
Expected return on plan assets 
 
  
 (.6) 
  
 (.6) 
  
 (1.8)
Recognized actuarial losses 
 
  
 .6  
  
 .6  
  
 .5 
Total 
 
$ 
 .4  
$ 
 .7  
$ 
 - 
 
The discount rate assumptions used in determining the actuarial present value of the benefit obligation for our 
U.S. defined benefit pension plan as of December 31, 2023 and 2024 were 5.0% and 5.5%, respectively. The impact of 
assumed increases in future compensation levels does not have an effect on the benefit obligation as the plan is frozen with 
regards to compensation. 
The weighted-average rate assumptions used in determining the net periodic pension cost for our U.S. defined 
benefit pension plan for 2022, 2023 and 2024 are presented in the table below. The impact of assumed increases in future 

 
F-30 
compensation levels also does not have an effect on the periodic pension cost as the plan is frozen with regards to 
compensation. 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
Rate 
     
2022 
     
2023 
     
2024 
Discount rate 
  
2.6%   
5.3%   
5.0% 
Long-term return on plan assets 
  
4.0%   
5.0%   
5.0% 
 
Variances from actuarially assumed rates will result in increases or decreases in accumulated pension obligations, 
pension expense and funding requirements in future periods. 
The amounts shown in the tables above for actuarial (gains) losses at December 31, 2023 and 2024 have not yet 
been recognized as components of our periodic defined benefit pension cost as of those dates. These amounts will be 
recognized as components of our periodic defined benefit cost in future years and are recognized, net of deferred income 
taxes, in our accumulated other comprehensive loss at December 31, 2023 and 2024. 
The table below details the changes in our consolidated other comprehensive income (loss) during 2022, 2023 
and 2024. 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
 
 
(In millions) 
Changes in plan assets and benefit obligations recognized in 
   other comprehensive income (loss): 
 
 
 
 
 
 
 
 
 
Current year: 
   
     
     
  
Net actuarial (losses) gains 
 
$ 
 135.1  
$ 
 (25.0) 
$ 
 14.9 
Amortization of unrecognized: 
 
  
   
  
   
  
  
Net actuarial losses 
 
  
 13.0  
  
 2.4  
  
 2.4 
Prior service cost 
 
  
 .1  
  
 .1  
  
 .1 
Settlement loss 
 
 
 .3  
 
 1.6  
 
 .4 
Total 
 
$ 
 148.5  
$ 
 (20.9) 
$ 
 17.8 
 
In determining the expected long-term rate of return on our U.S. and non-U.S. plan asset assumptions, we consider 
the long-term asset mix (e.g., equity vs. fixed income) for the assets for each of our plans and the expected long-term rates 
of return for such asset components. In addition, we receive third-party advice about appropriate long-term rates of return. 
Such assumed asset mixes are summarized below: 
• 
In Germany, the composition of our plan assets is established to satisfy the requirements of the German 
insurance commissioner. Our German pension plan assets represent an investment in a large collective 
investment fund established and maintained by Bayer AG in which several pension plans, including our 
German pension plans and Bayer’s pension plans, have invested. Our plan assets represent a very nominal 
portion of the total collective investment fund maintained by Bayer. These plan assets are a Level 3 in the 
fair value hierarchy because there is not an active market that approximates the value of our investment in 
the Bayer investment fund. We estimate the fair value of the Bayer plan assets based on periodic reports we 
receive from the managers of the Bayer fund and using a model we developed with assistance from our 
third-party actuary that uses estimated asset allocations and correlates such allocation to similar asset mixes 
in fund indexes quoted on an active market. We periodically evaluate the results of our valuation model 
against actual returns in the Bayer fund and adjust the model as needed. The Bayer fund periodic reports are 
subject to audit by the German pension regulator. 
• 
In Canada, we currently have a plan asset target allocation of up to 10% to equity securities and 90 - 100% 
to fixed income securities. We expect the long-term rate of return for such investments to approximate the 
applicable average equity or fixed income index. The Canadian assets are Level 1 inputs because they are 
traded in active markets. 

 
F-31 
• 
In Norway, we currently have a plan asset target allocation of 18% to equity securities, 63% to fixed income 
securities, 14% to real estate and the remainder primarily to other investments and liquid investments such 
as money markets. The expected long-term rate of return for such investments is approximately 7%, 5%, 7% 
and 8%, respectively. The majority of Norwegian plan assets are Level 1 inputs because they are traded in 
active markets; however, approximately 15% of our Norwegian plan assets are invested in real estate and 
other investments not actively traded and are therefore a Level 3 input. 
• 
In the U.S. we currently have a plan asset target allocation of 17% to equity securities, 80% to fixed income 
securities and the remainder is allocated to other strategies. The expected long-term rate of return for our 
equity securities and fixed income securities is approximately 7% and 5%, respectively (before plan 
administrative expenses). Approximately 25% of our U.S. plan assets are invested in funds that are valued at 
net asset value (“NAV”) and, in accordance with ASC 820-10, not subject to classification in the fair value 
hierarchy. As noted above, our LPC defined benefit pension plan was merged into our U.S. plan effective 
December 31, 2024. See Note 14. In preparation for merging the U.S. pension plans, pension assets held by 
the LPC defined benefit pension plan were converted to cash, resulting in an overall higher allocation to cash 
for our U.S. plan at December 31, 2024. In January 2025, our plan assets were rebalanced to align with the 
asset target allocation noted above. 
• 
We also have plan assets in Belgium. The Belgium plan assets are invested in certain individualized fixed 
income insurance contracts for the benefit of each plan participant as required by the local regulators and are 
therefore a Level 3 input.  
We regularly review our actual asset allocation for each plan and will periodically rebalance the investments in 
each plan to more accurately reflect the targeted allocation and/or maximize the overall long-term return when considered 
appropriate. 
The composition of our pension plan assets by asset category and fair value level at December 31, 2023 and 2024 
is shown in the tables below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Fair Value Measurements at December 31, 2023 
 
  
 
 
Quoted  Significant  
 
  
 
 
  
 
 
prices  
other 
 
Significant   
 
 
  
 
 
in active  observable unobservable 
Assets 
 
  
 
 
markets  
inputs  
inputs 
 measured at
 
    
Total     (Level 1)     (Level 2)      (Level 3)     
NAV 
 
  
(In millions) 
Germany 
 $  269.4  $ 
 -  $ 
 -  $ 
 269.4  $ 
 - 
Canada: 
   
     
     
     
     
  
Non local currency equities 
   
 2.7    
 2.7    
 -    
 -    
 - 
Local currency fixed income 
   
 86.2    
 86.2    
 -    
 -    
 - 
Cash and other 
   
 1.1    
 1.1    
 -    
 -    
 - 
Norway: 
   
     
     
     
     
  
Local currency equities 
   
 2.4    
 2.4    
 -    
 -    
 - 
Non local currency equities 
   
 7.2    
 7.2    
 -    
 -    
 - 
Local currency fixed income 
   
 23.9    
 4.4    
 19.5    
 -    
 - 
Non local currency fixed income 
   
 4.2    
 4.2    
 -    
 -    
 - 
Real estate 
   
 6.6    
 -    
 -    
 6.6    
 - 
Cash and other 
   
 3.0    
 2.8    
 -    
 .2    
 - 
U.S.: 
   
   
     
     
     
  
Equities 
   
 3.5    
 -    
 -    
 -    
 3.5 
Fixed income 
   
 8.4    
 -    
 -    
 -    
 8.4 
Cash and other 
   
 .6    
 .2    
 -    
 -    
 .4 
Other 
   
 15.9    
 -    
 -    
 15.9    
 - 
Total 
 $  435.1  $  111.2  $ 
 19.5  $ 
 292.1  $ 
 12.3 

 
F-32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair Value Measurements at December 31, 2024 
 
  
 
 
Quoted  Significant  
 
  
 
 
  
 
 
prices  
other 
 
Significant   
 
 
  
 
 
in active  observable unobservable 
Assets 
 
  
 
 
markets  
inputs  
inputs 
 measured at
 
    
Total     (Level 1)     (Level 2)      (Level 3)     
NAV 
 
 
(In millions) 
Germany 
 $  264.6  $ 
 -  $ 
 -  $ 
 264.6  $ 
 - 
Canada: 
   
   
     
     
     
  
Local currency equities 
   
 2.8    
 2.8    
 -    
 -    
 - 
Local currency fixed income 
   
 78.1    
 78.1    
 -    
 -    
 - 
Cash and other 
   
 .5    
 .5    
 -    
 -    
 - 
Norway: 
   
     
     
     
     
  
Local currency equities 
   
 2.0    
 2.0    
 -    
 -    
 - 
Non local currency equities 
   
 6.9    
 6.9    
 -    
 -    
 - 
Local currency fixed income 
   
 21.1    
 3.7    
 17.4    
 -    
 - 
Non local currency fixed income 
   
 4.2    
 4.2    
 -    
 -    
 - 
Real estate 
   
 6.2    
 -    
 -    
 6.2    
 - 
Cash and other 
   
 3.6    
 3.4    
 -    
 .2    
 - 
U.S.: 
   
   
     
     
     
  
Equities 
   
 2.1    
 -    
 -    
 -    
 2.1 
Fixed income 
   
 9.7    
 -    
 -    
 -    
 9.7 
Cash and other 
   
 37.1    
 36.7    
 -    
 -    
 .4 
Other 
   
 14.9    
 -    
 -    
 14.9    
 - 
Total 
 $  453.8  $  138.3  $ 
 17.4  $ 
 285.9  $ 
 12.2 
A rollforward of the change in fair value of Level 3 assets follows. 
 
 
 
 
 
 
 
 
 
December 31,  
 
     
2023 
     
2024 
 
 
(In millions) 
Fair value at beginning of year 
 
$ 
 259.0  
$ 
 292.1 
Gain on assets held at end of year 
 
  
 11.1  
  
 12.7 
Gain (loss) on assets sold during the year 
 
  
 14.4  
  
 (.7)
Assets purchased 
 
  
 1.7  
  
 1.5 
Assets sold 
 
  
 (3.5) 
  
 (2.3)
Currency exchange rate fluctuations 
 
  
 9.4  
  
 (17.4)
Fair value at end of year 
 
$ 
 292.1  
$ 
 285.9 
 
 
 
Note 11 – Other noncurrent liabilities: 
 
 
 
 
 
 
 
 
     
December 31,  
 
     
2023 
     
2024 
 
 
(In millions) 
Asset retirement obligation 
 $ 
 7.2  $ 
 14.3 
Accrued postretirement benefits 
 
 
 6.4  
 
 5.9 
Employee benefits 
 
  
 4.9  
  
 4.5 
Earn-out liability 
 
 
 -  
 
 4.3 
Other 
 
  
 3.3  
  
 2.7 
Total 
 
$ 
 21.8  
$ 
 31.7 
 
 
 
 

 
F-33 
See Note 16 to our Consolidated Financial Statements for additional details related to the LPC acquisition 
earn-out liability. 
 
 
 
Note 12 – Income taxes: 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
    
2022 
     
2023 
     
2024 
 
 
(In millions) 
Pre-tax income (loss): 
   
     
     
  
U.S. 
 $ 
 44.1  
$ 
 (1.5) 
$ 
 72.6 
Non-U.S. 
   
 89.8  
  
 (71.4) 
  
 77.0 
Total 
 $ 
 133.9  
$ 
 (72.9) 
$ 
 149.6 
 
   
 
  
 
  
Expected tax expense (benefit), at U.S. federal statutory 
   income tax rate of 21% 
 $ 
 28.1  
$ 
 (15.3) 
$ 
 31.4 
Non-U.S. tax rates 
   
 2.1  
  
 (6.3) 
  
 .2 
Incremental net tax expense (benefit) on earnings and losses of U.S. 
   and non-U.S. companies 
   
 (.5) 
  
 (4.7) 
  
 9.3 
Valuation allowance, net 
   
 (3.6) 
  
 2.6  
  
 13.8 
Global intangible low-tax income, net 
   
 2.1  
  
 (.3) 
  
 3.2 
Nondeductible expenses 
   
 .9  
  
 1.0  
  
 3.1 
U.S. state income taxes, net 
   
 1.2  
  
 .2  
  
 1.8 
Other 
   
 (.9) 
  
 (1.0) 
  
 .6 
Income tax expense (benefit) 
 $ 
 29.4  
$ 
 (23.8) 
$ 
 63.4 
 
   
 
  
 
  
Components of income tax expense (benefit): 
   
   
  
   
  
  
Current payable: 
   
   
  
   
  
  
U.S. federal and state 
 $ 
 10.7  
$ 
 2.0  
$ 
 7.0 
Non-U.S. 
   
 20.1  
  
 13.5  
  
 25.2 
 
   
 30.8  
  
 15.5  
  
 32.2 
 
   
 
  
 
  
Deferred income taxes (benefit): 
   
   
  
   
  
  
U.S. federal and state 
   
 (3.0) 
  
 (3.7) 
  
 28.4 
Non-U.S. 
   
 1.6  
  
 (35.6) 
  
 2.8 
 
   
 (1.4) 
  
 (39.3) 
  
 31.2 
Income tax expense (benefit) 
 $ 
 29.4  
$ 
 (23.8) 
$ 
 63.4 
 
   
 
  
 
  
Comprehensive provision for income taxes (benefit) allocable to: 
   
   
  
   
  
  
Net income (loss) 
 $ 
 29.4  
$ 
 (23.8) 
$ 
 63.4 
Other comprehensive income (loss): 
   
   
  
   
  
  
Pension plans 
  
 49.3  
 
 (6.7) 
 
 5.6 
OPEB plans 
  
 .4  
 
 (.2) 
 
 - 
Total 
 $ 
 79.1  
$ 
 (30.7) 
$ 
 69.0 
The amount shown in the preceding table of our income tax rate reconciliation for non-U.S. tax rates represents 
the result determined by multiplying the pre-tax earnings or losses of each of our non-U.S. subsidiaries by the difference 
between the applicable statutory income tax rate for each non-U.S. jurisdiction and the U.S. federal statutory tax rate. The 
amount shown on such table for incremental net tax benefit on earnings and losses of U.S. and non-U.S. companies 
includes, as applicable, (i) deferred income taxes (or deferred income tax benefits) associated with the current-year 
earnings of all of our non-U.S. subsidiaries and (ii) current U.S. income taxes (or current income tax benefit), including 
U.S. personal holding company tax, as applicable, attributable to current-year income (losses) of one of our non-U.S. 
subsidiaries, which subsidiary is treated as a dual resident for U.S. income tax purposes, to the extent the current-year 

 
F-34 
income (losses) of such subsidiary is subject to U.S. income tax under the U.S. dual-resident provisions of the Internal 
Revenue Code. 
The components of our net deferred income taxes at December 31, 2023 and 2024 are summarized in the 
following table. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31,  
 
 
2023 
 
2024 
 
     
Assets 
     Liabilities      
Assets 
     Liabilities 
 
 
(In millions) 
Tax effect of temporary differences related to: 
   
     
     
     
  
Inventories 
 
$ 
 1.1  
$ 
 -  
$ 
 -  
$ 
 (.3)
Property and equipment 
 
  
 -  
  
 (59.3) 
  
 -  
  
 (66.8)
Lease assets (liabilities) 
 
  
 5.7  
  
 (5.7) 
  
 5.2  
  
 (5.3)
Accrued OPEB costs 
 
  
 1.8  
  
 -  
  
 1.7  
  
 - 
Accrued pension costs 
 
  
 26.8  
  
 -  
  
 14.7  
  
 - 
Capitalized research and development costs 
 
 
 4.8  
 
 -  
 
 6.3  
 
 - 
Other accrued liabilities and deductible differences 
 
  
 12.1  
  
 -  
  
 13.7  
  
 - 
Other taxable differences 
 
  
 -  
  
 (3.5) 
  
 -  
  
 (8.9)
Unrecognized currency gain 
 
 
 -  
 
 -  
 
 -  
 
 (16.8)
Tax on unremitted earnings of non-U.S. subsidiaries 
 
  
 -  
  
 (10.8) 
  
 -  
  
 (8.8)
Tax loss and tax credit carryforwards 
 
  
 107.7  
  
 -  
  
 116.0  
  
 - 
Valuation allowance 
 
  
 (6.4) 
  
 -  
  
 (20.1) 
  
 - 
Adjusted gross deferred tax assets (liabilities) 
 
  
 153.6  
  
 (79.3) 
  
 137.5  
  
 (106.9)
Netting by tax jurisdiction 
 
  
 (70.3) 
  
 70.3  
  
 (82.4) 
  
 82.4 
Net noncurrent deferred tax asset (liability) 
 
$ 
 83.3  
$ 
 (9.0) 
$ 
 55.1  
$ 
 (24.5)
 
We periodically review our deferred tax assets (“DTA”) to determine if a valuation allowance is required.  At 
December 31, 2024, we have German corporate and trade net operating loss (“NOL”) carryforwards of $447.3 million 
(DTA of $70.8 million) and $40.1 million (DTA of $4.4 million), respectively; Belgian corporate NOL carryforwards of 
$72.0 million (DTA of $18.0 million) and Canadian corporate and provincial NOL carryforwards of $28.9 million (DTA 
of $4.3 million) and $31.1 million (DTA of $3.6 million), respectively. Prior to December 31, 2024, and using all available 
evidence, we had concluded that no deferred income tax asset valuation allowance was required to be recognized with 
respect to such carryforwards, principally because (i) such carryforwards have lengthy carryforward periods (the German 
and Belgian carryforwards may be carried forward indefinitely and the Canadian carryforwards may be carried forward 
20 years), (ii) we have utilized a portion of such carryforwards during the most recent three-year period and (iii) we 
currently expect to utilize the remainder of such carryforwards over the long term.  With regards to our Belgian DTA, 
given our Belgium unit’s operating results during the fourth quarter of 2024 and our current expectations for 2025 in that 
jurisdiction, we do not have sufficient positive evidence to overcome the significant negative evidence of having twelve 
quarters of cumulative losses. Accordingly, at December 31, 2024, we concluded that we were required to recognize a 
non-cash deferred income tax asset valuation allowance of $8.2 million under the more-likely-than-not recognition criteria 
with respect to our Belgian DTA. At December 31, 2024, we continue to conclude no valuation allowance is required to 
be recognized for our German and Canadian DTAs although prior to the complete utilization of such carryforwards, if we 
were to generate additional losses in our German or Canadian operations for an extended period of time, or if applicable 
laws were to change such that the carryforward periods were more limited, it is possible that we might conclude the benefit 
of such carryforwards would no longer meet the more-likely-than-not recognition criteria, at which point we would be 
required to recognize a valuation allowance against some or all of the then-remaining tax benefit associated with the 
carryforwards.    
The 2017 Tax Act limited our business interest expense to the sum of our business interest income and 30% of 
our adjusted taxable income as defined in the Tax Act. Any business interest expense disallowed as a deduction as a result 
of the limitation may be carried forward indefinitely. At December 31, 2023 and December 31, 2024, we have recorded 
deferred tax assets of $3.5 million and $13.3 million, respectively, for the carryforwards associated with the nondeductible 

 
F-35 
portion of our interest expense and have concluded we are required to recognize a valuation allowance for such deferred 
tax asset under the more-likely-than-not recognition criteria. During 2024 we recognized a non-cash deferred income tax 
expense of $5.7 million with respect to the valuation allowance recorded on a portion of our additional interest expense 
carryforwards not benefitted by future reversals of existing deferred tax liabilities.  
Prior to the enactment of the 2017 Tax Act, the undistributed earnings of our European subsidiaries were deemed 
to be permanently reinvested (we had not made a similar determination with respect to the undistributed earnings of our 
Canadian subsidiary). Pursuant to the one-time repatriation tax (Transition Tax) provisions of the 2017 Tax Act which 
imposed a one-time repatriation tax on post-1986 undistributed earnings, we recognized current income tax expense of 
$74.5 million and elected to pay such tax in annual installments over an eight-year period beginning in 2018. At 
December 31, 2024, the balance of our unpaid Transition Tax is $18.6 million, with the remaining payment due in 2025. 
The payment is recorded as a current payable to affiliate (income taxes payable to Valhi) on our Consolidated Balance 
Sheet at December 31, 2024.  
On December 10, 2024, the Department of the Treasury and the Internal Revenue Service  released final currency 
regulations under §987 and related rules (the “2024 Final Regulations”). The 2024 Final Regulations generally apply to 
tax years beginning after December 31, 2024, and include transition rules that require us to compute a pretransition gain 
or loss for currency translation related to the operations, assets and liabilities of our non-U.S. qualified business units. 
Pursuant to the 2024 Final Regulations, we have calculated a pretransition gain of $77.1 million and, accordingly, our 
income tax expense in 2024 includes a non-cash deferred income tax expense of $16.5 million recognized in the fourth 
quarter. 
 Tax authorities are examining certain of our U.S. and non-U.S. tax returns and may propose tax deficiencies, 
including penalties and interest. Because of the inherent uncertainties involved in settlement initiatives and court and tax 
proceedings, we cannot guarantee that these tax matters, if any, will be resolved in our favor, and therefore our potential 
exposure, if any, is also uncertain. We believe we have adequate accruals for additional taxes and related interest expense 
which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not 
have a material adverse effect on our consolidated financial position, results of operations or liquidity. 
We accrue interest and penalties on our uncertain tax positions as a component of our provision for income taxes. 
The amount of interest and penalties we accrued during 2022, 2023 and 2024 was not material. 
The following table shows the changes in the amount of our uncertain tax positions (exclusive of the effect of 
interest and penalties discussed above) during 2022, 2023 and 2024: 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
 
 
(In millions) 
Changes in unrecognized tax benefits: 
  
 
    
 
    
 
  
Unrecognized tax benefits at beginning of year 
 
$ 
 3.8  
$ 
 3.2  
$ 
 2.8 
Tax positions taken in current period 
 
  
 .7  
  
 .5  
  
 .5 
Lapse due to applicable statute of limitations 
 
  
 (1.1) 
  
 (1.0) 
  
 - 
Change in currency exchange rates 
 
  
 (.2) 
  
 .1  
  
 (.1)
Unrecognized tax benefits at end of year 
 
$ 
 3.2  
$ 
 2.8  
$ 
 3.2 
 
At December 31, 2024, all of our uncertain tax benefits are classified as a component of our noncurrent deferred 
tax asset. If our uncertain tax position at December 31, 2024 was recognized, a benefit of $3.2 million would affect our 
effective income tax rate. Excluding any potential adjustments resulting from on-going examinations by tax authorities, 
we currently estimate that our unrecognized tax benefits will not change materially during the next twelve months. 
We and Contran file income tax returns in U.S. federal and various state and local jurisdictions. We also file 
income tax returns in various non-U.S. jurisdictions, principally in Germany, Canada, Belgium and Norway. Our U.S. 
income tax returns prior to 2021 are generally considered closed to examination by applicable tax authorities. Our non-

 
F-36 
U.S. income tax returns are generally considered closed to examination for years prior to 2020 for Germany, 2021 for 
Belgium, and 2019 for Canada and Norway although certain periods may be extended if currently under examination or 
for the review of cross-border transactions. 
 
Note 13 – Stockholders’ equity: 
Long-term incentive compensation plan – Prior to 2020, our board of directors adopted a plan that provides for 
the award of stock to our board of directors, up to a maximum of 200,000 shares. We awarded 8,400 shares in 2022, 14,700 
shares in 2023 and 9,300 shares in 2024 under this plan. At December 31, 2024, 87,800 shares are available for awards. 
Stock repurchase program – Our board of directors has previously authorized the repurchase of up to 2.0 million 
shares of our common stock in open market transactions, including block purchases, or in privately-negotiated transactions 
at unspecified prices and over an unspecified period of time. We may repurchase our common stock from time to time as 
market conditions permit. The stock repurchase program does not include specific price targets or timetables and may be 
suspended at any time. Depending on market conditions, we may terminate the program prior to its completion. We use 
cash on hand or other sources of liquidity to acquire the shares. Repurchased shares are added to our treasury and 
subsequently cancelled upon approval of the board of directors. In 2022, we acquired 217,778 shares of our common stock 
in market transactions for an aggregate purchase price of $2.5 million and subsequently cancelled all such shares. In 2023, 
we acquired 313,814 shares of our common stock in market transactions for an aggregate purchase price of $2.8 million 
and subsequently cancelled all such shares. We made no treasury purchases in 2024. At December 31, 2024, 1,017,518 
shares are available for repurchase under this stock repurchase program. 

 
F-37 
Accumulated other comprehensive loss – Changes in accumulated other comprehensive loss for 2022, 2023 and 
2024 are presented in the table below. 
 
 
 
 
 
 
 
 
 
 
 
 
Years ended December 31,  
 
     
2022 
     
2023 
     
2024 
 
 
(In millions) 
Accumulated other comprehensive loss, net of tax: 
   
     
     
  
Currency translation: 
   
     
     
  
Balance at beginning of period 
 
$ 
 (240.4) 
$ 
 (269.2) 
$ 
 (265.5)
Other comprehensive income (loss) 
 
  
 (28.8) 
  
 3.7  
  
 (34.5)
Balance at end of period 
 
$ 
 (269.2) 
$ 
 (265.5) 
$ 
 (300.0)
 
 
  
 
  
 
  
Defined benefit pension plans: 
 
  
   
  
   
  
  
Balance at beginning of period 
 
$ 
 (163.3) 
$ 
 (63.1) 
$ 
 (76.0)
Other comprehensive income: 
 
  
 
 
 
 
Amortization of prior service cost and net losses 
  included in net periodic pension cost 
 
 
 9.9  
 
 2.0  
 
 1.9 
Net actuarial gain (loss) arising during year 
 
 
 90.3  
 
 (16.0) 
 
 10.0 
Plan settlement 
 
 
 -  
 
 1.1  
 
 .3 
Balance at end of period 
 
$ 
 (63.1) 
$ 
 (76.0) 
$ 
 (63.8)
 
 
  
 
  
 
  
OPEB plans: 
 
  
   
  
   
  
  
Balance at beginning of period 
 
$ 
 (.4) 
$ 
 .8  
$ 
 .4 
Other comprehensive loss - amortization  
   of prior service credit and net losses  
   included in net periodic OPEB cost 
 
  
 (.3) 
  
 (.2) 
  
 (.1)
Net actuarial gain (loss) arising during year 
 
 
 1.5  
 
 (.2) 
 
 - 
Balance at end of period 
 
$ 
 .8  
$ 
 .4  
$ 
 .3 
 
 
  
 
  
 
  
Total accumulated other comprehensive loss: 
 
  
   
  
   
  
  
Balance at beginning of period 
 
$ 
 (404.1) 
$ 
 (331.5) 
$ 
 (341.1)
Other comprehensive income (loss) 
 
  
 72.6  
  
 (9.6) 
  
 (22.4)
Balance at end of period 
 
$ 
 (331.5) 
$ 
 (341.1) 
$ 
 (363.5)
 
See Note 6 for further discussion on our marketable securities, Note 10 for amounts related to our defined benefit 
pension plans and Note 11 for our OPEB plans. 
 
Note 14 – Related party transactions: 
We may be deemed to be controlled by Ms. Simmons and the Family Trust. See Note 1. Corporations that may 
be deemed to be controlled by or affiliated with such individuals sometimes engage in (a) intercorporate transactions such 
as guarantees, management and expense sharing arrangements, shared fee arrangements, joint ventures, partnerships, 
loans, options, advances of funds on open account, and sales, leases and exchanges of assets, including securities issued 
by both related and unrelated parties and (b) common investment and acquisition strategies, business combinations, 
reorganizations, recapitalizations, securities repurchases, and purchases and sales (and other acquisitions and dispositions) 
of subsidiaries, divisions or other business units, which transactions have involved both related and unrelated parties and 
have included transactions which resulted in the acquisition by one related party of a publicly-held noncontrolling interest 
in another related party. While no transactions of the type described above are planned or proposed with respect to us other 
than as set forth in these financial statements, we continuously consider, review and evaluate, and understand that Contran 
and related entities consider, review and evaluate such transactions. Depending upon the business, tax and other objectives 
then relevant, it is possible that we might be a party to one or more such transactions in the future. 

 
F-38 
Receivables from and payables to affiliates are summarized in the table below. 
 
 
 
 
 
 
 
 
 
December 31,  
 
     
2023 
     
2024 
 
 
(In millions) 
Current receivables from affiliates: 
   
    
 
  
LPC 
 
$ 
 16.9  
$ 
 - 
Other 
 
  
 .4  
  
 .6 
 
 
$ 
 17.3  
$ 
 .6 
 
 
  
 
  
Current payables to affiliates: 
 
  
   
  
  
LPC 
 
$ 
 19.9  
$ 
 - 
Income taxes payable to Valhi (See Note 12) 
 
  
 10.8  
  
 17.9 
Other 
 
 
 .6  
 
 .1 
 
 
$ 
 31.3  
$ 
 18.0 
 
 
  
 
  
Noncurrent payable to affiliate - 
 
  
   
  
  
Income taxes payable to Valhi (See Note 12) 
 
$ 
 18.6  
$ 
 - 
 
Amounts payable to LPC were generally for the purchase of TiO2, while amounts receivable from LPC were 
generally from the sale of TiO2 feedstock. Purchases of TiO2 from LPC totaled $225.6 million in 2022 and $231.7 million 
in 2023. Sales of feedstock to LPC totaled $106.9 million in 2022 and $135.1 million in 2023. See Note 5 for the details 
on the LPC acquisition.  
From time to time, we may have loans and advances outstanding between us and various related parties pursuant 
to term and demand notes. We generally enter into these loans and advances for cash management purposes. When we 
loan funds to related parties, we are generally able to earn a higher rate of return on the loan than we would earn if we 
invested the funds in other instruments, and when we borrow from related parties, we are generally able to pay a lower 
rate of interest than we would pay if we had incurred third-party indebtedness. While certain of these loans to affiliates 
may be of a lesser credit quality than cash equivalent instruments otherwise available to us, we believe we have considered 
the credit risks in the terms of the applicable loans. 
In this regard: 
• 
prior to 2022 we entered into an unsecured revolving demand promissory note with Valhi under which as 
amended, we agreed to loan Valhi up to $25 million. Our loan to Valhi bore interest at prime plus 1.00%, 
payable quarterly, with all principal due on demand, but in any event no earlier than December 31, 2024. 
Loans made to Valhi at any time were at our discretion. At December 31, 2023, we had no outstanding loans 
to Valhi under this promissory note. In February 2024, this note was cancelled by mutual agreement between 
us and Valhi. 
• 
In February 2024, we received a $53.7 million subordinated, unsecured term loan from Contran. See Note 8. 
Interest income (including unused commitment fees) on our loan to Valhi was $.2 million in 2022, $.1 million in 
2023 and nominal in 2024. Interest expense on our loan from Contran was $5.1 million in 2024. 
Under the terms of various intercorporate services agreements (“ISAs”) entered into between us and various 
related parties, including Contran, employees of one company will provide certain management, tax planning, financial 
and administrative services to the other company on a fee basis. Such fees are based upon the compensation of individual 
Contran employees providing services for us and/or estimates of the time devoted to our affairs by such persons. Because 
of the number of companies affiliated with Contran, we believe we benefit from cost savings and economies of scale 
gained by not having certain management, financial and administrative staffs duplicated at each entity, thus allowing 
certain individuals to provide services to multiple companies but only be compensated by one entity. We negotiate fees 

 
F-39 
annually and agreements renew quarterly. The net ISA fee charged to us by Contran is included in selling, general and 
administrative expense and corporate expense on our Consolidated Statements of Operations and was $24.5 million in 
2022, $22.6 million in 2023 and $23.7 million in 2024. 
Contran and certain of its subsidiaries and affiliates, including us, purchase certain of their insurance policies and 
risk management services as a group, with the costs of the jointly-owned policies and services being apportioned among 
the participating companies. Tall Pines Insurance Company (Tall Pines), a subsidiary of Valhi, underwrites certain 
insurance policies for Contran and certain of its subsidiaries and affiliates, including us. Tall Pines purchases reinsurance 
from highly rated (as determined by A. M. Best or another internationally recognized ratings agency) third-party insurance 
carriers for substantially all of the risks it underwrites. Consistent with insurance industry practices, Tall Pines receives 
commissions from the reinsurance underwriters and/or assesses fees for certain of the policies that it underwrites. During 
2022, 2023 and 2024 we and LPC paid $20.8 million, $24.8 million and $25.6 million, respectively, under the group 
insurance program, which amounts principally represent insurance premiums, including $17.3 million, $19.6 million and 
$20.3 million, respectively, for policies written by Tall Pines. Amounts paid under the group insurance program also 
include payments to insurers or reinsurers for the reimbursement of claims within our applicable deductible or retention 
ranges that such insurers and reinsurers paid to third parties on our behalf, as well as amounts for claims and risk 
management services and various other third-party fees and expenses incurred by the program. We expect these 
relationships will continue in 2025. 
With respect to certain of such jointly-owned policies, it is possible that unusually large losses incurred by one 
or more insureds during a given policy period could leave the other participating companies without adequate coverage 
under that policy for the balance of the policy period. As a result, and in the event that the available coverage under a 
particular policy would become exhausted by one or more claims, Contran and certain of its subsidiaries and affiliates, 
including us, have entered into a loss sharing agreement under which any uninsured loss arising because the available 
coverage had been exhausted by one or more claims will be shared ratably by those entities that had submitted claims 
under the relevant policy. We believe the benefits, in the form of reduced premiums and broader coverage associated with 
the group coverage for such policies, justifies the risk associated with the potential for any uninsured loss. 
Contran and certain of its subsidiaries, including us, participate in a combined information technology data 
services program that Contran provides for primary data processing and failover. The program apportions its costs among 
the participating companies. The aggregate amount we paid Contran for such services was $.3 million in 2022, and 
$.4 million in each of 2023 and 2024. Under the terms of a sublease agreement between Contran and us, we lease certain 
office space from Contran. We paid Contran $.5 million in 2022, $.6 million in 2023 and $.7 million in 2024 for such rent 
and related ancillary services. We expect these relationships with Contran will continue in 2025. 
We are a party to a tax sharing agreement with Contran and Valhi providing for the allocation of tax liabilities 
and tax payments as described in Note 1. Under applicable law, we, along with every other member of the Contran Tax 
Group, are each jointly and severally liable for the aggregate federal income tax liability of Contran and the other 
companies included in the Contran Tax Group for all periods in which we are included in the Contran Tax Group. Valhi 
has agreed, however, to indemnify us for any liability for income taxes of the Contran Tax Group in excess of our tax 
liability computed in accordance with the tax sharing agreement. 
As noted above, effective December 31, 2024, our LPC defined benefit pension plan was merged into our U.S. 
defined benefit pension plan, which is maintained and administered by NL. Under the terms of the merger, each of us and 
NL are contractually obligated to bear our respective share of the merged plan costs, including any funding obligations, 
and we and NL each continue to account for our respective portions of the merged plan as if it were a separate employee 
benefit plan. If the merged plan were to be terminated in the future, we would be entitled to all funding surplus attributable 
to our participants in the plan. In February 2025, the NL board of directors approved the termination of the merged plan, 
with an effective date of June 30, 2025. We anticipate that the completion of the merged plan termination will occur in the 
second half of 2026, following the receipt of all necessary regulatory approvals. Termination of the merged plan would 
permanently remove all plan assets, liabilities and accumulated other comprehensive income (loss) from our financial 
statements. 

 
F-40 
Note 15 – Commitments and contingencies: 
Environmental matters – Our operations are governed by various environmental laws and regulations. Certain 
of our operations are and have been engaged in the handling, manufacture or use of substances or compounds that may be 
considered toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other 
companies engaged in similar businesses, certain of our past and current operations and products have the potential to 
cause environmental or other damage. We have implemented and continue to implement various policies and programs in 
an effort to minimize these risks. Our policy is to maintain compliance with applicable environmental laws and regulations 
at all of our facilities and to strive to improve our environmental performance and overall sustainability. Periodically we 
produce our Kronos Environmental Social Governance Report, which highlights our focus on sustainability of our 
manufacturing operations, as well as our environmental, social and governance strategy. From time to time, we may be 
subject to environmental regulatory enforcement under U.S. and non-U.S. statutes, the resolution of which typically 
involves the establishment or enhancement of compliance programs. It is possible that future developments, such as stricter 
requirements of environmental laws and enforcement policies thereunder, could adversely affect our production, handling, 
use, storage, transportation, sale or disposal of such substances. We believe all our manufacturing facilities are in 
substantial compliance with applicable environmental laws. 
Litigation matters – We are involved in various environmental, contractual, product liability, patent (or 
intellectual property), employment and other claims and disputes incidental to our business. At least quarterly our 
management discusses and evaluates the status of any pending litigation to which we are a party. The factors considered 
in such evaluation include, among other things, the nature of such pending cases, the status of such pending cases, the 
advice of legal counsel and our experience in similar cases (if any). Based on such evaluation, we make a determination 
as to whether we believe (i) it is probable a loss has been incurred, and if so if the amount of such loss (or a range of loss) 
is reasonably estimable, or (ii) it is reasonably possible but not probable a loss has been incurred, and if so if the amount 
of such loss (or a range of loss) is reasonably estimable, or (iii) the probability a loss has been incurred is remote. We have 
not accrued any amounts for litigation matters because it is not reasonably possible we have incurred a loss that would be 
material to our Consolidated Financial Statements, results of operations or liquidity. 
Concentrations of credit risk – Sales of TiO2 accounted for 92% of our net sales in 2022 and 90% in both 2023 
and 2024. The remaining sales result from the sale of ilmenite ore (a raw material used in the sulfate pigment production 
process), and the manufacture and sale of iron-based water treatment chemicals and certain titanium chemical products 
(derived from co-products of the TiO2 production processes). TiO2 is generally sold to the paint, plastics and paper 
industries. Such markets are generally considered “quality-of-life” markets whose demand for TiO2 is influenced by the 
relative economic well-being of the various geographic regions. We sell TiO2 to approximately 3,000 customers, with the 
top ten customers approximating 33% in 2022, 35% in 2023 and 39% in 2024 of net sales. One customer accounted for 
approximately 10% of our net sales in 2022, 12% of our net sales in 2023 and 10% in 2024.  
The table below shows the approximate percentage of our TiO2 sales by volume for our significant markets, 
Europe and North America, for the last three years. 
 
 
 
 
 
 
 
 
     
2022 
 
2023 
 
2024 
Europe 
  
45%  
44%  
44% 
North America 
  
39%  
41%  
40% 
 
Long-term contracts – We have long-term supply contracts that provide for certain of our TiO2 feedstock 
requirements through 2026. The agreements require us to purchase certain minimum quantities of feedstock with minimum 
purchase commitments aggregating approximately $542 million over the life of the contracts in years subsequent to 
December 31, 2024 (including approximately $484 million committed to be purchased in 2025). In addition, we have other 
long-term supply and service contracts that provide for various raw materials and services. These agreements require us 
to purchase certain minimum quantities or services with minimum purchase commitments aggregating approximately 
$67 million at December 31, 2024 (including approximately $40 million committed to be purchased in 2025). 
 

 
F-41 
Note 16 – Financial instruments: 
See Note 6 for information on how we determine fair value of our marketable securities. 
See Note 5 for information on how we determine fair value of our acquisition earn-out liability. The fair value 
measurement is based on significant inputs not observable in the market and therefore represents a Level 3 measurement 
as defined in ASC 820. Accretion of the earn-out liability was not material in 2024. There has been no other activity 
subsequent to Acquisition Date impacting the fair value of the acquisition earn-out liability. The fair value of the 
acquisition earn-out liability is included in other noncurrent liabilities on the Consolidated Balance Sheet.   
The following table presents the financial instruments that are not carried at fair value but which require fair value 
disclosure as of December 31, 2023 and 2024. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2023      December 31, 2024 
 
 Carrying  
Fair 
 
Carrying  
Fair 
 
     amount     
value      amount     
value 
 
 
(In millions) 
Cash, cash equivalents and restricted cash 
 
$  202.1  $  202.1  
$  114.7  $  114.7 
Long-term debt: 
 
  
  
 
   
    
Fixed rate 9.50% Senior Secured Notes due 2029 
 
 
 -   
 -  
 
 365.4   
 403.4 
Fixed rate 3.75% Senior Secured Notes due 2025 
 
 
 440.9   
 424.5  
 
 78.3   
 77.9 
Revolving credit facility 
 
 
 -   
 -  
 
 10.0   
 10.0 
 
At December 31, 2024, the estimated market price of our 3.75% Senior Secured Notes due 2025 was €996 per 
€1,000 principal amount and the estimated market price for our 9.50% Senior Secured Notes due 2029 was €1101 per 
€1,000 principal amount. The fair value of our 3.75% Senior Secured Notes due 2025 and 9.50% Senior Secured Notes 
due 2029 were based on quoted market prices; however, these quoted market prices represented Level 2 inputs because 
the markets in which the 3.75% Senior Secured Notes due 2025 and 9.50% Senior Secured Notes due 2029 trade were not 
active. Due to the variable interest rate, the carrying amount of our revolving credit facility is deemed to approximate fair 
value. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered 
equivalent to fair value. In addition, at December 31, 2024, we have a $53.7 million subordinated, unsecured term loan 
payable to a related party, Contran, due September 2029. See Notes 3, 9 and 14. 
 
Note 17 – Other operating income (expense), net: 
On August 24, 2020, LPC temporarily halted production due to Hurricane Laura. Although storm damage to core 
processing facilities was not extensive, a variety of factors, including loss of utilities and limited access and availability of 
employees and raw materials, prevented the resumption of operations until September 25, 2020. The majority of our losses 
from property damage and our share of LPC’s lost production and other costs resulting from the disruption of operations, 
were covered by insurance. We recognized aggregate gains of $2.7 million and $2.5 million in 2022 and 2023, respectively, 
related to our business interruption claim, which are included in other operating income (expense) – other income, net on 
our Consolidated Statements of Operations. 
 
Note 18 – Restructuring costs: 
In response to the extended period of reduced demand in 2023, we took measures to reduce our operating costs 
and improve our long-term cost structure such as the implementation of certain voluntary and involuntary workforce 
reductions during the third quarter of 2023 that primarily impacted our European operations. A substantial portion of our 
workforce reductions were accomplished through voluntary programs, for which eligible workforce reduction costs are 
recognized at the time both the employee and employer are irrevocably committed to the terms of the separation. These 
workforce reductions impacted approximately 100 employees. We recognized a total of approximately $6 million in 
charges primarily in the fourth quarter of 2023 related to workforce reductions we implemented during the second half of 
2023. 

 
F-42 
In the third quarter of 2024, we closed our sulfate process line at our facility in Varennes, Canada. As a result of 
the sulfate process line closure, we recognized charges to cost of sales in 2024 of approximately $2 million related to 
workforce reductions for employees impacted and approximately $14 million in non-cash charges primarily related to 
accelerated depreciation. 
A summary of the activity in our accrued restructuring costs for 2023 and 2024 is shown in the table below: 
 
 
 
 
 
 
 
 
 
Years ended December 31, 
 
     
2023 
    
2024 
 
  
(in millions) 
Changes in accrued workforce reduction costs: 
   
   
Balances at beginning of the year 
 $ 
 -  $ 
 5.0 
Workforce reduction costs accrued 
  
 5.8   
 2.0 
Workforce reduction costs paid 
  
 (.9)  
 (6.0)
Currency translation adjustments, net 
  
 .1   
 (.1)
Balance at the end of the year 
 $ 
 5.0  
$ 
 .9 
 
   
   
Amounts recognized in the balance sheet: 
   
   
Current liability 
 $ 
 5.0  $ 
 .9 
Noncurrent liability 
  
 -   
 - 
 
 $ 
 5.0  
$ 
 .9 
 
 
Note 19 – Recent accounting pronouncements: 
Adopted 
In November 2023, the Financial Accounting Standards Board (FASB) issued ASU 2023-07, Segment Reporting 
(Topic 280): Improvements to Reportable Segment Disclosures. The ASU requires public companies to disclose significant 
segment expenses and other segment items on an annual and interim basis. The ASU also mandates public companies to 
provide all annual segment disclosures currently required annually in interim periods. Public entities with a single 
reportable segment are required to provide the new disclosures and all disclosures required under ASC 280. Public 
companies are required to disclose the title and position of the CODM and explain how the CODM uses the reported 
measure of segment profit or loss in assessing segment performance and allocation resources. See Note 2.   
Pending Adoption 
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax 
Disclosures. The ASU requires additional annual disclosure and disaggregation for the rate reconciliation, income taxes 
paid and income tax expense by federal, state and non-U.S. tax jurisdictions. In addition, the standard increases the 
disclosure requirements for items included in the rate reconciliation that meet a quantitative threshold. The ASU is 
effective for us beginning with our 2025 Annual Report. The ASU may be applied prospectively; however, entities have 
the option to apply it retrospectively. We are in the process of evaluating the additional disclosure requirements. 
 
In November 2024, the FASB issued ASU No. 2024-03, Reporting Comprehensive Income - Expense 
Disaggregation Disclosures. The ASU requires additional information about specific expense categories in the notes to 
financial statements for both interim and annual reporting periods. The ASU is effective for us beginning with our 2027 
Annual Report, and for interim reporting, in the first quarter of 2028, with early adoption permitted. We are in the process 
of evaluating the additional disclosure requirements. 

EXHIBIT 21.1 
SUBSIDIARIES OF THE REGISTRANT 
 
 
 
 
 
 
 
 
NAME OF CORPORATION 
     
Jurisdiction of 
incorporation 
or organization 
   
  
% of voting 
securities held at 
December 31, 2024(a)  
Kronos Canada, Inc. 
 
Canada 
 
100   
Kronos International, Inc. 
 
Delaware 
 
100   
Kronos Titan GmbH 
 
Germany 
 
100   
Société Industrielle du Titane, S.A. 
 
France 
 
99 
Kronos Limited 
 
United Kingdom  
100   
Kronos Denmark ApS 
 
Denmark 
 
100   
Kronos Europe S.A./N.V. 
 
Belgium 
 
100   
Kronos Norge A/S 
 
Norway 
 
100   
Kronos Titan A/S 
 
Norway 
 
100   
Titania A/S 
 
Norway 
 
100   
Elkania DA 
 
Norway 
 
50   
Kronos Louisiana, Inc. 
 
Delaware 
 
100 
Kronos (US), Inc. 
 
Delaware 
 
100   
Kronos LPC, LLC 
 
Delaware 
 
100 
Louisiana Pigment Company, L.P. 
 
Delaware 
 
100   
 
(a) Held by the Registrant or the indicated subsidiary of the Registrant 
 

 
 
KRONOS WORLDWIDE, INC. REPORTS FOURTH QUARTER 2024 RESULTS 
DALLAS, TEXAS…March 6, 2025…Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $13.2 
million, or $.12 per share, in the fourth quarter of 2024 compared to a net loss of $5.3 million, or $.05 per share, in 
the fourth quarter of 2023. For the full year of 2024, Kronos Worldwide reported net income of $86.2 million, or $.75 
per share, compared to a net loss of $49.1 million, or $.43 per share, for the full year of 2023. Net income decreased 
in the fourth quarter 2024 compared to the fourth quarter of 2023 primarily due to increases in the Company’s income 
tax expense resulting from (i) final tax regulations on the treatment of certain currency translation gains and losses, 
which resulted in a  non-cash deferred income tax expense of $16.5 million ($.14 per share) and (ii) the recognition 
of a deferred income tax asset valuation allowance related to the Company’s Belgian net deferred tax assets, which 
resulted in a non-cash deferred income tax expense of $8.2 million ($.07 per share). Income before income taxes 
increased $24.9 million in the fourth quarter of 2024 as compared to the fourth quarter of 2023 due to higher income 
from operations as a result of the effects of higher sales and production volumes and lower production costs (primarily 
energy and raw materials). Net income increased in the full year of 2024 compared to full year of 2023 due to higher 
income from operations as a result of the effects of higher sales and production volumes and lower production costs 
(primarily energy and raw materials), partially offset by lower average TiO2 selling prices. Comparability of our results 
was also impacted by the effects of changes in currency exchange rates. Our results of operations for the full year of 
2023 were significantly impacted by reduced demand for TiO2 in all major markets and unabsorbed fixed production 
as a result of production curtailments in response to the sharp decline in demand. Demand improved in all of our major 
markets in 2024 compared to 2023 and we increased production volumes accordingly, contributing to our improved 
profitability. As previously reported, effective July 16, 2024, we acquired the 50% joint venture interest in Louisiana 
Pigment Company, L.P. (“LPC”) previously held by Venator Investments, Ltd. Prior to the acquisition, we held a 50% 
joint venture interest in LPC. Following the acquisition, LPC became a wholly-owned subsidiary of ours. We 
accounted for the acquisition as a business combination. The results of operations of LPC have been included in our 
results of operations beginning as of the acquisition date. Net income for the full year 2024 includes the recognition 
of a non-cash gain of $64.5 million ($50.9 million, or $.44 per share, net of income tax expense) associated with the 
remeasurement of our investment in LPC as a result of the acquisition. 
Net sales of $423.1 million in the fourth quarter of 2024 were $23.0 million, or 6%, higher than in the fourth quarter 
of 2023. Net sales of $1.9 billion for the full year of 2024 were $220.6 million, or 13%, higher than the full year of 
2023. Net sales increased in the fourth quarter of 2024 compared to the fourth quarter of 2023 primarily due to the 
effects of higher sales volumes due to strengthening demand for TiO2 in all our major markets and higher average 
TiO2 selling prices. Net sales increased for the full year of 2024 compared to the same period in 2023 primarily due 
to the net effects of higher sales volumes and lower average TiO2 selling prices. TiO2 sales volumes were 4% higher 
in the fourth quarter of 2024 as compared to the fourth quarter of 2023 and 20% higher in the full year of 2024 as 
compared to the full year of 2023. Sales volumes resulting from the LPC acquisition did not materially impact prior 
period comparisons. Average TiO2 selling prices were 2% higher in the fourth quarter of 2024 (primarily from our 
European and export markets) as compared to the fourth quarter of 2023 but 5% lower in the full year of 2024 as 
compared to the full year of 2023. For the full year, changes in product sales mix negatively affected net sales, 
primarily due to changes in product sales mix in export markets in 2024 as compared to 2023. Changes in currency 
exchange rates had a nominal effect on net sales in the fourth quarter of 2024 as compared to the fourth quarter of 
2023; however, changes in currency exchange rates (primarily the euro) increased our net sales by approximately $5 
million in the full year of 2024 as compared to the full year of 2023. The table at the end of this press release shows 
how each of these items impacted net sales.  

2 of 6 
 
Our TiO2 segment profit (see description of non-GAAP information below) in the fourth quarter of 2024 was $33.1 
million as compared to a segment loss of $1.3 million in the fourth quarter of 2023. For the full year of 2024, our 
segment profit was $141.0 million as compared to a segment loss of $39.8 million in the full year of 2023. Segment 
profit increased in the fourth quarter of 2024 compared to the fourth quarter of 2023 primarily due to higher income 
from operations due to an increase in sales and production volumes, lower production costs (primarily energy and raw 
materials) and higher average TiO2 selling prices. Segment profit increased for the full year of 2024 compared to the 
same period in 2023 primarily due to higher income from operations due to the net effects of an increase in sales and 
production volumes, lower production costs (primarily energy and raw materials) and lower average TiO2 selling 
prices. Due to improved overall demand and a more favorable production cost environment, we increased our 
production rates to 96% of practical capacity utilization in the full year of 2024 (87%, 99%, 92% and 97% in the first, 
second, third and fourth quarters of 2024, respectively) compared to 72% in the full year of 2023 (76%, 64%, 73% 
and 75% in the first, second, third and fourth quarters of 2023, respectively). As a result, our unabsorbed fixed 
production costs in the full year of 2024 were $12 million (incurred in the first quarter) compared to $96 million in 
the full year of 2023. Sales and production volumes resulting from the LPC acquisition did not materially impact 
comparisons to the prior periods. During the third quarter of 2024, we completed the closure of our sulfate process 
line in Canada and our segment profit for the full year of 2024 includes non-cash charges of approximately $14 million 
related to accelerated depreciation and a charge of approximately $2 million related to workforce reductions. Our 
selling, general and administrative expense for the full year of 2024 includes $2.2 million of transaction costs incurred 
in connection with the LPC acquisition. Fluctuations in currency exchange rates (primarily the euro) increased our 
segment profit by approximately $10 million in the full year of 2024 as compared to 2023. Fluctuations in currency 
exchange rates had a nominal effect on segment profit in the fourth quarter of 2024 as compared to the fourth quarter 
of 2023. 
Our net income (loss) before interest expense, income taxes and depreciation and amortization expense (EBITDA) 
(see description of non-GAAP information below) in the fourth quarter of 2024 was $41.7 million compared to 
EBITDA of $6.9 million in the fourth quarter of 2023. For the full year of 2024, our EBITDA was $252.9 million 
compared to EBITDA of ($7.2) million in the full year of 2023. EBITDA comparisons for the full year of 2024 were 
impacted by the $64.5 million non-cash gain associated with the remeasurement of our investment in LPC discussed 
above. 
Interest expense for the full year of 2024 includes a charge of $1.5 million ($1.1 million, or $.01 per share, net of 
income tax benefit) for the write-off of deferred financing costs.  
 
Our loss from operations in the full year of 2023 includes an insurance settlement gain related to a 2020 business 
interruption insurance claim of $2.5 million ($2.0 million, or $.02 per share, net of income tax expense), a fixed asset 
impairment related to the write-off of certain costs resulting from a capital project termination of $3.8 million ($2.8 
million, or $.02 per share, net of income tax expense) and restructuring costs related to workforce reductions of $5.8 
million ($4.3 million, or $.04 per share, net of income tax expense). Other components of net periodic pension and 
OPEB cost in 2023 includes a $1.3 million settlement loss incurred in the second quarter related to the termination 
and buy-out of our UK pension plan ($.9 million, or $.01 per share, net of income tax expense). 
 
The statements in this release relating to matters that are not historical facts are forward-looking statements that 
represent management's beliefs and assumptions based on currently available information. Although we believe that 
the expectations reflected in such forward-looking statements are reasonable, we cannot give any assurances that these 
expectations will prove to be correct. Such statements by their nature involve substantial risks and uncertainties that 
could significantly impact expected results, and actual future results could differ materially from those described in 
such forward-looking statements. While it is not possible to identify all factors, we continue to face many risks and 
uncertainties. The factors that could cause actual future results to differ materially include, but are not limited to, the 
following: 
 
• 
Future supply and demand for our products; 
• 
Our ability to realize expected cost savings from strategic and operational initiatives; 
• 
Our ability to integrate acquisitions, including LPC, into our operations and realize expected synergies and 
innovations; 
• 
The extent of the dependence of certain of our businesses on certain market sectors; 

3 of 6 
 
• 
The cyclicality of our business; 
• 
Customer and producer inventory levels; 
• 
Unexpected or earlier-than-expected industry capacity expansion; 
• 
Changes in raw material and other operating costs (such as energy and ore costs); 
• 
Changes in the availability of raw materials (such as ore); 
• 
General global economic and political conditions that harm the worldwide economy, disrupt our supply 
chain, increase material and energy costs or reduce demand or perceived demand for our TiO2 products or 
impair our ability to operate our facilities (including changes in the level of gross domestic product in various 
regions of the world, tariffs, natural disasters, terrorist acts, global conflicts and public health crises); 
• 
Operating interruptions (including, but not limited to, labor disputes, leaks, natural disasters, fires, 
explosions, unscheduled or unplanned downtime, transportation interruptions, certain regional and world 
events or economic conditions and public health crises); 
• 
Technology related disruptions (including, but not limited to, cyber-attacks; software implementation, 
upgrades or improvements; technology processing failures; or other events) related to our technology 
infrastructure that could impact our ability to continue operations, or at key vendors which could impact our 
supply chain, or at key customers which could impact their operations and cause them to curtail or pause 
orders; 
• 
Competitive products and substitute products; 
• 
Competition from Chinese suppliers with less stringent regulatory and environmental compliance 
requirements; 
• 
Customer and competitor strategies; 
• 
Potential consolidation of our competitors; 
• 
Potential consolidation of our customers; 
• 
The impact of pricing and production decisions; 
• 
Competitive technology positions; 
• 
Potential difficulties in upgrading or implementing accounting and manufacturing software systems; 
• 
The introduction of new, or changes in existing, tariffs, trade barriers or trade disputes (including tariffs 
imposed by the U.S. federal government on imports from Canada, where we have a manufacturing facility); 
• 
Fluctuations in currency exchange rates (such as changes in the exchange rate between the U.S. dollar and 
each of the euro, the Norwegian krone and the Canadian dollar and between the euro and the Norwegian 
krone), or possible disruptions to our business resulting from uncertainties associated with the euro or other 
currencies; 
• 
Our ability to renew or refinance credit facilities or other debt instruments in the future; 
• 
Changes in interest rates; 
• 
Our ability to comply with covenants contained in our revolving bank credit facility; 
• 
Our ability to maintain sufficient liquidity; 
• 
The ultimate outcome of income tax audits, tax settlement initiatives or other tax matters, including future 
tax reform; 
• 
Our ability to utilize income tax attributes, the benefits of which may or may not have been recognized under 
the more-likely-than-not recognition criteria; 
• 
Environmental matters (such as those requiring compliance with emission and discharge standards for 
existing and new facilities); 
• 
Government laws and regulations and possible changes therein including new environmental, health and 
safety, sustainability or other regulations (such as those seeking to limit or classify TiO2 or its use); and 
• 
Pending or possible future litigation or other actions. 

4 of 6 
 
Should one or more of these risks materialize (or the consequences of such a development worsen), or should the 
underlying assumptions prove incorrect, actual results could differ materially from those forecasted or expected. The 
Company disclaims any intention or obligation to update or revise any forward-looking statement whether as a result 
of changes in information, future events or otherwise. 
In an effort to provide investors with additional information regarding the Company's results of operations as 
determined by accounting principles generally accepted in the United States of America (GAAP), the Company has 
disclosed certain non-GAAP information which the Company believes provides useful information to investors: 
• 
The Company discloses segment profit, which is used by the Company’s management to assess the 
performance of the Company’s TiO2 operations. The Company believes disclosure of segment profit provides 
useful information to investors because it allows investors to analyze the performance of the Company’s TiO2 
operations in the same way that the Company’s management assesses performance. The Company defines 
segment profit as net income before income tax expense and certain general corporate items. These general 
corporate items include corporate expense and the components of other income (expense) except for trade 
interest income; and 
• 
The Company discloses EBITDA, which is also used by the Company’s management to assess the 
performance of the Company’s TiO2 operations. The Company believes disclosure of EBITDA provides 
useful information to investors because it allows investors to analyze the performance of the Company’s TiO2 
operations in the same way that the Company’s management assesses performance. The Company defines 
EBITDA as net income before interest expense, income taxes and depreciation and amortization expense. 
Kronos Worldwide, Inc. is a major international producer of titanium dioxide products. 
 
Investor Relations Contact: 
 
Bryan A. Hanley 
Senior Vice President & Treasurer 
Tel:  (972) 233-1700 
 

5 of 6 
 
KRONOS WORLDWIDE, INC. 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
 (In millions, except per share and metric ton data) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three months ended  
 
Year ended  
 
 
December 31,  
 
December 31,  
 
 
2023 
 
2024 
 
2023 
 
2024 
 
 
(unaudited) 
   
   
Net sales 
    $ 
 400.1     $ 
 423.1     $  1,666.5     $  1,887.1 
Cost of sales 
   
 344.5    
 336.7     1,501.6     1,527.8 
 
   
   
   
   
Gross margin 
   
 55.6    
 86.4    
 164.9    
 359.3 
 
   
   
   
   
Selling, general and administrative expense    
 54.3    
 51.2    
 211.2    
 225.6 
Other operating income (expense): 
   
     
     
     
  
Currency transactions, net 
   
 (3.2)   
 (3.3)   
 1.4    
 1.6 
Other income (expense), net 
   
 (.2)   
 .6    
 3.3    
 2.4 
Corporate expense 
   
 (3.6)   
 (3.9)   
 (14.4)   
 (14.8)
 
   
   
   
   
Income (loss) from operations 
   
 (5.7)   
 28.6    
 (56.0)   
 122.9 
 
   
   
   
   
Other income (expense): 
   
     
     
     
  
Gain on remeasurement of investment  
in TiO2 manufacturing joint venture 
  
 -   
 -   
 -   
 64.5 
Trade interest income 
   
 .8    
 .6    
 1.8    
 3.3 
Other interest and dividend income 
   
 1.1    
 .4    
 5.1    
 2.2 
Marketable equity securities 
   
 .3    
 (1.4)   
 (1.0)   
 1.2 
Other components of net periodic pension 
   and OPEB cost 
   
 (1.6)   
 (0.6)   
 (5.7)   
 (1.6)
Interest expense 
   
 (4.3)   
 (12.1)   
 (17.1)   
 (42.9)
 
   
   
   
   
Income (loss) before income taxes 
   
 (9.4)   
 15.5    
 (72.9)   
 149.6 
 
   
   
   
   
Income tax expense (benefit) 
   
 (4.1)   
 28.7    
 (23.8)   
 63.4 
 
   
   
   
   
Net income (loss) 
 $ 
 (5.3) $ 
 (13.2) $ 
 (49.1) $ 
 86.2 
 
   
   
   
   
Net income (loss) per basic and diluted share 
$ 
 (.05) $ 
 (.12) $ 
 (.43) $ 
 .75 
 
   
   
   
   
Weighted average shares used in the  
   calculation of net income per share 
   
 115.0    
 115.0    
 115.1    
 115.0 
 
   
   
   
   
TiO2 data - metric tons in thousands: 
   
     
     
     
  
Sales volumes 
   
 106    
 110    
 419    
 504 
Production volumes 
   
 105    
 136    
 401    
 535 
 
 
 

6 of 6 
 
KRONOS WORLDWIDE, INC. 
RECONCILIATION OF INCOME (LOSS) FROM 
OPERATIONS TO SEGMENT PROFIT (LOSS) 
(In millions) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three months ended    
Year ended  
 
 
December 31,  
  
December 31,  
 
 
2023 
  
2024 
  
2023 
  
2024 
 
 
(unaudited) 
  
   
 
Income (loss) from operations 
 $ 
 (5.7)  $ 
 28.6  $ 
 (56.0)  $ 
 122.9 
 
   
    
    
    
Adjustments: 
   
      
      
      
   
Trade interest income 
   
 .8     
 .6    
 1.8    
 3.3 
Corporate expense 
   
 3.6     
 3.9    
 14.4    
 14.8 
 
   
    
    
    
Segment profit (loss) 
 $ 
 (1.3)  $ 
 33.1  $ 
 (39.8)  $ 
 141.0 
 
 
RECONCILIATION OF NET INCOME (LOSS) TO EBITDA 
(In millions) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three months ended    
Year ended  
 
 
December 31,  
  
December 31,  
 
 
2023 
 
2024 
  
2023 
 
2024 
 
 
(unaudited) 
  
  
Net income (loss) 
 $ 
 (5.3) $ 
 (13.2)  $ 
 (49.1) $ 
 86.2 
 
   
   
    
   
Adjustments: 
   
     
     
     
  
Depreciation expense 
   
 12.0    
 14.1    
 48.6    
 60.4 
Interest expense 
   
 4.3    
 12.1    
 17.1    
 42.9 
Income tax expense (benefit) 
   
 (4.1)   
 28.7    
 (23.8)   
 63.4 
 
   
   
    
   
EBITDA 
 $ 
 6.9  $ 
 41.7  $ 
 (7.2) $ 
 252.9 
 
 
IMPACT OF PERCENTAGE CHANGE IN NET SALES 
(unaudited) 
 
 
 
 
 
 
 
 
    Three months ended   
Year ended    
 
 
December 31,  
  December 31,    
 
 
2024 vs. 2023 
  2024 vs. 2023   
 
 
 
  
 
Percentage change in net sales: 
  
   
    
TiO2 sales volume 
  
 4 %
 20 %
TiO2 product pricing 
  
 2   
 (5)  
TiO2 product mix/other 
  
 -  
 (2)  
Changes in currency exchange rates 
  
 -  
 -  
 
  
  
 
Total 
  
 6 %
 13 %
 
 
 


 
  
Kronos Worldwide, Inc.  
Three Lincoln Centre  
5430 LBJ Freeway, Suite 1700  
Dallas, TX 75240-2620  
(972) 233-1700